<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001754.pub4" GROUP_ID="INCONT" ID="964499090210054220" MERGED_FROM="" MODIFIED="2017-07-23 11:44:27 +0100" MODIFIED_BY="Sheila Wallace" REVIEW_NO="0001" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.1">
<COVER_SHEET MODIFIED="2017-07-23 11:44:23 +0100" MODIFIED_BY="Sheila Wallace">
<TITLE>Traditional suburethral sling operations for urinary incontinence in women</TITLE>
<CONTACT MODIFIED="2017-07-23 11:44:23 +0100" MODIFIED_BY="Sheila Wallace"><PERSON ID="90900046168935267548100707141328" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Haroon</FIRST_NAME><LAST_NAME>Rehman</LAST_NAME><POSITION>Trauma and Orthopaedic Registrar</POSITION><EMAIL_1>haroon.rehman.06@aberdeen.ac.uk</EMAIL_1><MOBILE_PHONE>+44 7907344561</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Orthopaedics</DEPARTMENT><ORGANISATION>Aberdeen Royal Infirmary, NHS Grampian</ORGANISATION><ADDRESS_1>Foresterhill</ADDRESS_1><CITY>Aberdeen</CITY><ZIP>AB25 2ZD</ZIP><REGION>Scotland</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2017-07-23 11:44:23 +0100" MODIFIED_BY="Sheila Wallace"><PERSON ID="90900046168935267548100707141328" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Haroon</FIRST_NAME><LAST_NAME>Rehman</LAST_NAME><POSITION>Trauma and Orthopaedic Registrar</POSITION><EMAIL_1>haroon.rehman.06@aberdeen.ac.uk</EMAIL_1><MOBILE_PHONE>+44 7907344561</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Orthopaedics</DEPARTMENT><ORGANISATION>Aberdeen Royal Infirmary, NHS Grampian</ORGANISATION><ADDRESS_1>Foresterhill</ADDRESS_1><CITY>Aberdeen</CITY><ZIP>AB25 2ZD</ZIP><REGION>Scotland</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="14201" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Carlos</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Bezerra</LAST_NAME><POSITION>Assistant Professor</POSITION><EMAIL_1>bezerrac@uol.com.br</EMAIL_1><EMAIL_2>bezerra694@gmail.com</EMAIL_2><ADDRESS><DEPARTMENT>Surgery, Divison of Urology</DEPARTMENT><ORGANISATION>Faculty of Medicine, Foudation ABC</ORGANISATION><ADDRESS_1>Rua Mediterrâneo, 290, sala 41</ADDRESS_1><CITY>São Bernardo do Campo</CITY><ZIP>09750-420</ZIP><REGION>São Paulo</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 11 41232700</PHONE_1><PHONE_2>+55 11 41232492</PHONE_2><FAX_1>+55 11 41217372</FAX_1></ADDRESS></PERSON><PERSON ID="14205" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Homero</FIRST_NAME><LAST_NAME>Bruschini</LAST_NAME><POSITION>Chief of Neurourology, Urodynamics and Female Urology, Professor of Urology</POSITION><EMAIL_1>bruschini@uol.com.br</EMAIL_1><ADDRESS><ORGANISATION>University of Sao Paulo</ORGANISATION><ADDRESS_1>Rua Barata Ribeiro, 414 cj 35</ADDRESS_1><CITY>São Paulo</CITY><ZIP>01308000</ZIP><REGION>São Paulo</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 11 3218 8282</PHONE_1><FAX_1>+55 11 3218 8283</FAX_1></ADDRESS></PERSON><PERSON ID="7298" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>June</FIRST_NAME><MIDDLE_INITIALS>D</MIDDLE_INITIALS><LAST_NAME>Cody</LAST_NAME><POSITION>Review Author</POSITION><EMAIL_1>djunecody@gmail.com</EMAIL_1><URL>http://incontinence.cochrane.org/</URL><ADDRESS><DEPARTMENT>c/o Cochrane Incontinence Group</DEPARTMENT><ORGANISATION>Newcastle University</ORGANISATION><ADDRESS_1>Institute of Health &amp; Society</ADDRESS_1><ADDRESS_2>Baddiley-Clarke Building, Richardson Road</ADDRESS_2><CITY>Newcastle upon Tyne</CITY><ZIP>NE2 4AX</ZIP><REGION>Tyne and Wear</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z1609221211042414731193967472946" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Patricia</FIRST_NAME><LAST_NAME>Aluko</LAST_NAME><POSITION>Researcher</POSITION><EMAIL_1>patricia.aluko@ncl.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Health and Society</DEPARTMENT><ORGANISATION>Newcastle University</ORGANISATION><ADDRESS_1>Richardson Road</ADDRESS_1><CITY>Newcastle Upon Tyne</CITY><ZIP>NE2 4AX</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2017-07-23 11:44:23 +0100" MODIFIED_BY="Sheila Wallace">
<UP_TO_DATE>
<DATE DAY="3" MONTH="6" YEAR="2010"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="3" MONTH="6" YEAR="2010"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="12" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1999"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="7" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-07-21 11:20:34 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-07-21 09:32:53 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="7" YEAR="2017"/>
<DESCRIPTION>
<P>Brief economic commentary (BEC) added. Economics-related sections revised.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-07-21 11:20:34 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="7" YEAR="2017"/>
<DESCRIPTION>
<P>Brief economic commentary (BEC) added. Economics-related sections revised: the Abstract, Plain language summary, Background, Methods (outcomes, search methods), and Discussion were amended. Appendix added with details of search strategies for BECs.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-07-13 12:56:32 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-07-13 12:56:28 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="12" YEAR="2010"/>
<DESCRIPTION>
<P>13 new studies added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-07-13 12:56:32 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="7" YEAR="2010"/>
<DESCRIPTION>
<P>This is the second update of the review of traditional slings. 13 new RCTs have been added (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Teixeira-2008" TYPE="STUDY">Teixeira 2008</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK> and two have been updated (Arunkalaivanan 2003; Lucas 2000; Kondo 2006)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-12-05 16:45:47 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2008-10-27 13:22:05 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="5" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment. The review was divided into two separate reviews: one on traditional sub-urethral sling operations (current review, updated) and another on sub-urethral self fixing sling operations (to include the new TVT and SPARC procedure) to be prepared. The trials on TVT versus other procedures other than traditional suburethral sling operations (four) were moved to the excluded trials list and will be included in the new review. Five new trials were included.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-11-10 10:21:31 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="2" YEAR="2003"/>
<DESCRIPTION>
<P>minor update, five studies added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2008-11-10 10:21:28 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="5" YEAR="2001"/>
<DESCRIPTION>
<P>first update</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2017-07-21 11:18:23 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Federal University of Sao Paulo - Sao Paulo</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Faculty of Medicine of Foudation of ABC</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2017-07-21 11:18:23 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2017-07-21 11:18:07 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Incontinence. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. The NIHR is the largest single funder of Cochrane Incontinence.</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2017-07-21 11:18:23 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>This project, to add brief economic commentaries to Cochrane Incontinence's reviews on surgery for urinary incontinence in women, was supported by the National Institute for Health Research (NIHR), via the Cochrane Review Incentive Scheme 2016, to Cochrane Incontinence. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-07-21 09:34:23 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2010-11-19 10:56:54 +0000" MODIFIED_BY="[Empty name]">Traditional sling operations for urinary incontinence in women</TITLE>
<SUMMARY_BODY MODIFIED="2017-07-21 09:34:23 +0100" MODIFIED_BY="[Empty name]">
<P>Traditional sling operations are used to treat women with stress urinary incontinence. This is loss of urine when coughing, laughing, sneezing or exercising due to damage to the muscles that hold up the bladder, and injuries to the nerves that may occur during childbirth. A significant amount of the woman's and her family's income can be spent on managing the symptoms. Sometimes stress incontinence occurs together with 'urge incontinence' - known as 'mixed incontinence'. The sling operation aims to hold up the bladder with a strip of material which may be biological or synthetic. The results showed that there is not enough information on which to judge whether traditional sling operations are better or worse than any other treatments. Long-term results are awaited. In terms of costs, a brief review of economic studies, which considered the overall costs and effects, suggested that traditional slings are less costly when compared with collagen injection but expensive when compared with minimally invasive slings. In this review there were few trials, of high quality, comparing slings with other forms of surgery and only one study comparing sling operations with non-surgical treatment.<BR/>
</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-07-21 09:34:02 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2017-07-21 09:33:08 +0100" MODIFIED_BY="[Empty name]">
<P>Stress urinary incontinence constitutes a significant health and economic burden to society. Traditional suburethral slings are one of the surgical operations used to treat women with symptoms of stress urinary incontinence.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-11-21 14:37:38 +0000" MODIFIED_BY="[Empty name]">
<P>To determine the effects of traditional suburethral slings on stress or mixed incontinence in comparison with other management options.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-07-21 09:33:21 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Incontinence Group Specialised Register (searched 3 June 2010) and the reference lists of relevant articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised or quasi-randomised trials that included traditional suburethral slings for the treatment of stress or mixed urinary incontinence.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2017-07-21 09:33:50 +0100" MODIFIED_BY="[Empty name]">
<P>At least three reviewers independently extracted data from included trials onto a standard form and assessed trial methodological quality. The data abstracted were relevant to predetermined outcome measures. Where appropriate, we calculated a summary statistic: a relative risk for dichotomous data and a weighted mean difference for continuous data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-07-21 09:33:50 +0100" MODIFIED_BY="[Empty name]">
<P>We included 26 trials involving 2284 women. The quality of evidence was moderate for most trials and there was generally short follow-up ranging from 6 to 24 months.</P>
<P>One medium-sized trial compared traditional suburethral sling operations with oxybutynin in the treatment of women with mixed urinary incontinence. Surgery appeared to be more effective than drugs in treating participant-reported incontinence (n = 75, risk ratio (RR) 0.18, 95% confidence interval (CI) 0.08 to 0.43).</P>
<P>One trial found that traditional slings were more effective than transurethral injectable treatment (RR for clinician-assessed incontinence within a year 0.21, 95% CI 0.09 to 0.21)</P>
<P>Seven trials compared slings with open abdominal retropubic colposuspension. Participant-reported incontinence was lower with the slings after one year (RR 0.75, 95% CI 0.62 to 0.90), but not when assessed by clinicians. Colposuspension, however, was associated with fewer peri-operative complications, shorter duration of use of indwelling catheter and less long-term voiding dysfunction. One study showed there was a 20% lower risk of bladder perforation with the sling procedure but a 50% increase in urinary tract infection with the sling procedure compared with colposuspension. Fewer women developed prolapse after slings (compared with after colposuspension) in two small trials but this did not reach statistical significance.</P>
<P>Twelve trials addressed the comparison between traditional sling operations and minimally invasive sling operations. These seemed to be equally effective in the short term (RR for incontinence within first year 0.97, 95% CI 0.78 to 1.20) but minimally invasive slings had a shorter operating time, fewer peri-operative complications (other than bladder perforation) and some evidence of less post-operative voiding dysfunction and detrusor symptoms.</P>
<P>Six trials compared one type of traditional sling with another. Materials included porcine dermis, lyophilised dura mater, fascia lata, vaginal wall, autologous dermis and rectus fascia. Participant-reported improvement rates within the first year favoured the traditional autologous material rectus fascia over other biological materials (RR 0.45, 95% CI 0.21 to 0.98). There were more complications with the use of non-absorbable Gore-Tex in one trial.</P>
<P>Data for comparison of bladder neck needle suspension with suburethral slings were inconclusive because they came from a single trial with a small specialised population.<BR/>
</P>
<P>No trials compared traditional suburethral slings with anterior repair, laparoscopic retropubic colposuspension or artificial sphincters. Most trials did not distinguish between women having surgery for primary or recurrent incontinence when reporting participant characteristics.</P>
<P>For most of the comparisons, clinically important differences could not be ruled out.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-07-21 09:34:02 +0100" MODIFIED_BY="[Empty name]">
<P>Traditional slings seem to be as effective as minimally invasive slings, but had higher rates of adverse effects. This should be interpreted with some caution however, as the quality of evidence for the studies was variable, follow-up short and populations small, particularly for identifying complication rates. Tradional sling procedures appeared to confer a similar cure rate in comparison to open retropubic colposuspension, but the long-term adverse event profile is still unclear. A brief economic commentary (BEC) identified two studies suggesting that traditional slings may be more cost-effective compared with collagen injection but not cost-effective when compared with minimally invasive sling operations. Reliable evidence to clarify whether or not traditional suburethral slings may be better or worse than other surgical or conservative management options is lacking.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-07-21 09:52:20 +0100" MODIFIED_BY="[Empty name]">
<P>The prevalence of urinary incontinence in adult women has been estimated to be between 10% to 40%, and is considered severe in about 3% to 17% (<LINK REF="REF-Hunskaar-2002" TYPE="REFERENCE">Hunskaar 2002</LINK>). This is a potentially debilitating social problem which leads to high health care costs (<LINK REF="REF-Fantl-1996" TYPE="REFERENCE">Fantl 1996</LINK>). In the USA, the annual total direct costs of urinary incontinence in both men and women is over USD 16 billion (1995 USD) (<LINK REF="REF-Chong-2011" TYPE="REFERENCE">Chong 2011</LINK>) with societal costs of USD 26.2 billion (1995 USD) (<LINK REF="REF-Wagner-1998" TYPE="REFERENCE">Wagner 1998</LINK>). Approximately, USD 13.12 billion (1995 USD) of the total direct costs of urinary incontinence is spent on stress urinary incontinence (SUI) (<LINK REF="REF-Kunkle-2015" TYPE="REFERENCE">Kunkle 2015</LINK>; <LINK REF="REF-Chong-2011" TYPE="REFERENCE">Chong 2011</LINK>). About 70% of this USD 13.12 billion (1995 USD) is borne by people with SUI, mainly through routine care (purchasing pads and disposable underwear (diapers), laundry and dry cleaning). This constitutes a significant individual financial burden. Of the remaining 30%, 14% is spent on nursing home admission, 9% on treatment, 6% on addressing complications and 1% on diagnosis (<LINK REF="REF-Chong-2011" TYPE="REFERENCE">Chong 2011</LINK>). A study reported that about 1% of median annual household income (USD 50,000 to USD 59,999 in 2006) was spent by women on incontinence management. This study estimated that women spent an annual mean amount of USD 751 to USD 1277 (2006 USD) on incontinence. This increases based on the severity of the symptoms (<LINK REF="REF-Subak-2008" TYPE="REFERENCE">Subak 2008</LINK>). The indirect cost associated exerts social and psychological burden which is unquantifiable. (<LINK REF="REF-Chong-2011" TYPE="REFERENCE">Chong 2011</LINK>; <LINK REF="REF-Kilonzo-2004" TYPE="REFERENCE">Kilonzo 2004</LINK>). Nevertheless, <LINK REF="REF-Birnbaum-2004" TYPE="REFERENCE">Birnbaum 2004</LINK> estimated that the annual average direct medical costs of SUI for one year (1998) was USD 5642 and USD 4208 for indirect workplace costs. The cost of management and treatment of SUI appears to have increased over time due to increasing prevalence and increased desire for improved quality of life. This in turn has resulted from improved recognition of the condition, as well as increased use of surgical and non-surgical managements.</P>
<CONDITION MODIFIED="2017-07-21 09:51:52 +0100" MODIFIED_BY="[Empty name]">
<P>Continence is achieved through an interplay of the normal anatomical and physiological properties of the bladder, urethra and sphincter, pelvic floor and the nervous system co-ordinating these organs. The active relaxation of the bladder, coupled with the ability of the urethra and sphincter to contain urine within the bladder by acting as a closure mechanism during filling, allow storage of urine until an appropriate time and place to void is reached. The role of the pelvic floor in providing support to the bladder and urethra, and allowing normal abdominal pressure transmission to the proximal urethra is also considered essential in the maintenance of continence. Crucial to the healthy functioning of the bladder, urethra, sphincter and pelvic floor is co-ordination between them, facilitated by an intact nervous system control.</P>
<P>Incontinence occurs when this normal relationship between the lower urinary tract components is disrupted, resulting from nerve damage or direct mechanical trauma to the pelvic organs. Advancing age, higher parity, vaginal delivery, obesity and menopause are associated with an increase in risk (<LINK REF="REF-Wilson-1996" TYPE="REFERENCE">Wilson 1996</LINK>).<BR/>
<BR/>There are different types of urinary incontinence. Stress urinary incontinence is the most common type (<LINK REF="REF-Wilson-1996" TYPE="REFERENCE">Wilson 1996</LINK>). The symptom of 'stress incontinence' is the involuntary loss of urine from the urethra during physical activities that increase abdominal pressure, in the absence of a detrusor (bladder wall muscle) contraction or an over-distended bladder (<LINK REF="REF-Blaivas-1997a" TYPE="REFERENCE">Blaivas 1997a</LINK>). Two mechanisms for stress incontinence are recognised: hyper-mobility or significant displacement of the urethra and bladder neck during exertion, and intrinsic urethral sphincter deficiency (<LINK REF="REF-Blaivas-1988" TYPE="REFERENCE">Blaivas 1988</LINK>). In women, these mechanisms may co-exist (<LINK REF="REF-O_x0027_Donnell-1994" TYPE="REFERENCE">O'Donnell 1994</LINK>). Few clinical trials have distinguished between the two conditions, probably because there is no standardised and validated test available to date (<LINK REF="REF-Blaivas-1988" TYPE="REFERENCE">Blaivas 1988</LINK>; <LINK REF="REF-McGuire-1993" TYPE="REFERENCE">McGuire 1993</LINK>). Women whose incontinence may be due to either of these two mechanisms were considered together in this review.</P>
<P>The diagnosis of 'urodynamic stress incontinence' requires urodynamic investigation to exclude detrusor overactivity, in addition to history-taking, physical examination, frequency/volume charts and urine analysis. Some authors have described women with only the symptom of stress incontinence (diagnosis made on clinical evaluation without urodynamics). Women with stress incontinence, both with and without urodynamic investigation,were eligible for inclusion in this review.</P>
<P>'Urge incontinence' is the symptom of involuntary loss of urine associated with a sudden, strong desire (urgency) to void. 'Detrusor overactivity' is a diagnosis that denotes involuntary detrusor contractions which are not due to neurological disorders, and diagnosis must be made using urodynamic techniques (<LINK REF="REF-Blaivas-1997a" TYPE="REFERENCE">Blaivas 1997a</LINK>). Women with both the symptom and the urodynamic diagnosis of detrusor overactivity were eligible for inclusion in the review only if they had co-existing stress incontinence ('mixed' incontinence).</P>
<P>Women with mixed incontinence included in this review either had symptoms of stress plus urge incontinence or other urinary symptoms (diagnosed clinically), or urodynamic stress incontinence plus detrusor overactivity (diagnosed using urodynamics).</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-07-21 09:52:11 +0100" MODIFIED_BY="[Empty name]">
<P>Treatments for stress urinary incontinence include conservative, mechanical, pharmacological and surgical interventions.</P>
<OL>
<LI>Conservative treatment centres on physical methods, including pelvic floor muscle training, electrical stimulation, biofeedback and weighted cones.</LI>
<LI>Mechanical devices, which prevent or reduce urinary leakage are available, such as meatal plugs/patches and urethral and vaginal inserts.</LI>
<LI>Drug therapies, principally oestrogens and, less often, alpha adrenergic agents, can be used. A trial of conservative therapy is generally undertaken before resorting to surgery.</LI>
</OL>
<P>These interventions are the subject of separate Cochrane Reviews.</P>
<P>Surgical procedures to remedy stress incontinence generally aim to lift and support the urethro-vesical junction. There is disagreement, however, regarding the precise mechanism by which continence is achieved. Choice of procedures is often influenced by coexistent problems, surgeon's preference and the physical features of the person affected.</P>
<P>Numerous surgical methods have been described, but essentially they fall into eight categories.</P>
<OL>
<LI>Open abdominal retropubic suspension (e.g. colposuspension (Burch), Marshall-Marchetti-Krantz (MMK), (<LINK REF="REF-Lapitan-2009" TYPE="REFERENCE">Lapitan 2009</LINK>)</LI>
<LI>Laparoscopic retropubic suspension (<LINK REF="REF-Dean-2006" TYPE="REFERENCE">Dean 2006</LINK>)</LI>
<LI>Vaginal anterior repair (anterior colporrhaphy) (<LINK REF="REF-Glazener-2001" TYPE="REFERENCE">Glazener 2001</LINK>)</LI>
<LI>Traditional suburethral slings</LI>
<LI>Minimally invasive suburethral slings (<LINK REF="REF-Ogah-2010" TYPE="REFERENCE">Ogah 2010</LINK>)</LI>
<LI>Bladder neck needle suspensions (<LINK REF="REF-Glazener-2004" TYPE="REFERENCE">Glazener 2004</LINK>)</LI>
<LI>Peri-urethral injections (<LINK REF="REF-Keegan-2007" TYPE="REFERENCE">Keegan 2007</LINK>)</LI>
<LI>Artificial sphincters</LI>
</OL>
<P>In this review we concentrated on traditional suburethral sling operations.</P>
</INTERVENTION>
<THEORY MODIFIED="2017-07-21 09:52:11 +0100" MODIFIED_BY="[Empty name]">
<P>The aim is to restore or enhance the woman&#8217;s urethral support during a sudden movement, such as a cough or sneeze. This is achieved by lifting and supporting the urethro-vesical junction with autologous or synthetic material.</P>
<P>A traditional suburethral sling operation requires a combined abdominal and vaginal approach. Strips of material are tunnelled under the urethra and are attached either to the rectus muscle or the ileopectineal ligaments. The materials that have been used for slings may be biological or synthetic. Autologous biological materials include: rectus fascia, fascia lata, pubococcygeal muscle, vaginal wall, aponeurosis and pyramidalis fascia. Exogenous biological materials include: ox fascia and porcine dermis (Pelvicol). Synthetic materials include: Teflon, Mersilene tape in a silicon tube, Lyodura, polytetrafluoroethylene (Gore-Tex), Marlex mesh and silastic.</P>
<P>A modification of the suburethral sling procedure is the 'minimally invasive' polypropylene mesh applied through a minimally invasive technique (e.g. tension-free vaginal tape (TVT), suprapubic arc (SPARC)) in which a prolene tape covered by a plastic sheath is inserted around the mid-urethra without fixation and in some centres under local anaesthesia (<LINK REF="REF-Smith-2002" TYPE="REFERENCE">Smith 2002</LINK>). These have been considered in a separate Cochrane Review (<LINK REF="REF-Ogah-2010" TYPE="REFERENCE">Ogah 2010</LINK>).</P>
<P>We included only traditional sling operations, using an open abdominal approach and fixed with sutures, in this review.</P>
</THEORY>
<IMPORTANCE MODIFIED="2017-07-21 09:52:20 +0100" MODIFIED_BY="[Empty name]">
<P>The wide variety of surgical treatments for urinary incontinence indicates the lack of consensus as to which procedure is the best. Provided that a sufficient number of trials of adequate quality have been conducted, the most reliable evidence is likely to come from consideration of all well-designed randomised controlled trials. Hence, there is a need for an easily accessible, periodically updated, comprehensive systematic review of such trials, which will not only help to identify optimal practice, but also highlight gaps in the evidence base.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2017-07-21 09:52:20 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of traditional suburethral sling procedures for treatment of urodynamic stress urinary incontinence (urodynamic diagnosis), or for symptoms of stress or mixed incontinence (clinical diagnosis) in women.</P>
<P>We made the following comparisons for traditional suburethral sling procedures (abdominal and vaginal).</P>
<OL>
<LI>Traditional suburethral sling operation versus no treatment or sham operation</LI>
<LI>Traditional suburethral sling operation versus conservative management (e.g. pelvic floor muscle training, electrical stimulation, cones, biofeedback)</LI>
<LI>Traditional suburethral sling operation versus drugs</LI>
<LI>Traditional suburethral sling operation versus injectables</LI>
<LI>Traditional suburethral sling operation versus colposuspension</LI>
<LI>Traditional suburethral sling operation versus bladder neck needle suspension (abdominal and vaginal)</LI>
<LI>Traditional suburethral sling operation versus anterior repair</LI>
<LI>Traditional suburethral sling operation versus laparoscopic procedures</LI>
<LI>Traditional suburethral sling operation versus a minimally invasive sling</LI>
<LI>One type of traditional sling operations versus another traditional sling operation</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2017-07-21 10:01:05 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-07-21 09:54:26 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2017-07-21 09:53:50 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised or quasi-randomised controlled trials of women with urodynamic stress incontinence (urodynamic diagnosis), or symptoms of stress or mixed urinary incontinence (clinical diagnosis), in which at least one trial arm involved traditional suburethral sling procedures.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2017-07-21 09:53:50 +0100" MODIFIED_BY="[Empty name]">
<P>Adult women with stress urinary incontinence due to hyper-mobility or intrinsic sphincter deficiency, or both, diagnosed clinically or with urodynamics, or with mixed incontinence. We accepted classification of diagnoses as defined by the trial authors.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2017-07-21 09:53:50 +0100" MODIFIED_BY="[Empty name]">
<P>At least one arm of a study had to involve traditional suburethral sling procedures to treat stress or mixed incontinence. Comparison interventions could include other surgical techniques and non-surgical interventions.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-07-21 09:54:26 +0100" MODIFIED_BY="[Empty name]">
<P>We selected outcome measures used in this review on the basis of their relevance to the clinical cure or improvement of incontinence. We regarded the principal measures of effectiveness as the proportion of women cured (continent or dry) following surgery, and the proportion of women whose incontinence was improved.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Women's observations</HEADING>
<OL>
<LI>Perception of cure and improvement in the short term (less than 12 months) and longer term (more than 12 months)</LI>
<LI>Urgency symptoms or urgency incontinence</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Quantification of symptoms</HEADING>
<OL>
<LI>Pad changes over 24 hours (from self-reported number of pads used)</LI>
<LI>Incontinent episodes over 24 hours (from self completed bladder chart)</LI>
<LI>Pad tests of quantified leakage (mean volume or weight of urine loss)</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Clinician's observations</HEADING>
<OL>
<LI>Cure and improvement in the short term (less than 12 months) and longer term (more than 12 months)</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Surgical outcome measures</HEADING>
<OL>
<LI>Duration of operation</LI>
<LI>Length of inpatient stay</LI>
<LI>Time to return to normal activity level</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Adverse events</HEADING>
<OL>
<LI>Peri-operative surgical complications (e.g. infection, bacteriuria, haemorrhage, bladder perforation)</LI>
<LI>De novo urge symptoms or urge incontinence (clinical diagnosis without urodynamics)</LI>
<LI>Voiding dysfunction/difficulty after three months (with or without urodynamic confirmation)</LI>
<LI>Detrusor overactivity (urodynamic diagnosis)</LI>
<LI>Entero-rectocele</LI>
<LI>Repeat incontinence surgery</LI>
<LI>Later prolapse surgery</LI>
<LI>Surgical complications and other types of adverse event</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Quality of life</HEADING>
<OL>
<LI>General health status measures (e.g. Short Form 36 (<LINK REF="REF-Ware-1993" TYPE="REFERENCE">Ware 1993</LINK>)), or specific instruments designed to assess incontinence e.g. the Bristol Female Lower Urinary Tract Symptoms questionnaire (BFLUTS) (<LINK REF="REF-Jackson-1996" TYPE="REFERENCE">Jackson 1996</LINK>)</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7. Other outcomes</HEADING>
<OL>
<LI>Non-prespecified outcomes judged important when performing the review</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-07-21 10:00:28 +0100" MODIFIED_BY="[Empty name]">
<P>We did not impose language or other restrictions on any of these searches.</P>
<ELECTRONIC_SEARCHES MODIFIED="2017-07-21 10:00:28 +0100" MODIFIED_BY="[Empty name]">
<P>This review has drawn on the search strategy developed for the Cochrane Incontinence Group. We identified relevant trials from the Cochrane Incontinence Group Specialised Register of controlled trials, which is described under Group's details in the Cochrane Library (for more details please see the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/INCONT/frame.html">Specialized Register</A> section of the Group's module in the Cochrane Library). The Register contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, CINAHL, and handsearching of journals and conference proceedings. The date of the most recent search of the Register for this review was 3 June 2010.</P>
<P>The trials in the Cochrane Incontinence Specialised Register are also contained in CENTRAL. The terms used to search the Cochrane Incontinence Specialised Register are given below:<BR/>(TOPIC.URINE.INCON*)<BR/>AND<BR/>({DESIGN.CCT*} OR {DESIGN.RCT*})<BR/>AND<BR/>({INTVENT.SURG.SLIN*} OR {INTVENT.SURG.SUBURETHRAL SLING.} OR {INTVENT.SURG.ABDO.SLING.})<BR/>(All searches were of the keyword field of <LINK REF="REF-Reference-Manager-2012" TYPE="REFERENCE">Reference Manager 2012</LINK>).</P>
<P>For previous versions of this review one of the review authors performed extra literature searches - these are described in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>On 6 April 2017 we performed additional searches for the brief economic commentary (BEC), conducted in MEDLINE (1 January 1946 to March 2017), Embase (1 January 1980 to 2017 Week 12) and NHS EED (1st Quarter 2016). Details of the searches run and the search terms used can be found in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2017-07-21 09:55:59 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of relevant articles for other possibly relevant trials.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-07-21 10:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>We excluded studies from the review if they were not randomised or quasi-randomised controlled trials for incontinent women or if they made comparisons other than those pre-specified. Excluded studies are listed in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> tables, with the reasons for their exclusion.</P>
<P>We processed included trial data as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).<BR/>
</P>
<STUDY_SELECTION MODIFIED="2017-07-21 09:55:59 +0100" MODIFIED_BY="[Empty name]">
<P>The review authors evaluated the reports of all possibly eligible studies for appropriateness for inclusion without prior consideration of the results and we retrieved in full any reports of potentially eligible trials.</P>
<P>We resolved any differences of opinion related to study inclusion, methodological quality or data extraction by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-07-21 09:55:59 +0100" MODIFIED_BY="[Empty name]">
<P>At least three review authors independently undertook data extraction using a standard form containing pre-specified outcomes. Where data may have been collected but not reported, we sought clarification from the trial authors.<BR/>
<BR/>The review authors resolved any differences of opinion related to study inclusion, methodological quality or data extraction by discussion, and when necessary, we referred to a fourth reviewer for arbitration.</P>
<P>We conducted the review using the standard Cochrane software, Review Manager 5 (RevMan 5) (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and processed included trial data as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-07-21 10:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>Each review author independently undertook 'Risk of bias' assessment. The system for classifying methodological quality of controlled trials was based on an assessment of the three principal potential sources of bias. These are:</P>
<UL>
<LI>selection bias from insecure random allocation of treatments;</LI>
<LI>attrition bias from dropouts or losses to follow-up, particularly if there is a differential dropout rate between groups;</LI>
<LI>biased ascertainment (detection bias) of outcome where knowledge of the allocation might have influenced the measurement of outcome.</LI>
</UL>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2017-07-21 10:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>Where appropriate, we calculated a combined estimate of treatment effect across similar studies for each pre-specified outcome, using risk ratios (RR) for dichotomous outcomes or mean differences for continuous outcomes, with 95% confidence intervals where possible. For categorical (dichotomous) outcomes the numbers reporting an outcome were related to the numbers at risk in each group to derive a RR. For continuous variables we used means and standard deviations to derive a mean difference (MD). We used a fixed-effect approach to the analysis unless there was evidence of heterogeneity across studies.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2017-07-21 10:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>Where statistical synthesis of data from more than one study was not possible or considered not appropriate, we undertook a narrative review of eligible studies. We sought data on the number of participants with each outcome event, by allocated treated group, irrespective of compliance and whether or not the participant was later thought to be ineligible or otherwise excluded from treatment or follow-up to allow an intention-to-treat analysis when possible.</P>
<P>We defined an intention-to-treat analysis to mean that all participants were analysed in their randomised groups whether or not they received the allocated intervention. We included data as they were reported and did not impute missing values.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-07-21 10:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>We investigated differences between trials when apparent from either visual inspection of the results or when statistically significant heterogeneity was demonstrated by using the Chi<SUP>2</SUP> test at the 10% probability level or assessment of the I<SUP>2</SUP> statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). If there was no obvious reason for the heterogeneity (after consideration of populations, interventions, outcomes and settings of the individual trials) or it persisted despite the removal of outlying trials, we used a random-effects model.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-07-21 10:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>We used the Mantel-Haenszel statistical method for meta-analysis. We used a fixed-effect approach to the analysis unless there was evidence of heterogeneity across studies.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2017-07-21 10:01:05 +0100" MODIFIED_BY="[Empty name]">
<P>We grouped trial data by type of incontinence - either urodynamic stress incontinence, based on a urodynamic diagnosis, or stress or mixed incontinence, based on a symptom classification. We carried out quantitative synthesis when we identified more than one eligible study.</P>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-07-21 10:17:52 +0100" MODIFIED_BY="[Empty name]">
<P>This is the second update of the review of traditional suburethral sling operations for urinary incontinence in women. We have added data from 16 RCTs, of which 13 are new RCTs (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Teixeira-2008" TYPE="STUDY">Teixeira 2008</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>) and three are updates of previously included trials (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>).</P>
<SEARCH_RESULTS MODIFIED="2017-07-21 10:04:08 +0100" MODIFIED_BY="[Empty name]">
<P>Altogether we reviewed 128 reports of 61 studies, of which we included 26 and excluded 35.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-07-21 10:17:52 +0100" MODIFIED_BY="[Empty name]">
<P>We identified 26 randomised or quasi randomised trials that met the inclusion criteria. These trials included 2284 women (1287 with traditional slings), and sample sizes ranging from 20 to 655 participants.</P>
<P>With the exception of the <LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK> and <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK> trials, in general, included trials were small with short follow-up.</P>
<P>One trial (<LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>) compared traditional suburethral sling operations with oxybutynin in the treatment of women with mixed urinary incontinence, another (<LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>) with suburethral injectable treatment and another (<LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>) with bladder neck needle suspension.</P>
<P>Seven trials compared slings with open abdominal retropubic colposuspension (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>; <LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>).</P>
<P>Twelve trials addressed the comparison between traditional sling operations and minimally invasive sling operations (<LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK>; <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Teixeira-2008" TYPE="STUDY">Teixeira 2008</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>).</P>
<P>Six trials compared one type of traditional sling with another (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>; <LINK REF="STD-Viseshsindh-2003" TYPE="STUDY">Viseshsindh 2003</LINK>).</P>
<P>There were no trials comparing suburethral slings with anterior repair, laparoscopic retropubic colposuspension or artificial sphincters.</P>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>The 26 studies used 10 materials for the sling procedure.</P>
<SUBSECTION>
<HEADING LEVEL="5">Autologous biological materials</HEADING>
<UL>
<LI>Autologous dermal graft patch (<LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>)</LI>
<LI>Autologous fascia lata (<LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>)</LI>
<LI>Autologous rectus fascia (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>; <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Viseshsindh-2003" TYPE="STUDY">Viseshsindh 2003</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>)</LI>
<LI>Autologous rectus fascia of smaller length (<LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Other biological materials</HEADING>
<UL>
<LI>Cadaveric fascia lata (<LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>, <LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>)</LI>
<LI>FortaPerm (<LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>)</LI>
<LI>Lyphohilised dura matter (<LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>)</LI>
<LI>Porcine dermis also known as Pelvicol (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>, <LINK REF="STD-Teixeira-2008" TYPE="STUDY">Teixeira 2008</LINK>)</LI>
<LI>Vaginal wall sling - slings made of tissue harvested from the woman's own vaginal wall (<LINK REF="STD-Viseshsindh-2003" TYPE="STUDY">Viseshsindh 2003</LINK>)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Synthetic non-absorbable materials</HEADING>
<UL>
<LI>Gore-Tex sling (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>)</LI>
<LI>Polytetrafluoroethylene - PTFE (<LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>)</LI>
<LI>Teflon Sling (<LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>)</LI>
</UL>
<P>One trial (<LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>), reported in abstract form, did not mention the type of material used for the suburethral sling.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Comparators</HEADING>
<P>There were seven comparators across 23 studies.</P>
<UL>
<LI>Anticholinergic (<LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>)</LI>
<LI>Intravaginal slingplasty (<LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>)</LI>
<LI>Minimally invasive sling (<LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK>; <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>, <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Teixeira-2008" TYPE="STUDY">Teixeira 2008</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>)</LI>
<LI>Retropubic colposuspension: Burch colposuspension (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>); Marshall-Marchetti-Krantz (<LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>)</LI>
<LI>Stamey bladder neck (needle) suspension (<LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>)</LI>
<LI>Transurethral Macroplastique (injectable material, <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>)</LI>
</UL>
<P>One trial was designed to study an anticholinergic agent (oxybutynin) in comparison with surgery (Burch or sling) for women with mixed urinary incontinence (<LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>). It was possible to abstract only the data from sling surgery in comparison with medical treatment to include in the analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>Inclusion criteria were not always clearly defined. Seven trials included women with mixed urinary incontinence (MUI, both stress and urgency) (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>). One large trial involved women with self-reported stress urinary incontinence (SUI), (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>). All others were restricted to women with a urodynamic diagnosis of stress incontinence (USI, previously known as genuine stress incontinence). All trials included both pre- and post-menopausal women, but none were treated with hormone replacement therapy. One study was restricted to women with vaginal narrowing due to atrophic vaginitis or previous surgical scars (<LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">Previous continence surgery status</HEADING>
<P>Two trials (<LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>) only included women without previous interventions for incontinence and another (<LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>) only included women who had had recurrent incontinence after a previous vaginal hysterectomy and at least one anterior repair. The others included women with both primary and recurrent stress incontinence but did not report outcome data separately according to previous continence surgery.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcome measures</HEADING>
<P>The included studies did not report outcome measures in a standardised fashion.</P>
<P>Seventeen trials used women's observations to report urinary incontinence outcomes with clinical history or questionnaire about urinary incontinence on effort (SUI) or use of pads (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK>; <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>; <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>).</P>
<P>Nine trials used clinician's observations of SUI using stress testing or urodynamics (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>)</P>
<P>Two trials did not adequately describe the parameters on which they based their outcomes (<LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>). We therefore assumed that data from <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK> were patient-reported.</P>
<P>Three trials (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>) assessed woman-reported improvement of incontinence within 12 months. <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK> assessed improvement using a urinary symptom questionnaire; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK> considered the use of one or fewer than one incontinence pad per day as subjective improvement; and one trial reported as an abstract did not specify outcome measures (<LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Follow-up</HEADING>
<P>Not all studies reported initial and long-term follow-up. Seven authors (<LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>; <LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Viseshsindh-2003" TYPE="STUDY">Viseshsindh 2003</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>) presented their results at three- and/or six- and/or nine-month assessment. Ten of the studies presented an intermediate follow-up at around one year (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>; <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>). Seven studies described longer but not ideal, follow-up of one to five years (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK> <LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Teixeira-2008" TYPE="STUDY">Teixeira 2008</LINK>). One trial provided full information in two reports of short- and long-term (more than five years) follow-up (<LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>).<BR/>
<BR/>Further characteristics of the trials are reported in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-07-21 10:17:52 +0100" MODIFIED_BY="[Empty name]">
<P>We excluded 35 studies. Fifteen trials compared minimally invasive or variant sling procedures with each other, or other operations: (<LINK REF="STD-Amat-2007" TYPE="STUDY">Amat 2007</LINK>; <LINK REF="STD-Choe-2000" TYPE="STUDY">Choe 2000</LINK>; <LINK REF="STD-Chong-2003" TYPE="STUDY">Chong 2003</LINK>; <LINK REF="STD-Darai-2007" TYPE="STUDY">Darai 2007</LINK>; <LINK REF="STD-Debodinance-1993" TYPE="STUDY">Debodinance 1993</LINK>; <LINK REF="STD-Halaska-2001" TYPE="STUDY">Halaska 2001</LINK>; <LINK REF="STD-Han-2001" TYPE="STUDY">Han 2001</LINK>; <LINK REF="STD-Kocjancic-2008" TYPE="STUDY">Kocjancic 2008</LINK>; <LINK REF="STD-Liapis-2002" TYPE="STUDY">Liapis 2002</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>; <LINK REF="STD-O_x0027_Sullivan-2000" TYPE="STUDY">O'Sullivan 2000</LINK>; <LINK REF="STD-Seo-2007" TYPE="STUDY">Seo 2007</LINK>; <LINK REF="STD-Ward-2002a" TYPE="STUDY">Ward 2002a</LINK>; <LINK REF="STD-Yoo-2007" TYPE="STUDY">Yoo 2007</LINK>). Minimally invasive sling and open colposuspension procedures are considered in other Cochrane Reviews (<LINK REF="REF-Ogah-2010" TYPE="REFERENCE">Ogah 2010</LINK>; <LINK REF="REF-Lapitan-2009" TYPE="REFERENCE">Lapitan 2009</LINK>). <LINK REF="STD-Lemieux-1991" TYPE="STUDY">Lemieux 1991</LINK> compared clamping and non-clamping of catheters after incontinence surgery.</P>
<P>Twelve studies were not randomised (<LINK REF="STD-Atherton-2000" TYPE="STUDY">Atherton 2000</LINK>; <LINK REF="STD-Bruschini-2005" TYPE="STUDY">Bruschini 2005</LINK>; <LINK REF="STD-Corcos-2001" TYPE="STUDY">Corcos 2001</LINK>; <LINK REF="STD-Debodinance-1994" TYPE="STUDY">Debodinance 1994</LINK>; <LINK REF="STD-Giri-2004" TYPE="STUDY">Giri 2004</LINK>; <LINK REF="STD-Giri-2006" TYPE="STUDY">Giri 2006</LINK>; <LINK REF="STD-Hung-2001" TYPE="STUDY">Hung 2001</LINK>; <LINK REF="STD-Ishenko-1999" TYPE="STUDY">Ishenko 1999</LINK>; <LINK REF="STD-Kuo-2001" TYPE="STUDY">Kuo 2001</LINK>; <LINK REF="STD-Obrink-1978" TYPE="STUDY">Obrink 1978</LINK>; <LINK REF="STD-Schostak-2001" TYPE="STUDY">Schostak 2001</LINK>; <LINK REF="STD-Wang-1999" TYPE="STUDY">Wang 1999</LINK>). <LINK REF="STD-Choe-2001" TYPE="STUDY">Choe 2001</LINK> did not adequately perform a final analysis.</P>
<P>There was uncertainty regarding the population used in two trials (<LINK REF="STD-Aurunkalaivanan-2001" TYPE="STUDY">Aurunkalaivanan 2001</LINK>; <LINK REF="STD-Barrington-2003" TYPE="STUDY">Barrington 2003</LINK>). Four trials (<LINK REF="STD-Goldberg-2001" TYPE="STUDY">Goldberg 2001</LINK>; <LINK REF="STD-Kwon-2002" TYPE="STUDY">Kwon 2002</LINK>; <LINK REF="STD-Meschia-2001" TYPE="STUDY">Meschia 2001</LINK>; <LINK REF="STD-Trezza-2001" TYPE="STUDY">Trezza 2001</LINK>) dealt with a diagnosis other than SUI.</P>
<P>Further details are provided in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-07-21 10:18:24 +0100" MODIFIED_BY="[Empty name]">
<P>We have summarised our 'Risk of bias' findings in the included trials in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2017-07-21 10:18:24 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Adequate sequence generation</HEADING>
<P>Three trials used an adequate method of sequence generation (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>). Three trials used randomisation charts to generate the randomisation sequence, without providing further information about the process (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>): nevertheless these were judged to be adequate. Nineteen trials just stated that women were randomised, without any other detail of the process (<LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK>; <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>; <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Teixeira-2008" TYPE="STUDY">Teixeira 2008</LINK>; <LINK REF="STD-Viseshsindh-2003" TYPE="STUDY">Viseshsindh 2003</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>). There was inadequate sequence generation in one trial (<LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>), which used the date-of-birth method, where even dates were assigned to one group and odd to the other. In one trial, one woman was randomised to one arm of the study in comparison with two randomised to the other intervention (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>The reported method of concealment of randomisation was secure in two trials (<LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>). Allocation concealment was unknown for most of the remaining trials as the trial authors did not record it. Inadequate allocation concealment was present in one trial (<LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>) where the date-of-birth method was used to randomise participants. Another trial (<LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>) mentioned sealed, opaque envelopes, but no mention of numbering, and thus we judged it unclear for allocation concealment.</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2010-12-08 12:05:01 +0000" MODIFIED_BY="[Empty name]">
<P>Masking of women or surgeons was not reported in most trials, but is difficult to achieve in surgical trials.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2017-07-21 10:18:24 +0100" MODIFIED_BY="[Empty name]">
<P>Most trials had complete outcome data at follow-up, or losses were evenly distributed between the randomised groups, and thus were unlikely to have had a significant effect on the final analysis. Two trials (<LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>) did not account for losses at follow-up, which might potentially have been a source of bias.</P>
</EXCLUSIONS>
<OTHER_BIAS_SOURCES MODIFIED="2017-07-21 10:18:24 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Comparability of groups at baseline</HEADING>
<P>Baseline comparisons were given in ten trials (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>; <LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>). One author stated that the two groups were comparable without supplying data (<LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>), and the others did not mention baseline comparisons between the groups (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>; <LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>; <LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>; <LINK REF="STD-Viseshsindh-2003" TYPE="STUDY">Viseshsindh 2003</LINK>). Third party outcome assessment was not performed in any of the trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Definition of cure</HEADING>
<P>We calculated the number of incontinent women from the cure rate provided in the reports of trials. The definition of cure was not uniform in the identified studies. For example, although <LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK> considered only the 'dry' participants as cured, he included the improved ones in the success rates, without reporting what 'improvement' meant. Others only considered 'dry' participants to be cured (<LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>). The most detailed description of results were reported by <LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK> and <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>, with data describing both objective (pad tests and urodynamics) and subjective (self-reported, voiding diaries) cure rates. Reporting of other outcomes was variable and incomplete.</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome measures used in this review were not consistently reported in the trials.</P>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1. Traditional suburethral sling operation versus no treatment or sham operation</HEADING>
<P>No trials identified.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2. Traditional suburethral sling operation versus conservative management (e.g. pelvic floor muscle training, electrical stimulation, cones, biofeedback)</HEADING>
<P>No trials identified.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 3. Traditional suburethral sling operation versus drugs</HEADING>
<P>One trial studied women with mixed urinary incontinence treated with oxybutynin or surgery (<LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>). Oxybutinin is a drug treatment for urgency urinary incontinence, overactive bladder and detrusor overactivity, not for stress incontinence. The type of surgery was selected according to Valsalva leak point pressure (VLPP) (those with VLPP less than 90 cm of water had rectus fascia sling and those with VLPP more than 90 cm of water had Burch colposuspension). The results for the total surgically managed group were similar to those for the subgroup having slings. We therefore included in tables only data from women with oxybutynin and sling.</P>
<P>The study suggested that slings are significantly better for treating mixed urinary incontinence than oxybutynin<I>.</I> Results were analysed in terms of participant-reported incontinence within one year (RR 0.18, 95% CI 0.08 to 0.43) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). Fewer women had persistent urgency urinary incontinence after the sling surgery (RR 0.29, 95% CI 0.09 to 0.94) (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 4. Traditional suburethral sling versus injectables</HEADING>
<P>We identified one small trial that compared slings (21) with injectable Macroplastique (22) in 45 women (<LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>).</P>
<P>The only statistically significant outcome was number with incontinence (clinician-observed) within the first year, essentially the number not cured, which favours the traditional sling: 4/21 versus 20/22, (RR 0.21, 95% 0.09 to 0.21) (<LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>).</P>
<P>There were no statistically significant differences between groups but we found wide confidence intervals for the following outcomes.</P>
<UL>
<LI>Number of women with incontinence (participant-reported) within the first year (RR 0.42, 95% CI 0.09 to 1.93) (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>)</LI>
<LI>Number of women with incontinence (participant-reported) after the first year (RR 0.12, 95% CI 0.01 to 2.02) (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>)</LI>
<LI>Voiding dysfunction (RR 4.19, 95% CI 0.51 to 34.50) (<LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>)</LI>
<LI>De novo detrusor overactivity (urodynamic diagnosis) (RR 3.14, 95% CI 0.13 to 72.96) (<LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>)</LI>
<LI>Urinary tract infection (RR 1.57, 95% CI 0.29 to 8.49) (<LINK REF="CMP-004.06" TYPE="ANALYSIS">Analysis 4.6</LINK>)</LI>
</UL>
<P>
<LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK> reported a significant reduction in incontinence impact questionnaire scores compared with baseline (P less than 0.01) in both groups, though he provided no data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 5. Traditional suburethral sling versus open abdominal retropubic colposuspension</HEADING>
<P>Seven trials compared slings with open abdominal retropubic colposuspension (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>; <LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>). The extent to which we could consider the trials together was limited because of differences in the procedures compared, the populations studied, the outcomes assessed, and the length of follow-up. Two trials involved the pubovaginal sling technique using autologous rectus fascia (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>). <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK> used a Lyodura sling, <LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK> used the Zoedler sling, and <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK> used the Gore-Tex-type. Fischer (<LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>) did not specify the sling material.</P>
<P>Only one of these trials (<LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>) reported follow-up for more than five years and presented both short- and long-term data in two full reports.</P>
<SUBSECTION>
<HEADING LEVEL="4">5.1 Women's observations (outcomes 5.1 to 5.4)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Short-term incontinence or improvement</HEADING>
<P>Evidence from four trials (<LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK>; <LINK REF="STD-Henriksson-1978" TYPE="STUDY">Henriksson 1978</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>) showed no statistically significant difference in the number of women reporting incontinence within one year of treatment between the two treatment groups (RR 0.40, 95% CI 0.11 to 1.41) (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>) but the confidence interval was wide and from the data we could not rule out a difference favouring either group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Medium-/long-term incontinence or improvement</HEADING>
<P>Data for failure rates at one to five year follow-up were available from five trials (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>). The summary statistic, combining urodynamic and symptom-only diagnosis, showed a lower incontinence rate with sling procedures (RR 0.75, 95% CI 0.62 to 0.90) (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>). This reflects the results of the <LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK> trial, which had the largest population sample. The data from the trials in which women all had urodynamic stress incontinence showed no significant difference in urinary incontinence after one year (RR 0.72, 95% CI 0.31 to 1.67) (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>.1).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Long-term cure</HEADING>
<P>Only one trial provided data beyond five years (<LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>, included in the outcome woman-reported incontinence after one year): there was no statistically significant difference between the groups, but with very wide confidence intervals (RR 2.31, 95% CI 0.24 to 22.62) (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.2 Quantification of symptoms (outcomes 5.5 to 5.7)</HEADING>
<P>There were no data from any of the trials for these outcomes and thus we could not perform meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.3 Clinician's observations (outcomes 5.8 to 5.9)</HEADING>
<P>No data were available for objective cure within one year of treatment.</P>
<P>Consistent with the results in the woman-reported assessment of incontinence, there were no statistically significant differences in clinically-assessed incontinence rates at one year (RR 0.95, 95% CI 0.64 to 1.41) (<LINK REF="CMP-005.09" TYPE="ANALYSIS">Analysis 5.9</LINK>). Again, wide confidence intervals mean that we cannot rule out a difference between slings or open colposuspension in either direction. This was based on data from three studies with data on assessment after one year (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.4 Surgical outcome measures (outcomes 5.10 to 5.12)</HEADING>
<P>Data on surgical parameters came from four trials (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>).</P>
<P>One trial (<LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>) compared operative times between groups. There was no statistically significant difference between the groups but the confidence interval was wide (MD 6 minutes, 95% CI -0.5 to 13) (<LINK REF="CMP-005.10" TYPE="ANALYSIS">Analysis 5.10</LINK>).</P>
<P>Meta-analysis of data from two trials (<LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>) showed that women in the colposuspension group had their catheters removed earlier (MD 8 days, 95% CI 6.8 to 9.2) (<LINK REF="CMP-005.11" TYPE="ANALYSIS">Analysis 5.11</LINK>). However, it is unclear if this was due to the procedures themselves or differences in hospital policies.</P>
<P>Three trials reported length of inpatient stay. Two trials showed similar lengths of stay for both treatment groups (<LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>). One trial (<LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>) reported that women stayed eight days less after colposuspension compared to after a traditional sling procedure, which is reflected in the statistically significant summary total, (MD 2 days, 95% CI 1.5 to 2.6) (<LINK REF="CMP-005.12" TYPE="ANALYSIS">Analysis 5.12</LINK>). There was statistically significant heterogeneity, which was removed when <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK> was excluded from the analysis, but it was unclear why this trial reported such a large difference in hospital stay: this may also have been due to differences in hospital policies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.5 Adverse events (outcomes 5.14 to 5.21)</HEADING>
<P>In four trials (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>) there were statistically significantly fewer perioperative complications in the open colposuspension group (RR 1.31, 95% CI 1.14 to 1.51) (<LINK REF="CMP-005.14" TYPE="ANALYSIS">Analysis 5.14</LINK>). This finding was mostly due to data from only one, large, trial (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>), which included data on bladder perforation and urinary tract infection (there was a 20% lower risk of bladder perforation with the sling procedure (RR 0.20, 95% CI 0.04 to 0.91) (<LINK REF="CMP-005.15" TYPE="ANALYSIS">Analysis 5.15</LINK>), and a 50% increase in urinary tract infection with the sling procedure (RR 1.50, 95% CI 1.33 to 1.70) (<LINK REF="CMP-005.16" TYPE="ANALYSIS">Analysis 5.16</LINK>) as compared with colposuspension).</P>
<P>One small trial (<LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>) reported data on de novo urge symptoms or incontinence: there were no statistically significant differences between the groups but the confidence interval was wide (RR 2.00, 95% CI 0.54 to 7.39) (<LINK REF="CMP-005.17" TYPE="ANALYSIS">Analysis 5.17</LINK>). Evidence from four small trials (<LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>) demonstrated no statistically significant difference in detrusor overactivity between the groups (RR 1.42, 95% CI 0.52 to 3.87) (<LINK REF="CMP-005.18" TYPE="ANALYSIS">Analysis 5.18</LINK>).</P>
<P>Pooled data from five trials (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>; <LINK REF="STD-Sand-2000" TYPE="STUDY">Sand 2000</LINK>) showed that significantly more women had voiding dysfunction after sling (13% versus 2% after open colposuspension, RR 6.08, 95% CI 3.10 to 11.95) (<LINK REF="CMP-005.19" TYPE="ANALYSIS">Analysis 5.19</LINK>).</P>
<P>Two trials (<LINK REF="STD-Demirci-2001" TYPE="STUDY">Demirci 2001</LINK>; <LINK REF="STD-Enzelsberger-1996" TYPE="STUDY">Enzelsberger 1996</LINK>) reported that more women had new or recurrent prolapse after open colposuspension (7/53) compared to after a sling procedure (1/53, RR 0.20, 95% CI 0.04 to 1.11) (<LINK REF="CMP-005.20" TYPE="ANALYSIS">Analysis 5.20</LINK>), but this did not reach statistical significance. However there was no information about subsequent surgery for either urinary incontinence or prolapse in any trial.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.6 Quality of life (outcomes 5.22)</HEADING>
<P>Data were reported in different formats, thus meta-analysis was not possible.</P>
<P>
<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK> reported a significantly greater improvement in quality of life for those receiving the Burch procedure compared to the sling procedure, stating their P value was 0.033. <LINK REF="STD-Fischer-2001" TYPE="STUDY">Fischer 2001</LINK> reported no significant difference in the Incontinence Impact Questionnaire and Urogenital Distress Inventory scores between the colposuspension group and the sling group, although actual numbers were not reported.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 6. Traditional suburethral sling versus bladder neck needle suspension (abdominal and vaginal)</HEADING>
<P>Only one small trial compared porcine dermis sling with Stamey needle suspension (<LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>). This was a small trial with only 10 women in each arm. The women were unsuitable for abdominal colposuspension (the trial author's preferred procedure) because they had vaginal narrowing secondary to either previous interventions or atrophic vaginitis. All women had urodynamic stress incontinence. Groups were comparable for age, parity, previous interventions and hormonal status. Follow-up was reported at three and 24 months.</P>
<SUBSECTION>
<HEADING LEVEL="4">6.1 Women's observations (outcomes 6.1 and 6.2)</HEADING>
<P>Although there were no significant differences in participant-reported incontinence rates between the groups in the short or longer term, numbers were too small to address such differences (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>; <LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6.4 Surgical outcome measures (outcomes 6.3)</HEADING>
<P>The sling group needed an indwelling catheter for longer, and more adjuvant therapy, resulting in a longer stay in hospital (MD 13 days longer, 95% CI 5 to 21) (<LINK REF="CMP-006.03" TYPE="ANALYSIS">Analysis 6.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6.5 Adverse events (outcomes 6.4 to 6.7)</HEADING>
<P>Nine of the 10 women who had sling operations had complications, compared with two of the 10 who had needle suspension. These included: pyrexia, blood loss, wound infection and pulmonary embolus (RR 4.50, 95% CI 1.28 to 15.81) (<LINK REF="CMP-006.04" TYPE="ANALYSIS">Analysis 6.4</LINK>). Data reported for urge incontinence, late voiding dysfunction and detrusor overactivity showed no statistically significant differences, and confidence intervals were wide.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 7. Traditional suburethral sling operation versus anterior repair</HEADING>
<P>No trials identified.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 8. Traditional suburethral sling operation versus laparoscopic procedures</HEADING>
<P>No trials identified.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 9. Traditional suburethral sling operation versus a minimally invasive sling</HEADING>
<P>Twelve trials addressed this comparison (<LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK>; <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Teixeira-2008" TYPE="STUDY">Teixeira 2008</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">9.1 Women's observations (outcomes 9.1 to 9.4)</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Short-term incontinence</HEADING>
<P>Incontinence within 12 months of operation was investigated by eight RCTs with a total of 693 participants. Assessment of failure was self-reported by participants and by responses to symptom-based questionnaires. There was no significant difference between participant-reported incontinence rate (RR 0.97, 95% CI 0.78 to 1.20) (<LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>). This translates to 267 per 1000 women being incontinent after a traditional sling compared with 275 per 1000 after a minimally invasive sling (<LINK REF="SOF-04" TYPE="SOF">Summary of results table 4</LINK>, 9.1).</P>
<P>Out of a total of 432 women, 11% of women who had traditional sling operations and 15% of those with minimally invasive sling operations reported no improvement. This was not a statistically significant difference and the confidence intervals were wide (RR 0.78, 95% CI 0.48 to 1.27) (<LINK REF="CMP-009.02" TYPE="ANALYSIS">Analysis 9.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Medium-/long-term incontinence</HEADING>
<P>Data on incontinence after the first year was available from four RCTs (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>). Incontinence was reported by 31.6% of those women in the traditional sling and 25.3% of those in the minimally invasive slings groups. This was not statistically significant (RR 1.23, 95% CI 0.91 to 1.66) (<LINK REF="CMP-009.03" TYPE="ANALYSIS">Analysis 9.3</LINK>). This translates to 311 per 1000 women being incontinent after a traditional sling compared with 253 per 1000 after a minimally invasive sling (<LINK REF="SOF-04" TYPE="SOF">Summary of results table 4</LINK>, 9.3).</P>
<P>Improvement after a year was addressed by two trials (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>) and there was no statistically significant difference between the two types of sling (RR 1.30, 95% CI 0.57 to 2.94) (<LINK REF="CMP-009.04" TYPE="ANALYSIS">Analysis 9.4</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">9.2 Quantification of symptoms (outcome 9.5)</HEADING>
<P>One small trial reported the mean weight of urine on pad test (<LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>). The pooled data showed no statistically significant difference in groups (MD 31.00 g, 95% CI -57.53 to -4.47) (<LINK REF="CMP-009.05" TYPE="ANALYSIS">Analysis 9.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">9.3 Clinician's observations (outcomes 9.6 and 9.7)</HEADING>
<P>Clinician-reported incontinence within one year, defined as complete absence of urinary leakage during cough stress test, was assessed in two small trials (<LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>). There was no statistically significant difference between the two groups (RR 1.29, 95% CI 0.45 to 3.71) (<LINK REF="CMP-009.06" TYPE="ANALYSIS">Analysis 9.6</LINK>). <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK> further addressed objective cure after the first year but again the findings were not statistically significant and the confidence interval was wide (RR 1.72, 95% CI 0.82 to 3.61) (<LINK REF="CMP-009.07" TYPE="ANALYSIS">Analysis 9.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">9.4 Surgical outcome measures (outcomes 9.8 to 9.10)</HEADING>
<P>Traditional suburethral sling operations took significantly longer to complete with a mean operating time of 102 minutes compared to 42 minutes for minimally invasive synthetic suburethral sling operations (MD 60 minutes, 95% CI 57 to 63) (<LINK REF="CMP-009.08" TYPE="ANALYSIS">Analysis 9.8</LINK>). There was statistically significant heterogeneity that could not be explained by differences in either the populations, interventions or settings of the individual trials. This heterogeneity persisted even after we performed sensitivity analysis excluding <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>, the largest trial, which showed a much longer operating time for the traditional sling operation than the other trials. However, a random-effects model still showed that traditional suburethral slings took significantly longer to perform (MD 52 minutes, 95% CI 23 to 81) (analysis not shown).</P>
<P>In two small studies (<LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK>), length of hospital stay was also shorter after minimally invasive synthetic suburethral sling operations (RR 0.49 days, 95% CI 0.26 to 0.72) (<LINK REF="CMP-009.09" TYPE="ANALYSIS">Analysis 9.9</LINK>). <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK> and <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK> reported that the time to catheter removal was longer after a traditional sling procedure, but this was not statistically significant (MD 0.11 days, 95% -0.07 to 0.30) (<LINK REF="CMP-009.10" TYPE="ANALYSIS">Analysis 9.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">9.5 Adverse events (outcomes 9.11 to 9.20)</HEADING>
<P>Pooled data from three trials (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>) showed a statistically significant higher risk of perioperative complications after traditional sling operations (RR 1.59, 95% CI 1.03 to 2.44) (<LINK REF="CMP-009.11" TYPE="ANALYSIS">Analysis 9.11</LINK>).</P>
<P>Seven RCTs (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Bai-2005" TYPE="STUDY">Bai 2005</LINK>; <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>; <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK>; <LINK REF="STD-Song-2004" TYPE="STUDY">Song 2004</LINK>; <LINK REF="STD-Tcherniakovsky-2009" TYPE="STUDY">Tcherniakovsky 2009</LINK>; <LINK REF="STD-Wadie-2005" TYPE="STUDY">Wadie 2005</LINK>) reported bladder perforation: there were more perforations after minimally invasive slings but this did not reach statistical significance (RR 0.62, 95% CI 0.34 to 1.11) (<LINK REF="CMP-009.12" TYPE="ANALYSIS">Analysis 9.12</LINK>), and the confidence interval was wide. <LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK> further reported urethral injury alone (RR 0.36, 95% CI 0.02 to 8.39) (<LINK REF="CMP-009.13" TYPE="ANALYSIS">Analysis 9.13</LINK>), which again was not statistically significant.</P>
<P>The combined results from three trials showed less de novo urgency symptoms or urgency after minimally invasive synthetic suburethral sling operations (RR 3.13, 95% CI 0.96 to 10.24) (<LINK REF="CMP-009.14" TYPE="ANALYSIS">Analysis 9.14</LINK>) but this did not reach statistical significance and the confidence interval was wide. However, three trials showed that de novo detrusor overactivity was significantly less after minimally invasive synthetic suburethral sling operations (RR 3.21, 95% CI 1.29 to 8.03) (<LINK REF="CMP-009.15" TYPE="ANALYSIS">Analysis 9.15</LINK>). This was principally due to the higher weighting given to the largest trial (<LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>).</P>
<P>The combined results from five trials showed that more women had postoperative voiding dysfunction after traditional slings than after minimally invasive sling operations (RR 1.60, 95% CI 0.94 to 2.71) (<LINK REF="CMP-009.16" TYPE="ANALYSIS">Analysis 9.16</LINK>) but this did not quite reach statistical significance and the confidence interval was wide.</P>
<P>More women in the traditional sling group required release of sling (9% versus 2%), reported in two trials (RR 3.67, 95% CI 0.95 to 14.22) (<LINK REF="CMP-009.17" TYPE="ANALYSIS">Analysis 9.17</LINK>) but again this was not statistically significant.</P>
<P>There was no statistically significant difference in:</P>
<OL>
<LI>urinary retention up to 6 weeks (RR 5.51, 95% CI 0.68 to 44.63) (<LINK REF="CMP-009.18" TYPE="ANALYSIS">Analysis 9.18</LINK>) reported in one trial;</LI>
<LI>vaginal erosion (RR 0.35, 95% CI 0.02 to 8.10) (<LINK REF="CMP-009.19" TYPE="ANALYSIS">Analysis 9.19</LINK>) based on one trial.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">9.6 Quality of life</HEADING>
<P>Seven studies assessed quality of life. Four of these studies used a number of validated questionnaires, and two studies (<LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>; <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>) used invalidated questionnaires. The data were reported in different ways, thus meta-analysis was not possible and the individual results are reported below .</P>
<OL>
<LI>
<LINK REF="STD-Amaro-2007" TYPE="STUDY">Amaro 2007</LINK> used the Portuguese version of King's Health Questionnaire (KHQ). There were no statistically significant differences between groups in: general health condition; impact of incontinence; role, physical and social limitations; personal relationships; emotions; sleep and severity perception of urinary incontinence at 36 months.</LI>
<LI>
<LINK REF="STD-Silva-Filho-2006" TYPE="STUDY">Silva Filho 2006</LINK> also used the KHQ, showing a significantly greater improvement in those who underwent the traditional suburethral sling operation in the following domains: general health perception, physical, social and role limitations; and in emotions and severity measures. There were no significant differences in the incontinence impact, personal relationships, sleep or energy domains.</LI>
<LI>There was statistically significant improvement postoperatively in the Incontinence Impact Questionnaires (IIQ-7) and Urogenital Distress Inventories (UDI-6) within both groups but there was no significant difference in the degree of improvement between the groups (<LINK REF="STD-Kondo-2006" TYPE="STUDY">Kondo 2006</LINK>).</LI>
<LI>IIQ score was also used by <LINK REF="STD-Sharifiaghdas-2008" TYPE="STUDY">Sharifiaghdas 2008</LINK> to determine subjective cure. The means were reported 44.3 (range 35.2 to 61.5) in the minimally invasive procedure and 48.5 (range 38.5 to 69.7) in the sling group (P = 0.46). A score less than 50 represents a good quality of life, between 50 and 70 moderate quality of life, and greater than 70 poor quality of life. There was no significant difference in quality of life between groups. Fifteen (72%) of the minimally invasive group and 20 (55%) of the sling group were satisfied with the operation (P value reported by trial authors = 0.3)</LI>
<LI>There was no significant difference in any of the domains of the Bristol female lower urinary tract symptom score (BFLUTS) assessed in <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>.</LI>
<LI>A subjective 10-point patient satisfaction questionnaire was used by <LINK REF="STD-Basok-2008" TYPE="STUDY">Basok 2008</LINK>: there was no evidence of difference between the groups with satisfaction rates of 82% and 87.5% in the traditional sling and minimally invasive sling respectively.</LI>
<LI>A 10-point questionnaire-based assessment was used by <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK>: the mean score was 8.03 for minimally invasive synthetic suburethral slings and 8.05 for traditional sling, with a median of nine for both groups.</LI>
</OL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 10. One type of traditional sling operations versus another traditional sling operation</HEADING>
<P>Six trials addressed this comparison (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>; <LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>; <LINK REF="STD-Viseshsindh-2003" TYPE="STUDY">Viseshsindh 2003</LINK>). Traditional sling in this comparison refers to autologous rectus fascial slings, except for one trial, which used autologous dermal graft patch (<LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>). New sling refers to Pelvicol (<LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>), FortaPerm (<LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>), Gore-Tex (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>), cadaveric fascia lata (<LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>) and a sling made out of vaginal wall (<LINK REF="STD-Viseshsindh-2003" TYPE="STUDY">Viseshsindh 2003</LINK>). The majority of the trials compared different biological materials with each other, except for <LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>, in which rectus fascia was compared with Gore-Tex.</P>
<SUBSECTION>
<HEADING LEVEL="4">10.1 Women's observations (outcomes 10.1 to 10.5)</HEADING>
<P>Three trials (<LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK>; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>; <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>) reported this outcome.</P>
<SUBSECTION>
<HEADING LEVEL="5">Short-term incontinence</HEADING>
<P>A total of 307 women studied within the first 12 months after surgery showed similar incontinence rates between traditional sling operations using autologous materials (35%, 56/161), and traditional sling operations using Pelvicol, FortaPerm and autologous material of shorter length (34%, 49/146). However, the confidence intervals were wide (RR 0.89, 95% CI 0.66 to 1.19) (<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>). Two trials using a biological sling (Pelvicol, <LINK REF="STD-Guerrero-2008" TYPE="STUDY">Guerrero 2008</LINK> and FortaPerm, <LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK>) also reported improvement rates that significantly favoured the traditional autologous sling material rectus fascia (RR 0.22, 95% CI 0.08 to 0.59) (<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>.1). However, when the comparator was the synthetic non-absorbable material Gore-Tex, the trial was too small to be conclusive (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Medium-/long-term incontinence rate</HEADING>
<P>A total of 379 women studied after 12 months also showed no statistically significant difference in incontinence rates (RR 0.89, 95% CI 0.72 to 1.10) (<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>). However, results once more reported improvement after one year in favour of the traditional autologous sling material rectus fascia (RR 0.33, 95% CI 0.17 to 0.64) (<LINK REF="CMP-010.04" TYPE="ANALYSIS">Analysis 10.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Long-term incontinence rate</HEADING>
<P>Only one trial reported the incontinence rate after five years (<LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>), and showed no statistically significant difference between different lengths of the autologous material used (RR 1.17, 95% CI 0.86 to 1.59) (<LINK REF="CMP-010.05" TYPE="ANALYSIS">Analysis 10.5</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">10.2 Quantification of symptoms (outcome 10.6)</HEADING>
<P>Only one trial (<LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>) reported data on mean weight of urine on a pad test (RR 3.10, 95% CI -7.30 to 13.50) (<LINK REF="CMP-010.06" TYPE="ANALYSIS">Analysis 10.6</LINK>): this result was not statistically significant.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">10.3 Clinician's observations</HEADING>
<P>Number of women with incontinence, as assessed by the clinician, was not reported in any of the trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">10.4 Surgical outcome measures (outcome 10.7)</HEADING>
<P>The duration of operation for the traditional, long length sling procedure was significantly longer (MD 8.00, 95% CI 3.32 to 12.68) (<LINK REF="CMP-010.07" TYPE="ANALYSIS">Analysis 10.7</LINK>), in one trial (<LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>), which compared long and short lengths of autologous fascia. Length of hospital stay was not reported in any trial.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">10.5 Adverse events (outcomes 10.8 to 10.13)</HEADING>
<P>There was significant heterogeneity in the incidence of adverse effects (perioperative complications) between groups in two trials, which was attributed to more complications with the use of synthetic non-absorbable Gore-Tex in one trial (RR 0.05, 95% CI 0.00 to 0.80) (<LINK REF="CMP-010.08" TYPE="ANALYSIS">Analysis 10.8</LINK>.3; <LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>); in the other trial there was no statistically significant difference between two biological slings (RR 1.14, 95% CI 0.78 to 1.66) (<LINK REF="CMP-010.08" TYPE="ANALYSIS">Analysis 10.8</LINK>.1; <LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>).</P>
<P>No statistically significant difference was found in assessment of the following adverse events, reported in only one trial (<LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK>):</P>
<OL>
<LI>bladder perforation (RR 0.69, 95% CI 0.12 to 4.03) (<LINK REF="CMP-010.09" TYPE="ANALYSIS">Analysis 10.9</LINK>);</LI>
<LI>urinary tract infection (RR 1.73, 95% CI 0.66 to 4.54) (<LINK REF="CMP-010.10" TYPE="ANALYSIS">Analysis 10.10</LINK>);</LI>
<LI>de novo detrusor urgency or urge symptoms (RR 3.11, 95% CI 0.65 to 14.97) (<LINK REF="CMP-010.11" TYPE="ANALYSIS">Analysis 10.11</LINK>);</LI>
<LI>voiding dysfunction (RR 1.16, 95% CI 0.65 to 2.07) (<LINK REF="CMP-010.12" TYPE="ANALYSIS">Analysis 10.12</LINK>).</LI>
</OL>
<P>Two trials reported de novo detrusor overactivity (<LINK REF="STD-Barbalias-1997" TYPE="STUDY">Barbalias 1997</LINK>; <LINK REF="STD-Shin-2001" TYPE="STUDY">Shin 2001</LINK>), once more showing no statistically significant difference between the groups (<LINK REF="CMP-010.13" TYPE="ANALYSIS">Analysis 10.13</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">10.6 Quality of life</HEADING>
<P>Data were reported in different ways, thus meta-analysis was not possible.</P>
<OL>
<LI>
<LINK REF="STD-Lucas-2000" TYPE="STUDY">Lucas 2000</LINK> showed significant improvement in the average scores for both the UDI-6, reported P value = 0.007, and the IIQ-7, P = 0.002 when compared with baseline. The scores between groups were similar.</LI>
<LI>
<LINK REF="STD-Pacetta-2005" TYPE="STUDY">Pacetta 2005</LINK> evaluated participants using Incontinence Quality of Life (I-QOL), reporting an improvement from 45 at baseline to 97 at one year in the autologous fascia group and from 39 to 92 for the FortaPerm group.</LI>
</OL>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-07-21 11:03:15 +0100" MODIFIED_BY="[Empty name]">
<P>To supplement the main systematic review of effects, we sought to identify economic evaluations that have compared traditional suburethral sling operations with any of the other main categories of surgical methods listed in the background section. A supplementary search in Ovid NHS EED, MEDLINE and Embase identified two such economic evaluations. Details of the search strategies are given in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<SUMMARY_OF_RESULTS MODIFIED="2017-07-21 11:03:02 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling operation versus no treatment or sham operation</HEADING>
<P>To date, there still remains no RCT comparing traditional sling procedures with laparoscopic procedures for stress urinary incontinence. No related economic evidence was identified for the brief economic commentary.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling operation versus conservative management (e.g. pelvic floor muscle training, electrical stimulation, cones, biofeedback)</HEADING>
<P>We did not find trials comparing suburethral slings with conservative management such as pelvic exercises or vaginal cones, or with some other surgical operations (anterior repair, laparoscopic retropubic suspension, injections or artificial sphincters). No related economic evidence was identified for the brief economic commentary.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling operation versus drugs</HEADING>
<P>One trial compared surgery (Burch or traditional sling procedure) with oxybutynin drug therapy for women with mixed incontinence symptoms (<LINK REF="STD-Osman-2003" TYPE="STUDY">Osman 2003</LINK>). Oxybutinin is an anticholinergic drug which is usually used to treat urgency urinary incontinence and not stress urinary incontinence. The trial showed significantly better results in the group managed surgically with a traditional sling procedure to treat mixed urinary incontinence than oxybutynin, with a cure rate of 83% for stress urinary incontinence and 88% for urgency incontinence in comparison to 0% and 57%, respectively (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
<P>However, post-operative morbidity was not reported well and the results of a single, medium-sized trial in determining the effects in either group should be considered cautiously and requires replication.</P>
<P>No related economic evidence was identified for the brief economic commentary.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling versus injectable</HEADING>
<P>Only one small trial assessed this comparison (<LINK REF="STD-Maher-2005" TYPE="STUDY">Maher 2005</LINK>), showing a clear difference in clinician-assessed incontinence rate at six months favouring pubovaginal sling (19%; 4/21) versus transurethral Macroplastique (91%; 20/22). Incontinence rate was taken as those women not 'cured'. Cure was defined as no urinary leakage due to stress urinary incontinence on repeat urodynamics.</P>
<P>Advantages to injection therapy were lower morbidity rates: there were equivalent incontinence and participant-satisfaction rates at six months' follow-up between groups. At five years 69% (9/13) of women were satisfied with sling surgery versus 29% (4/14) of those who received Macroplastique. There was, however, only a 60% long-term follow-up rate in this study, therefore this result must be interpreted with caution.</P>
<P>In a comparative cost analysis of a retrospective observational study conducted by <LINK REF="REF-Berman-1997" TYPE="REFERENCE">Berman 1997</LINK> in the USA, traditional suburethral retropubic sling procedures were compared with transurethral collagen injections in women with SUI. Women were followed up for 15 months post surgery and 71% of the traditional sling arm were symptom free compared with 27% in the collagen injection arm (P = 0.05). The average cost per woman treated with the traditional sling procedure was USD 10,382 (1995 USD), while the collagen injection was USD 4996 (1995 USD) (P &lt; 0.001). Although the cost of the traditional sling is double that of the collagen injection, the study authors argued that traditional suburethral retropubic sling procedure is more cost-effective than collagen injection due to its higher effectiveness.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling versus open abdominal retropubic colposuspension</HEADING>
<P>The inclusion of the large trial on traditional slings (<LINK REF="STD-Albo-2007" TYPE="STUDY">Albo 2007</LINK>) strengthened the trend towards a better performance of the traditional slings in terms of participant-reported incontinence rates, but higher post-operative voiding dysfunction rates compared to open colposuspension.</P>
<P>The limited data available suggest that the overall rates of peri-operative and late surgical complications are similar after sling and colposuspension operations. However, the pattern of complications varies. </P>
<P>A cost-effectiveness analysis (<LINK REF="REF-Kilonzo-2004" TYPE="REFERENCE">Kilonzo 2004</LINK>) compared minimally invasive slings with open abdominal retropubic colposuspension, laparoscopic colposuspension, traditional suburethral retropubic sling procedure, and injectables. The data utilised in this study were based on a Technology Assessment Review conducted for the National Institute for Clinical Excellence (NICE), UK (<LINK REF="REF-Cody-2003" TYPE="REFERENCE">Cody 2003</LINK>). The study utilised clinical data from a systematic review of RCTs conducted up to mid-2003 (<LINK REF="REF-Lapitan-2003" TYPE="REFERENCE">Lapitan 2003</LINK>; <LINK REF="REF-Moehrer-2002" TYPE="REFERENCE">Moehrer 2002</LINK>; <LINK REF="REF-Ward-2002b" TYPE="REFERENCE">Ward 2002b</LINK>) and results based upon economic modelling for a time horizon of up to 10 years. The analysis of costs and resources used was based on the UK payer&#8217;s perspective (UK National Health Service). Based on clinical evidence, this study assumed that traditional sling effectiveness was equivalent to open abdominal retropubic colposuspension. The cost of open colposuspension was reported as GBP 1301 per woman (2001) with an operation time of 52.4 minutes and average hospital stay of 7.1 days, while traditional slings cost GBP 1340 per woman (2001 GBP) with an operation time of 45.6 minutes and average hospital stay of 7.2 days.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling versus bladder neck needle suspension (abdominal and vaginal)</HEADING>
<P>The one small trial that compared needle operations with slings included an atypical population who were unsuitable for colposuspension (<LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>). The procedures were restricted to women with vaginal narrowing deemed unsuitable for open abdominal retropubic colposuspension. There were too few women to provide reliable data about cure rates. Although the sling operations were associated with more post-operative morbidity, the results could not be generalised to the whole population having surgery because of the atypical nature of the women involved in the trial, such that complications may have been caused by surgical difficulties due to vaginal narrowing. However, the group managed by needle suspensions did not seem to have the same complications.</P>
<P>No related economic evidence was identified for the brief economic commentary.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling operation versus anterior repair.</HEADING>
<P>To date, there still remains no RCTs comparing traditional sling procedures with anterior repair for stress urinary incontinence.</P>
<P>No related economic evidence was identified for the brief economic commentary.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling operation versus laparoscopic procedures</HEADING>
<P>To date, there still remains no RCT comparing traditional sling procedures with laparoscopic procedures for stress urinary incontinence.</P>
<P>For the economic evidence, <LINK REF="REF-Kilonzo-2004" TYPE="REFERENCE">Kilonzo 2004</LINK> also assumed that the effectiveness of laparoscopic colposuspension was equivalent or possibly worse than open colposuspension, while the effectiveness of open colposuspension was equivalent to traditional sling. The study reported the cost of laparoscopic colposuspension to be GBP 1317 (2001 GBP) with an operation time of 60 minutes and an average hospital stay of 4.6 days, compared with traditional sling, which costs GBP 1340 (2001 GBP) with an operation time of 45.6 minutes and average hospital stay of 7.2 days.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Traditional suburethral sling operation versus a minimally invasive sling</HEADING>
<P>Historically, traditional suburethral sling procedures were used for women who had recurrent stress incontinence (after a previous failed continence operation). However, the current review includes women with new or recurrent incontinence, without reporting the results separately. They were designed to restore normal urethrovesical junction support by mechanically compressing or kinking the proximal urethra.</P>
<P>Minimally invasive synthetic suburethral sling operations appeared to be as effective as traditional suburethral slings in the short term (RR 0.97, 95% CI 0.78 to 1.20), although the confidence interval was compatible with minimally invasive slings, being 20% better or 12% worse. The operating time and length of stay were also significantly shorter with minimally invasive synthetic suburethral sling operations, and women had fewer perioperative complications and less detrusor overactivity. The main perioperative complication of minimally invasive sling procedures was bladder perforation, although this did not appear to have longer-term implications. However, because the information was not available, it was not possible to determine if either type of sling was more effective in women who had had previous failed continence surgery.</P>
<P>. More data on the advantages and disadvantages of the different types of biological and synthetic sling materials would be useful to aid decision making. Materials may vary in the degree of discomfort or erosion they cause.</P>
<P>
<LINK REF="REF-Kilonzo-2004" TYPE="REFERENCE">Kilonzo 2004</LINK> also reported on this comparison. The study reported the cost in 2001 in GBP to be GBP 1058 (2001 GBP) per woman with an average of 2.9 days hospital stay and 30 minutes operation time for minimally invasive slings, compared with traditional slings, which cost GBP 1340 (2001 GBP) per woman, with an average hospital stay of 7.2 days and operation of time of 45.6 minutes. There was an 86% probability that minimally invasive sling was cost-effective compared to open colposuspension, with a willingness-to-pay of GBP 30,000 (2001 GBP). Minimally invasive sling was found to be slightly less effective than open colposuspension in terms of Quality Adjusted Life Years (QALYs) for the first four years. Beyond five years, minimally invasive sling was more effective. The study concluded that minimally invasive slings were likely to be more cost-effective than open colposuspensions. Based on the assumption in <LINK REF="REF-Kilonzo-2004" TYPE="REFERENCE">Kilonzo 2004</LINK> that the effectiveness of traditional sling was taken to be equivalent to open colposuspension, therefore the cost-effectiveness results for the comparison of minimally invasive slings with traditional slings would be similar to the cost-effectiveness of minimally invasive slings versus open colposuspension.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">One type of traditional sling operation versus another traditional sling operation</HEADING>
<P>Some synthetic slings may have a higher incidence of erosion, infections and urge symptoms. There was some evidence that these were more common after Gore-Tex.</P>
<P>Meta-analysis showed a significantly greater improvement of symptoms (participant-reported) both within and after one year, using autologous materials. There was no evidence of a difference in peri-operative complications or post-operative morbidity between autologous and other materials. Trials, however, were few in number, with short follow-up and small populations.</P>
<P>More evidence is needed to compare slings made of autologous materials (e.g. rectus fascia, vaginal wall) with synthetic or exogenous biological materials (e.g. Teflon, polytetrafluoroethylene, porcine dermis, dura mater). Some materials may be inappropriate in particular groups of women, such as those with religious beliefs which preclude the use of animal tissues.</P>
<P>No related economic evidence was identified for the brief economic commentary.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-07-21 11:03:02 +0100" MODIFIED_BY="[Empty name]">
<P>Evidence relating to primary outcome was available, but limited in determining the effectiveness of traditional suburethral sling operations in the treatment of urinary incontinence. The limited evidence suggests that traditional slings may be equally as effective as other surgical treatments currently available, but variability in the quality of trials is a major limiting factor.</P>
<P>None of the trials reviewed contained all relevant participant-reported outcomes. More data on pain after different procedures (both post-operative and long term) and time to return to 'normal' daily living following surgery would have been useful.</P>
<P>The review may not be applicable to clinicians everywhere. High-income countries are increasingly using minimally invasive procedures and synthetic materials as the first-line treatment for stress urinary incontinence. The use of traditional suburethral operations, which appear to be just as effective, might be reserved for countries where new technology is not available or too expensive.</P>
<P>Where possible, we analysed data in subgroups according to clinical characteristics of the type of incontinence (urodynamic stress incontinence, stress incontinence symptoms or mixed urinary incontinence). Further analysis according to clinical characteristics of women such as: primary versus recurrent SUI, intrinsic urethral sphincter deficiency versus urethral hypermobility, obesity, ethnicity, vaginal delivery versus caesarean-section, presence or absence of prolapse, anaesthesia used, or experience of the surgeon might make the findings of the review more generalisable. The majority of trials, however, did not report these characteristics.</P>
<P>.Quality of life, emotional well-being, and social implications were poorly reported, or reported using a variety of instruments, thus precluding meta-analysis. These outcomes are of great importance to women and decision makers.</P>
<P>For the economic evidence, we did not subject the two identified economic evaluations to critical appraisal and we do not attempt to draw any firm or general conclusions regarding the relative costs or efficiency of traditional suburethral retropubic slings in treatment of stress urinary incontinence. However, based on the economic evidence available, it can be suggested that traditional suburethral retropubic sling procedure is cost-effective compared to collagen injection but not cost-effective when compared with minimally invasive slings.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2017-07-21 11:03:15 +0100" MODIFIED_BY="[Empty name]">
<P>In general, the scientific quality of the trials was low or moderate. Although the trial authors stated that their trials were randomised, most of the reports did not give sufficient detail about the method of sequence generation or concealment of allocation. Only two trials used an adequate randomisation method. Blinding surgeons or women was generally not possible, but none reported external, third-party, blinded assessment at follow-up. The total number of women enrolled was 2284, but some trials only recruited 10 women per arm. In addition, several types of slings were compared with different interventions, meaning that different materials had to be grouped together for comparisons. This meant that the numbers in each comparison were small and the confidence intervals wide.</P>
<P>The populations varied, including women with and without previous surgery, and one study included only women who were deemed not suitable for another procedure (<LINK REF="STD-Hilton-1989" TYPE="STUDY">Hilton 1989</LINK>). Although the majority had urodynamic stress incontinence, some trials included women with mixed urinary incontinence. Baseline comparability of the groups was not reported in all trials. Several trials assessed different types of sling in comparison with autologous rectus fascia, suggesting that the latter was considered as the 'standard' comparator. Although seven trials used open abdominal retropubic colposuspension as the comparator, each used a different type of sling, and three followed up the women for only six months. Rather more trials used a minimally invasive sling as the comparator, as this has arguably become the gold standard procedure for continence surgery, at least in high-income countries.</P>
<P>In general, most trials reported different outcome measures, often poorly. The principal measure of effectiveness used in most studies was the proportion of women with incontinence following surgery. Few researchers have considered other outcomes, such as activities of daily living and quality of life. Few addressed general health status, repeat incontinence surgery, later prolapse surgery and time to return to normal activity level. Satisfaction with, and acceptability of, the treatment were also seldom addressed but are also important factors in choice of management.</P>
</QUALITY_OF_EVIDENCE>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-07-21 11:06:42 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2017-07-21 11:03:28 +0100" MODIFIED_BY="[Empty name]">
<P>Traditional slings seemed to be as effective as minimally invasive slings, but had higher rates of adverse effects. This should be interpreted with some caution however, as the quality of evidence in the studies was variable, follow-up short, and randomised trials do have inherent limitations in identifying complication rates. Traditional sling procedures appeared to confer a similar cure rate in comparison to open retropubic colposuspension, but the long-term adverse event profile is still unclear.</P>
<P>The data were too few to address whether the types of suburethral slings tested were as effective as other sling materials, injectables, drugs, or needle suspension. There was limited evidence from one small trial that slings made of non-absorbable synthetic Gore-Tex had more complications than slings made of biological rectus fascia.</P>
<P>The broader effects of suburethral slings could not be established since trials did not include appropriate outcome measures, such as general health status, pad testing, third-party analysis and time to return to normal activity level, and follow-up was limited.</P>
<P>Evidence to clarify whether or not traditional suburethral slings may be better or worse than surgical or conservative management options, other than those reported in this review, is lacking.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-07-21 11:06:42 +0100" MODIFIED_BY="[Empty name]">
<P>The methodology of trials and their appropriate reporting must be addressed in future research. Some of the evidence was limited by the poor quality and small numbers of the included randomised trials. The CONSORT guidelines should be used to ensure adequate reporting (<LINK REF="REF-Schultz-2010" TYPE="REFERENCE">Schultz 2010</LINK>).</P>
<P>There is a need for further trials of adequate power, better quality and reporting standard to assess the effectiveness of suburethral slings in comparison with other surgical techniques and different types of slings, and in specific situations such as in women who have already had previous continence surgery, or with anatomical restrictions.</P>
<P>Future research in incontinence treatments should incorporate standardised, validated and simple outcome measures, both participant-reported and clinician-observed. Outcomes should be relevant to women who have incontinence and are seeking treatment, and policymakers commissioning treatment, in order to allow comparison between treatments. In particular, quality of life, psychological and economic outcomes should be incorporated. Surgical trials related to urinary incontinence should systematically address surgical morbidity outcomes such as adverse peri- and post-operative events, length of hospital stay, time to return to normal activities, development of urge symptoms or detrusor overactivity and especially the need for repeat surgery or alternative interventions. Long-term follow-up (at least one year, preferably five years or more) is essential for the proper evaluation of incontinence treatments.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-07-21 11:06:42 +0100" MODIFIED_BY="[Empty name]">
<P>We would like to express our thanks to Sheila Wallace who helped us by providing information not found in Brazil. We are also very grateful to Professor Aldemar Araujo Castro from the Brazilian Cochrane Centre who provided a prompt and valuable contribution to the review. Professor Adrian Grant provided advice with interpretation of data and the final form of the first version of the review. Dr Jonathan Cook provided expert statistical advice.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-07-21 11:06:42 +0100" MODIFIED_BY="[Empty name]">
<P>Haroon Rehman: no interests to declare <BR/>Carlos CB Bezerra: no interests to declare<BR/>Homero Bruschini: no interests to declare<BR/>June D Cody: no interests to declare</P>
<P>Patricia Aluko: July 2017 - this project, to add brief economic commentaries to Cochrane Incontinence's reviews on surgery for urinary incontinence in women was supported by the National Institute for Health Research (NIHR), via the Cochrane Review Incentive Scheme 2016, to Cochrane Incontinence. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-07-21 11:06:42 +0100" MODIFIED_BY="[Empty name]">
<P>The review was conceived by CB and HB, and updated by HR and DJC. CB co-ordinated the steps of the review process with the help of DJC. Screening papers, appraising their quality and abstracting data were done by CB, HB and HR separately (published data only). The review was written by CB who extracted, analysed and interpreted data with the help of HB, and updated by HR. DJC assisted in the update for Feb 2003 by appraising, quality assessing, extracting data and assisting with interpretation.</P>
<P>For the July 2017 addition of the brief economic commentaries (BECs) to this review, Patricia Aluko was responsible for the entire BEC-related work on this review she ran the search for studies, screened the searches, extracted data from relevant studies, revised any existing economics-related text, added the BEC-related text, and responded to any peer referee comments. All review authors had the opportunity to comment on the revised review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-07-21 11:06:54 +0100" MODIFIED_BY="[Empty name]">
<P>July 2017 update &#8211; Brief economic commentaries (BECs) have been added to all of Cochrane Incontinence's reviews on surgery for urinary incontinence in women. The economic elements throughout the review have been revised &#8211; if incorrect they have been stripped out. New economics-related text has been added. This involved revisions to the Background section, Methods section (e.g. search section referring to added Appendix), Discussion section, Abstract and Plain language summary. An appendix has been added with details of the economics searches. The conclusions of the review have not changed. The rest of the review has not changed.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2010-12-08 12:05:02 +0000" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-07-23 11:44:27 +0100" MODIFIED_BY="Sheila Wallace">
<STUDIES MODIFIED="2017-07-21 11:26:40 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2017-07-21 11:25:05 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Albo-2007" MODIFIED="2017-07-21 11:23:45 +0100" MODIFIED_BY="[Empty name]" NAME="Albo 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-07-16 16:29:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Albo M, Wruck L, Baker J, Brubaker L, Chai T, Dandreo KJ, et al</AU>
<TI>The relationships among measures of incontinence severity in women undergoing surgery for stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2007</YR>
<VL>177</VL>
<NO>5</NO>
<PG>1810-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333947"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:22:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE, et al</AU>
<TI>Burch colposuspension versus fascial sling to reduce urinary stress incontinence</TI>
<SO>New England Journal of Medicine</SO>
<YR>2007</YR>
<VL>356</VL>
<NO>21</NO>
<PG>2143-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333948"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-16 09:52:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brubaker L, Chiang S, Zyczynski H, Norton P, Kalinoski DL, Stoddard A, et al</AU>
<TI>The impact of stress incontinence surgery on female sexual function</TI>
<SO>American Journal of Obstetrics &amp; Gynecology
</SO>
<YR>2009</YR>
<VL>200</VL>
<NO>5</NO>
<PG>562.e1-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333949"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 10:01:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brubaker L, Stoddard A, Richter H, Zimmern P, Moalli P, Kraus SR, et al</AU>
<TI>Mixed incontinence: comparing definitions in women having stress incontinence surgery</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>4</NO>
<PG>268-73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333950"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:08:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Chai T, Albo M, Richter H, Norton P, Dandreo K, Kenton K, et al</AU>
<TI>Adverse events from a randomized trial for the surgical treatment of stress urinary incontinence (Abstract number 512)</TI>
<SO>Proceedings of the 37th Annual Meeting of the International Continence Soceity (ICS), 20-24 Aug 2007, Rotterdam, Netherlands</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2010-07-22 10:25:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333951"/><IDENTIFIER MODIFIED="2010-07-22 10:25:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23535"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 10:25:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chai TC, Albo ME, Richter HE, Norton PA, Dandreo KJ, Kenton K, et al</AU>
<TI>Complications in women undergoing Burch colposuspension versus autologous rectus fascial sling for stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2009</YR>
<VL>181</VL>
<NO>5</NO>
<PG>2192-7</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:25:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333952"/><IDENTIFIER MODIFIED="2010-07-22 10:25:17 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="31150"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 10:33:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Daneshgari F, Kong W, Swartz M</AU>
<TI>Complications of mid urethral slings: important outcomes for future clinical trials</TI>
<SO>Journal of Urology</SO>
<YR>2008</YR>
<VL>180</VL>
<NO>5</NO>
<PG>1890-7</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:33:26 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333953"/><IDENTIFIER MODIFIED="2010-07-22 10:33:26 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="27706"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 10:33:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Daneshgari F</AU>
<TI>Words of wisdom. Re: Burch colposuspension versus fascial sling to reduce urinary stress incontinence</TI>
<SO>European Urology</SO>
<YR>2007</YR>
<VL>52</VL>
<NO>6</NO>
<PG>1794-5</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:33:57 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333954"/><IDENTIFIER MODIFIED="2010-07-22 10:33:57 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="26271"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 10:37:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diokno AC, Richter HE, Kenton K, Norton P, Albo M, Kraus S, et al</AU>
<TI>Risk factors associated with failure of surgical treatment for stress urinary incontinence at 24 months follow-up (Abstract number 115)</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>5</NO>
<PG>745</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:37:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333955"/><IDENTIFIER MODIFIED="2010-07-22 10:37:58 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23533"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 10:41:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>FitzGerald MP, Burgio KL, Borello-France DF, Menefee SA, Schaffer J, Kraus S, et al</AU>
<TI>Pelvic-floor strength in women with incontinence as assessed by the brink scale</TI>
<SO>Physical Therapy</SO>
<YR>2007</YR>
<VL>87</VL>
<NO>10</NO>
<PG>1316-24</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:41:29 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333956"/><IDENTIFIER MODIFIED="2010-07-22 10:41:29 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23825"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:22:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kenton K, Tennstedt S, Litman H, Zimmern P, Getti C, Kusek JW, et al</AU>
<TI>Improvement in quality of life in women at two years after undergoing the Burch colposuspension or fascial sling procedure (Abstract number 206)</TI>
<SO>Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20-24, Cairo, Egypt</SO>
<YR>2008</YR>
<IDENTIFIERS MODIFIED="2010-07-22 10:46:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333957"/><IDENTIFIER MODIFIED="2010-07-22 10:46:46 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="31863"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 10:50:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kraus SR, Markland A, Chai TC, Stoddard A, FitzGerald MP, Leng W, et al</AU>
<TI>Race and ethnicity do not contribute to differences in preoperative urinary incontinence severity or symptom bother in women who undergo stress incontinence surgery</TI>
<SO>American Journal of Obstetrics &amp; Gynecology.</SO>
<YR>2007</YR>
<VL>197</VL>
<NO>1</NO>
<PG>92-6</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:50:59 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333958"/><IDENTIFIER MODIFIED="2010-07-22 10:50:59 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23802"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:22:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lemack G, Krauss S, Litman H, FitzGerald M, Chai T, Nager C, et al</AU>
<TI>Preoperative urodynamic testing does not predict postoperative voiding dysfunction among women undergoing surgery for SUI: results from a prospective randomized trial comparing Burch versus pubovaginal sling (Abstract number 7, poster)</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>2</NO>
<PG>123</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:57:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333959"/><IDENTIFIER MODIFIED="2010-07-22 10:57:27 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="26919"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 10:58:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lemack GE, Krauss S, Litman H, FitzGerald MP, Chai T, Nager C, et al</AU>
<TI>Normal preoperative urodynamic testing does not predict voiding dysfunction after Burch colposuspension versus pubovaginal sling</TI>
<SO>Journal of Urology</SO>
<YR>2008</YR>
<VL>180</VL>
<NO>5</NO>
<PG>2076-80</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:58:05 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333960"/><IDENTIFIER MODIFIED="2010-07-22 10:58:05 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="27705"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:22:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lemack GE, Xu Y, Brubaker L, Nager C, Chai T, Moalli P, et al</AU>
<TI>Clinical and demographic factors associated with Valsalva leak point pressure among women undergoing Burch bladder neck suspension or autologous rectus fascial sling procedures</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>3</NO>
<PG>392-6</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:58:49 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333961"/><IDENTIFIER MODIFIED="2010-07-22 10:58:49 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23233"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:10:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mallett VT, Brubaker L, Stoddard AM, Borello-France D, Tennstedt S, Hall L, et al</AU>
<TI>The expectations of patients who undergo surgery for stress incontinence</TI>
<SO>American Journal of Obstetrics &amp; Gynecology.</SO>
<YR>2008</YR>
<VL>198</VL>
<NO>3</NO>
<PG>308.e1-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333962"/><IDENTIFIER TYPE="OTHER" VALUE="27182"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:12:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Markland AD, Kraus SR, Richter HE, Nager CW, Kenton K, Kerr L, et al</AU>
<TI>Prevalence and risk factors of fecal incontinence in women undergoing stress incontinence surgery</TI>
<SO>American Journal of Obstetrics &amp; Gynecology.</SO>
<YR>2007</YR>
<VL>197</VL>
<NO>6</NO>
<PG>662-7</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:12:08 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333963"/><IDENTIFIER MODIFIED="2010-07-22 11:12:08 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="26334"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:18:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nager C, Chai T, FitzGerald M, Lemack G, Kraus S, Sirls L, et al</AU>
<TI>Valsalva leak point pressure and detrusor overactivity do not predict, but urodynamic stress incontinence does predict continence outcomes after Burch or pubovaginal sling procedures (Abstract number 85)</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>5</NO>
<PG>709-11</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:18:00 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333964"/><IDENTIFIER MODIFIED="2010-07-22 11:18:00 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23532"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:17:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nager CW, Albo ME, FitzGerald MP, McDermott S, Wruck L, Kraus S, et al</AU>
<TI>Reference urodynamic values for stress incontinent women</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>3</NO>
<PG>333-40</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:17:35 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333965"/><IDENTIFIER MODIFIED="2010-07-22 11:17:35 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23232"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:19:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nager CW, Albo ME, FitzGerald MP, McDermott SM, Kraus S, Richter HE, et al</AU>
<TI>Process for development of multicenter urodynamic studies</TI>
<SO>Urology</SO>
<YR>2007</YR>
<VL>69</VL>
<NO>1</NO>
<PG>63-67; discussion 67-8</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:19:57 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333966"/><IDENTIFIER MODIFIED="2010-07-22 11:19:57 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23195"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:20:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nager CW, FitzGerald M, Kraus SR, Chai TC, Zyczynski H, Sirls L, et al</AU>
<TI>Urodynamic measures do not predict stress continence outcomes after surgery for stress urinary incontinence in selected women</TI>
<SO>Journal of Urology</SO>
<YR>2008</YR>
<VL>179</VL>
<NO>4</NO>
<PG>1470-4</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:20:36 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333967"/><IDENTIFIER MODIFIED="2010-07-22 11:20:36 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="27210"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:39:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richter H, Goode P, Brubaker L, Zyczynski H, Stoddard A, Dandreo K, et al</AU>
<TI>Two-year outcomes after surgery for stress urinary incontinence in older versus younger women (Abstract number 95)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>7</NO>
<PG>682-3</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:39:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333968"/><IDENTIFIER MODIFIED="2010-07-22 11:39:11 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="31854"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-16 09:56:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richter HE, Burgio KL, Brubaker L, Moalli PA, Markland AD, Mallet V, et al</AU>
<TI>Factors associated with incontinence frequency in a surgical cohort of stress incontinent women</TI>
<SO>American Journal of Obstetrics &amp; Gynecology
</SO>
<YR>2005</YR>
<VL>193</VL>
<NO>6</NO>
<PG>2088-93</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:30:24 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333969"/><IDENTIFIER MODIFIED="2010-07-22 11:30:24 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21231"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:31:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richter HE, Diokno A, Kenton K, Norton P, Albo M, Kraus S, et al</AU>
<TI>Predictors of treatment failure 24 months after surgery for stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2008</YR>
<VL>179</VL>
<NO>3</NO>
<PG>1024-30</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:31:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333970"/><IDENTIFIER MODIFIED="2010-07-22 11:31:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="27213"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:31:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richter HE, Diokno AC, Kenton K, Norton P, Albo M, Kraus S, et al</AU>
<TI>Predictors of treatment failure 24 months after surgery for stress urinary incontinence (Abstract number 5 Oral)</TI>
<SO>Journal of Pelvic Medicine &amp; Surgery</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>5</NO>
<PG>227-8</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:31:18 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333971"/><IDENTIFIER MODIFIED="2010-07-22 11:31:18 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="34197"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:40:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richter HE, Goode PS, Brubaker L, Zyczynski H, Stoddard AM, Dandreo KJ, et al</AU>
<TI>Two-year outcomes after surgery for stress urinary incontinence in older compared with younger women</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2008</YR>
<VL>112</VL>
<NO>3</NO>
<PG>621-9</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:40:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333972"/><IDENTIFIER MODIFIED="2010-07-22 11:40:27 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="29193"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-16 09:57:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strohbehn K</AU>
<TI>Shades of dry - 
curing urinary stress incontinence. [comment]</TI>
<SO>New England Journal of Medicine</SO>
<YR>2007</YR>
<VL>356</VL>
<NO>21</NO>
<PG>2198-200</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333973"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:47:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Subak LL, Brubaker L, Chai TC, Creasman JM, Diokno AC, Goode PS, et al</AU>
<TI>High costs of urinary incontinence among women electing surgery to treat stress incontinence</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2008</YR>
<VL>111</VL>
<NO>4</NO>
<PG>899-907</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:47:56 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333974"/><IDENTIFIER MODIFIED="2010-07-22 11:47:56 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="27122"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:09:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Tennstedt S, Borello-France D, FitzGerlad MP, Goode P, Kraus S, Kusek J, et al</AU>
<TI>Identification of factors related to health-related quality of life in women with stress urinary incontinence that may improve with surgical treatment (Abstract number 321)</TI>
<SO>Proceedings of the International Continence Society (ICS), 35th Annual Meeting, 2005 Aug 28-Sep 2, Montreal, Canada</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2010-07-22 11:52:21 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333975"/><IDENTIFIER MODIFIED="2010-07-22 11:52:21 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21098"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:23:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tennstedt S; Urinary Incontinence Treatment Network</AU>
<TI>Design of the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr)</TI>
<SO>Urology</SO>
<YR>2005</YR>
<VL>66</VL>
<NO>6</NO>
<PG>1213-7</PG>
<IDENTIFIERS MODIFIED="2010-07-22 11:52:00 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333976"/><IDENTIFIER MODIFIED="2010-07-22 11:52:00 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21530"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 11:53:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tennstedt SL, FitzGerald MP, Nager CW, Xu Y, Zimmern P, Kraus S, et al</AU>
<TI>Quality of life in women with stress urinary incontinence</TI>
<SO>International Urogynecology Journal &amp; Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>5</NO>
<PG>543-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333977"/><IDENTIFIER TYPE="OTHER" VALUE="30914"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:23:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tennstedt SL, Litman HJ, Zimmern P, Ghetti C, Kusek JW, Nager CW, et al</AU>
<TI>Quality of life after surgery for stress incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>12</NO>
<PG>1631-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333978"/><IDENTIFIER TYPE="OTHER" VALUE="31221"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:23:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walsh LP, Zimmern PE, Pope N, Shariat SF; Urinary Incontinence Treatment Network</AU>
<TI>Comparison of the Q-tip test and voiding cystourethrogram to assess urethral hypermobility among women enrolled in a randomized clinical trial of surgery for stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2006</YR>
<VL>176</VL>
<NO>2</NO>
<PG>646-649, discussion 650</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333979"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 12:09:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zimmern P, Nager CW, Albo M, FitzGerald MP, McDermott S, Urinary Incontinence Treatment Network</AU>
<TI>Interrater reliability of filling cystometrogram interpretation in a multicenter study</TI>
<SO>Journal of Urology</SO>
<YR>2006</YR>
<VL>175</VL>
<NO>6</NO>
<PG>2174-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333980"/><IDENTIFIER TYPE="OTHER" VALUE="22424"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-22 12:08:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zimmern P, Tennstedt S, Dickinson T, Dandreo K</AU>
<TI>Lessons learned from a patient burden survey following a large randomized controlled trial for the surgical management of stress urinary incontinence in women (Abstract number 152)</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>7</NO>
<PG>770-1</PG>
<IDENTIFIERS MODIFIED="2010-07-22 12:08:45 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333981"/><IDENTIFIER MODIFIED="2010-07-22 12:08:45 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="20805"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:23:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zimmern P; Urinary Incontinence Treatment Network (UITN)</AU>
<TI>Design of the SISTEr (Stress Incontinence Surgical Treatment Efficacy Trial) Study: a randomized surgical trial comparing Burch colposuspension and the autologous rectus fascia sling. A clinical trial of the NIH/NIDDK urinary incontinence treatment network (UITN) (Abstract number 81)</TI>
<SO>Progres en Urologie</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>3 Suppl 3</NO>
<PG>26</PG>
<IDENTIFIERS MODIFIED="2010-07-22 12:08:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333982"/><IDENTIFIER MODIFIED="2010-07-22 12:08:17 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="19780"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6333946"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amaro-2007" MODIFIED="2010-07-16 16:08:37 +0100" MODIFIED_BY="[Empty name]" NAME="Amaro 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-07-16 16:08:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amaro JL, Yamamoto HA, Kawano PR, Fugita O, Gameiro MOO, Barros G, et al</AU>
<TI>A prospective randomized trial of autologous fascial sling (AFS) versus tension-free vaginal tape (TVT) for treatment of stress urinary incontinence (SUI) (Poster abstract number 1460)</TI>
<SO>Journal of Urology</SO>
<YR>2007</YR>
<VL>177</VL>
<NO>4 Suppl 4</NO>
<PG>482</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333984"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6333983"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arunkalaivanan-2003" MODIFIED="2017-07-21 11:09:25 +0100" MODIFIED_BY="[Empty name]" NAME="Arunkalaivanan 2003" YEAR="2003">
<REFERENCE MODIFIED="2017-07-21 11:09:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Abdel-Fattah M, Arunkalaivanan AS, Barrington JW</AU>
<TI>Pelvicol (trademark) implant v TVT (trademark): an update (Abstract)</TI>
<SO>Proceedings of the 27th Annual Meeting of the International Urogynecological Association, 21-24 Aug 2002, Prague, Czech Republic</SO>
<YR>2002</YR>
<IDENTIFIERS MODIFIED="2010-07-14 15:38:00 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333985"/><IDENTIFIER TYPE="OTHER" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-16 16:03:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Barrington JW, Arunkalaivanan AS</AU>
<TI>Pelvicol pubovaginal sling versus tension-free vaginal tape for treatment of urodynamic stress incontinence: a prospective randomized three-year follow-up study</TI>
<SO>European Urology</SO>
<YR>2004</YR>
<VL>46</VL>
<NO>5</NO>
<PG>629-35</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843727"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-16 10:04:12 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 17965&lt;/p&gt;" NOTES_MODIFIED="2017-07-16 10:04:12 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Arunkalaivan AS, Barrington JW</AU>
<TI>Randomized trial of porcine dermal sling (Pelvicol TM implant) vs. tension-free vaginal tape (TVT) in the surgical treatment of stress incontinence: a questionnaire-based study</TI>
<SO>International Urogynecology Journal</SO>
<YR>2003</YR>
<VL>14</VL>
<PG>17-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333986"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-14 15:32:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arunkalaivanan AS, Barrington JW</AU>
<TI>Comparison of porcine pubo vaginal sling (Pelvicol) vs tension free vaginal tape (TVT) in the surgical management of stress incontinence (Abstract)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>Suppl 3</NO>
<PG>S21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843729"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843725"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bai-2005" MODIFIED="2010-07-21 10:26:58 +0100" MODIFIED_BY="[Empty name]" NAME="Bai 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-07-21 10:26:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bai SW, Sohn WH, Chung DJ, Park JH, Kim SK</AU>
<TI>Comparison of the efficacy of Burch colposuspension, pubovaginal sling, and tension-free vaginal tape for stress urinary incontinence</TI>
<SO>International Journal of Gynaecology &amp; Obstetrics</SO>
<YR>2005</YR>
<VL>91</VL>
<NO>3</NO>
<PG>246-51</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:26:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843731"/><IDENTIFIER MODIFIED="2010-07-21 10:26:58 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21260"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-07-07 16:42:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843730"/><IDENTIFIER MODIFIED="2010-07-07 16:42:58 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="{21260}"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barbalias-1997" MODIFIED="2010-07-21 10:21:06 +0100" MODIFIED_BY="[Empty name]" NAME="Barbalias 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-07-21 10:21:06 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{5560}&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:21:06 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barbalias G, Liatsikos E, Barbalias D</AU>
<TI>Use of slings made of indigenous and allogenic material (Goretex) in type III urinary incontinence and comparison between them</TI>
<SO>European Urology</SO>
<YR>1997</YR>
<VL>31</VL>
<NO>4</NO>
<PG>394-400</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:21:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843733"/><IDENTIFIER TYPE="MEDLINE" VALUE="97331564"/><IDENTIFIER MODIFIED="2010-07-21 10:21:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="5560"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843732"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Basok-2008" MODIFIED="2010-07-21 16:04:06 +0100" MODIFIED_BY="[Empty name]" NAME="Basok 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-07-21 16:04:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Basok EK, Yildirim A, Atsu N, Basaran A, Tokuc R</AU>
<TI>Cadaveric fascia lata versus intravaginal slingplasty for the pubovaginal sling: surgical outcome, overall success and patient satisfaction rates</TI>
<SO>Urologia Internationalis</SO>
<YR>2008</YR>
<VL>80</VL>
<NO>1</NO>
<PG>46-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843735"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843734"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Demirci-2001" MODIFIED="2017-07-21 11:24:00 +0100" MODIFIED_BY="[Empty name]" NAME="Demirci 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-07-16 10:06:48 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{13419}&lt;/p&gt;" NOTES_MODIFIED="2017-07-16 10:06:48 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Demirci F, Yucel O</AU>
<TI>Comparison of free rectus fascial sling and Burch colposuspension procedures in type I and type II genuine stress incontinence (Abstract)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2000</YR>
<VL>11</VL>
<NO>Suppl 1</NO>
<PG>S48</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:30:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843740"/><IDENTIFIER MODIFIED="2010-07-21 10:30:27 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="13419"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:24:00 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{13079}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:24:00 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Demirci F, Yucel O</AU>
<TI>Comparison of pubovaginal sling and Burch colposuspension procedures in type I/II genuine stress incontinence</TI>
<SO>Archives of Gynecology &amp; Obstetrics</SO>
<YR>2001</YR>
<VL>265</VL>
<NO>4</NO>
<PG>190-4</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:27:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843741"/><IDENTIFIER MODIFIED="2010-07-21 10:27:46 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="13079"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843739"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Enzelsberger-1996" MODIFIED="2017-07-21 11:24:17 +0100" MODIFIED_BY="[Empty name]" NAME="Enzelsberger 1996" YEAR="1996">
<REFERENCE MODIFIED="2017-07-21 11:24:09 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{2759}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:24:09 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Enzelsberger H, Helmer H, Schatten C</AU>
<TI>Comparison of Burch and Lyodura sling procedures for repair of unsuccessful incontinence surgery</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1996</YR>
<VL>88</VL>
<NO>2</NO>
<PG>251-6</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:32:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333987"/><IDENTIFIER TYPE="MEDLINE" VALUE="96305278"/><IDENTIFIER MODIFIED="2010-07-21 10:32:46 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="2759"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:24:17 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{100} {6204}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:24:17 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Enzelsberger H, Kurz C, Seifert M, Raimann H, Schatten C</AU>
<TI>Surgical treatment of recurrent stress incontinence: Burch versus Lyodura sling operation--a prospective study</TI>
<TO>Zur operativen behandlung der rezidivstre binkontinenz: Burch versus Lyoduraschlingeoperation - eine prospektive studie</TO>
<SO>Geburtshilfe und Frauenheilkunde</SO>
<YR>1993</YR>
<VL>53</VL>
<NO>7</NO>
<PG>467-71</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:33:15 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333988"/><IDENTIFIER TYPE="MEDLINE" VALUE="93380604"/><IDENTIFIER MODIFIED="2010-07-21 10:33:15 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="6197"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843742"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fischer-2001" MODIFIED="2010-07-21 10:36:06 +0100" MODIFIED_BY="[Empty name]" NAME="Fischer 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-07-21 10:36:06 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{12008}&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:36:06 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fischer JR, Hale DS, McClellan E, Benson JT</AU>
<TI>The use of urethral electrodiagnosis to select the method of surgery in women with intrinsic sphincter deficiency (Abstract)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>Suppl 1</NO>
<PG>S33</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:36:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843746"/><IDENTIFIER MODIFIED="2010-07-21 10:36:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="12008"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843745"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guerrero-2008" MODIFIED="2017-07-21 11:24:27 +0100" MODIFIED_BY="[Empty name]" NAME="Guerrero 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-07-21 11:24:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Guerrero K, Whareham K, Watkins A, Ismail S, Lucas M, Emery S</AU>
<TI>A randomised control trial comparing TVT, Pelvicol and autologous fascial slings for the management of stress urinary incontinence in women (Abstract number 1)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>7</NO>
<PG>571</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:36:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333990"/><IDENTIFIER MODIFIED="2010-07-21 10:36:58 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="31847"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:09:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Lucas M, Emery S, Alan W, Kathy W</AU>
<TI>Failure of porcine xenograft sling in a randomised controlled trial of three sling materials in surgery for stress incontinence (Abstract)</TI>
<SO>Proceedings of the International Continence Society (34th Annual Meeting) and the International UroGynecological Association, 23-27 August, 2004, Paris</SO>
<YR>2004</YR>
<PG>Abstract number 309</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333991"/><IDENTIFIER TYPE="OTHER" VALUE="19056"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6333989"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Henriksson-1978" MODIFIED="2010-07-21 10:39:05 +0100" MODIFIED_BY="[Empty name]" NAME="Henriksson 1978" YEAR="1978">
<REFERENCE MODIFIED="2010-07-21 10:38:42 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{5152}&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:38:42 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Henriksson L, Asmussen M, Löfgren O, Ulmsten U</AU>
<TI>A urodynamic comparison between abdominal urethrocystopexy and vaginal sling plasty in female stress incontinence</TI>
<SO>Urologia Internationalis</SO>
<YR>1978</YR>
<VL>33</VL>
<PG>111-6</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:38:42 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843758"/><IDENTIFIER MODIFIED="2010-07-21 10:38:42 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="5152"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-21 10:39:05 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{2670}&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:39:05 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Henriksson L, Ulmsten U</AU>
<TI>A urodynamic evaluation of the effects of abdominal urethrocystopexy and vaginal sling urethroplasty in women with stress incontinence</TI>
<SO>American Journal of Obstetrics &amp; Gynecology</SO>
<YR>1978</YR>
<VL>131</VL>
<NO>1</NO>
<PG>77-82</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:39:05 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843759"/><IDENTIFIER TYPE="MEDLINE" VALUE="78163583"/><IDENTIFIER MODIFIED="2010-07-21 10:39:05 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="2670"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843757"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hilton-1989" MODIFIED="2010-07-21 10:40:40 +0100" MODIFIED_BY="[Empty name]" NAME="Hilton 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-07-21 10:40:40 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{453}&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:40:40 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hilton P</AU>
<TI>A clinical and urodynamic study comparing the Stamey bladder neck suspension and suburethral sling procedures in the treatment of genuine stress incontinence</TI>
<SO>British Journal of Obstetrics &amp; Gynaecology</SO>
<YR>1989</YR>
<VL>96</VL>
<NO>2</NO>
<PG>213-20</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:40:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843761"/><IDENTIFIER TYPE="MEDLINE" VALUE="89194157"/><IDENTIFIER MODIFIED="2010-07-21 10:40:40 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="453"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843760"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kondo-2006" MODIFIED="2017-07-21 11:09:47 +0100" MODIFIED_BY="[Empty name]" NAME="Kondo 2006" YEAR="2003">
<REFERENCE MODIFIED="2010-07-21 10:42:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kondo A, Isobe Y, Kimura K, Kamihira O, Matsuura O, Gotoh M, et al</AU>
<TI>Efficacy, safety and hospital costs of tension-free vaginal tape and pubovaginal sling in the surgical treatment of stress incontinence</TI>
<SO>Journal of Obstetrics &amp; Gynaecology Research</SO>
<YR>2006</YR>
<VL>32</VL>
<NO>6</NO>
<PG>539-44</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:42:53 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843763"/><IDENTIFIER MODIFIED="2010-07-21 10:42:53 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="22233"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:09:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kondo A, Isobe Y, Kimura K, Kamihira O, Matsuura O</AU>
<TI>A randomized control trial of tension-free vaginal tape vs pubovaginal sling: cure rates and QOL improvement (Abstract number 629)</TI>
<SO>Proceedings of the International Continence Society (ICS), 35th Annual Meeting, 2005 Aug 28-Sep 2, Montreal, Canada</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2010-07-21 10:42:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843764"/><IDENTIFIER MODIFIED="2010-07-21 10:42:23 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21077"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-21 10:46:55 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 17109&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:46:55 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kondo A, Kimura K, Isobe Y, Kamihira O, Matsuura O</AU>
<TI>A randomised control trial of tension-free vaginal tape in comparison with pubovaginal sling in the treatment of stress incontinence (Abstract)</TI>
<SO>Neurourology Urodynamics</SO>
<YR>2003</YR>
<VL>22</VL>
<NO>5</NO>
<PG>485-7</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:46:55 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843765"/><IDENTIFIER MODIFIED="2010-07-21 10:46:55 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="17109"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843762"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lucas-2000" MODIFIED="2017-07-16 10:17:27 +0100" MODIFIED_BY="[Empty name]" NAME="Lucas 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-07-16 10:17:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Guerrero K, Watkins A, Emery S, Wareham K, Stephenson T, Logan V, et al</AU>
<TI>A randomised controlled trial comparing two autologous fascial sling techniques for the treatment of stress urinary incontinence in women: short, medium and long-term follow-up</TI>
<SO>International Urogynecology Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>11</NO>
<PG>1263-70</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:47:47 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843767"/><IDENTIFIER MODIFIED="2010-07-21 10:47:47 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23957"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-21 10:50:39 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{8995}&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:50:39 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Lucas M, Emery S, Stephenson T, Wareham K, Cheung I, Russell I et al</AU>
<SO>A randomised study to assess and compare the clinical effectiveness of two surgical techniques for the treatment of stress urinary incontinence in women</SO>
<YR>2000</YR>
<PB>The Wales Office of Research &amp; Development for Health &amp; Social Care</PB>
<CY>Report No. RC080. Cardiff, Wales, UK</CY>
<IDENTIFIERS MODIFIED="2010-07-21 10:50:39 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843768"/><IDENTIFIER MODIFIED="2010-07-21 10:50:39 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="8995"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-21 10:51:07 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 12901&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:51:07 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lucas M, Emery S, Stephenson T, Wareham K, Cheung I</AU>
<TI>A randomised study to assess and compare the clinical effectiveness of two surgical techniques for the treatment of stress urinary incontinence in women</TI>
<SO>Spotlight (Newsletter of The Wales Office of Research)</SO>
<YR>2000</YR>
<IDENTIFIERS MODIFIED="2010-07-21 10:51:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843769"/><IDENTIFIER MODIFIED="2010-07-21 10:51:07 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="12901"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843766"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maher-2005" MODIFIED="2017-07-21 11:24:38 +0100" MODIFIED_BY="[Empty name]" NAME="Maher 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-07-21 11:24:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maher CF, Dwyer PL, Carey MP, Cornish A, Schluter PJ</AU>
<TI>Pubovaginal sling or transurethral Macroplastique for genuine stress incontinence and intrinsic sphincter deficiency: a prospective randomised trial (Abstract)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>Suppl 3</NO>
<PG>S9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333992"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-30 14:23:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Maher CF, O'Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P</AU>
<TI>Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial</TI>
<SO>BJOG: an International Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2005</YR>
<VL>112</VL>
<NO>6</NO>
<PG>797-801</PG>
<IDENTIFIERS MODIFIED="2010-07-20 10:00:44 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843772"/><IDENTIFIER MODIFIED="2010-07-20 10:00:44 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="20579"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843770"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Osman-2003" MODIFIED="2010-07-21 10:52:13 +0100" MODIFIED_BY="[Empty name]" NAME="Osman 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-07-21 10:52:13 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 16660&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:52:13 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osman T</AU>
<TI>Stress incontinence surgery for patients presenting with mixed incontinence and a normal cystometrogram</TI>
<SO>BJU International</SO>
<YR>2003</YR>
<VL>92</VL>
<PG>964-8</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:52:13 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843779"/><IDENTIFIER MODIFIED="2010-07-21 10:52:13 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="16660"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843778"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pacetta-2005" MODIFIED="2010-07-22 14:33:02 +0100" MODIFIED_BY="[Empty name]" NAME="Pacetta 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-07-22 14:33:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pacetta AM, Carramao SS, Limoge DC, Mendes V, Date A, Sousa E, et al</AU>
<TI>Stress urinary incontinence: a prospective randomized study comparing FortaPerm to autologous fascia (Abstract number 109)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2005</YR>
<VL>16</VL>
<NO>Suppl 2</NO>
<PG>S58</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843781"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843780"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sand-2000" MODIFIED="2017-07-21 11:24:47 +0100" MODIFIED_BY="[Empty name]" NAME="Sand 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-07-16 10:21:35 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 16706&lt;/p&gt;" NOTES_MODIFIED="2017-07-16 10:21:35 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Culligan PJ, Goldberg RP, Sand PK</AU>
<TI>A randomized controlled trial comparing a modified Burch procedure and a suburethral sling: long-term follow-up</TI>
<SO>International Urogynecology Journal</SO>
<YR>2003</YR>
<VL>14</VL>
<PG>229-33</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:53:29 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333993"/><IDENTIFIER MODIFIED="2010-07-21 10:53:29 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="16706"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:09:58 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{5689}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:09:58 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Culligan PJ, Winkler HA, Blackhurst DW, Sand PK</AU>
<TI>A prospective randomized study of modified Burch retro pubic urethropexy and suburethral sling for genuine stress incontinence and low pressure urethra (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 28th Annual Meeting, 14-17 Sept, Jerusalem, Israel</SO>
<YR>1998</YR>
<PG>133</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:54:00 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843784"/><IDENTIFIER MODIFIED="2010-07-21 10:54:00 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="5689"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:24:47 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{12004}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:24:47 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldberg RP, Sand PK, Koduri S, Culligan PJ</AU>
<TI>A prospective randomized study comparing modified Burch retropubic urethropexy and suburethral sling: long term follow-up (abstract)</TI>
<SO>International Urogynaecology Journal</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>Suppl 1</NO>
<PG>S6</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:55:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333994"/><IDENTIFIER MODIFIED="2010-07-21 10:55:40 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="12004"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-21 10:59:01 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{9013}&lt;/p&gt;" NOTES_MODIFIED="2010-07-21 10:59:01 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sand PK, Winkler H, Blackhurst DW, Culligan PJ</AU>
<TI>A prospective randomized study comparing modified Burch retropubic urethropexy and suburethral sling for treatment of genuine stress incontinence with low-pressure urethra</TI>
<SO>American Journal of Obstetrics &amp; Gynecology</SO>
<YR>2000</YR>
<VL>182</VL>
<NO>1 Pt 1</NO>
<PG>30-4</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:59:01 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843786"/><IDENTIFIER TYPE="MEDLINE" VALUE="20114937"/><IDENTIFIER MODIFIED="2010-07-21 10:59:01 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="11781"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843782"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharifiaghdas-2008" MODIFIED="2010-07-20 09:59:26 +0100" MODIFIED_BY="[Empty name]" NAME="Sharifiaghdas 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-07-20 09:59:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharifiaghdas F, Mortazavi N</AU>
<TI>Tension-free vaginal tape and autologous rectus fascia pubovaginal sling for the treatment of urinary stress incontinence: a medium-term follow-up</TI>
<SO>Medical Principles &amp; Practice</SO>
<YR>2008</YR>
<VL>17</VL>
<NO>3</NO>
<PG>209-14</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843788"/><IDENTIFIER TYPE="OTHER" VALUE="31878"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843787"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shin-2001" MODIFIED="2017-07-21 11:10:06 +0100" MODIFIED_BY="[Empty name]" NAME="Shin 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-07-21 11:10:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Shin MS, Kim JH, Koh JS, Jung JH</AU>
<TI>Comparison of the results of sling procedure using autologous dermal graft patch and cadaveric fascia lata as a sling material for stress urinary incontinence (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 31st Annual Meeting, 18-21 Sept, Seoul, Korea</SO>
<YR>2001</YR>
<PG>Abstract number 313</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:24:20 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843790"/><IDENTIFIER MODIFIED="2010-07-21 10:24:20 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="14477"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843789"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Silva-Filho-2006" MODIFIED="2010-07-20 17:02:55 +0100" MODIFIED_BY="[Empty name]" NAME="Silva Filho 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-07-20 17:02:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Silva-Filho AL, Candido EB, Noronha A, Triginelli SA</AU>
<TI>Comparative study of autologous pubovaginal sling and synthetic transobturator (TOT) SAFYRE sling in the treatment of stress urinary incontinence</TI>
<SO>Archives of Gynecology &amp; Obstetrics</SO>
<YR>2006</YR>
<VL>273</VL>
<NO>5</NO>
<PG>288-92</PG>
<IDENTIFIERS MODIFIED="2010-07-20 17:02:55 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843792"/><IDENTIFIER MODIFIED="2010-07-20 17:02:55 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21600"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843791"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Song-2004" MODIFIED="2017-07-21 11:25:05 +0100" MODIFIED_BY="[Empty name]" NAME="Song 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-07-21 11:25:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Song YF, Huang HJ, Xu B, Hao L</AU>
<TI>[Comparative study of tension-free vaginal tape and fascia lata for stress urinary incontinence]. [Chinese]</TI>
<SO>Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]</SO>
<YR>2004</YR>
<VL>39</VL>
<NO>10</NO>
<PG>658-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843794"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843793"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tcherniakovsky-2009" MODIFIED="2010-07-21 11:00:23 +0100" MODIFIED_BY="[Empty name]" NAME="Tcherniakovsky 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-07-21 11:00:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tcherniakovsky M, Fernandes CE, Bezerra CA, Del Roy CA, Wroclawski ER</AU>
<TI>Comparative results of two techniques to treat stress urinary incontinence: synthetic transobturator and aponeurotic slings</TI>
<SO>International Urogynecology Journal</SO>
<YR>2009</YR>
<VL>20</VL>
<NO>8</NO>
<PG>961-6</PG>
<IDENTIFIERS MODIFIED="2010-07-21 11:00:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843796"/><IDENTIFIER MODIFIED="2010-07-21 11:00:23 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="32120"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843795"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Teixeira-2008" MODIFIED="2017-07-21 11:10:15 +0100" MODIFIED_BY="[Empty name]" NAME="Teixeira 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-07-21 11:10:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Teixeira M, Pinto AR, Montalvao M, Candoso B</AU>
<TI>Systemic and local inflammatory response in collagen vs. polypropylene tapes for stress urinary incontinence: is there any difference? (Abstract number 527)</TI>
<SO>Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20-24, Cairo, Egypt</SO>
<YR>2008</YR>
<IDENTIFIERS MODIFIED="2010-07-20 10:02:36 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843798"/><IDENTIFIER MODIFIED="2010-07-20 10:02:36 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="31878"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843797"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Viseshsindh-2003" MODIFIED="2017-07-16 10:25:11 +0100" MODIFIED_BY="[Empty name]" NAME="Viseshsindh 2003" YEAR="2003">
<REFERENCE MODIFIED="2017-07-16 10:25:11 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 15733&lt;/p&gt;" NOTES_MODIFIED="2017-07-16 10:25:11 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Viseshsindh W, Kochakarn W, Waikakul W, Roongruangsilp U</AU>
<TI>A randomized controlled trial of pubovaginal sling versus vaginal wall sling for stress urinary incontinence</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>2003</YR>
<VL>86</VL>
<NO>4</NO>
<PG>308-15</PG>
<IDENTIFIERS MODIFIED="2010-07-21 10:21:18 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333995"/><IDENTIFIER MODIFIED="2010-07-21 10:21:18 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="15733"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843801"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wadie-2005" MODIFIED="2017-07-21 11:10:41 +0100" MODIFIED_BY="[Empty name]" NAME="Wadie 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-07-21 11:10:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wadie B, Henawy A</AU>
<TI>Does urethral pressure measurement correlate to the outcome of incontinence surgery? (Abstract number 546)</TI>
<SO>Proceedings of the 37th Annual Meeting of the ICS, 20-24 Aug 2007, Rotterdam, The Netherlands</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2010-07-21 11:02:03 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333997"/><IDENTIFIER MODIFIED="2010-07-21 11:02:03 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="26689"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:10:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Wadie BS, Edwan A, Nabeeh A</AU>
<TI>Autologous fascial sling verus polypropylene tape at short term follow up, a prospective randomized study (Abstract number 636)</TI>
<SO>Proceedings of the International Continence Society (ICS), 35th Annual Meeting, 2005 Aug 28-Sep 2, Montreal, Canada</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2010-07-21 11:02:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333998"/><IDENTIFIER MODIFIED="2010-07-21 11:02:27 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21100"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-16 10:25:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wadie BS, Edwan A, Nabeeh AM</AU>
<TI>Autologous fascial sling vs polypropylene tape at short-term follow up: a prospective randomized study</TI>
<SO>Journal of Urology</SO>
<YR>2005</YR>
<VL>174</VL>
<NO>3</NO>
<PG>990-3</PG>
<IDENTIFIERS MODIFIED="2010-07-21 11:03:32 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6333999"/><IDENTIFIER MODIFIED="2010-07-21 11:03:32 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="20796"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-21 11:04:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wadie BS, El Hefnawy AS</AU>
<TI>Urethral pressure measurement in stress incontinence: does it help?</TI>
<SO>International Urology &amp; Nephrology</SO>
<YR>2009</YR>
<VL>41</VL>
<NO>3</NO>
<PG>491-5</PG>
<IDENTIFIERS MODIFIED="2010-07-21 11:04:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334000"/><IDENTIFIER MODIFIED="2010-07-21 11:04:23 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="32131"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6333996"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-07-21 11:26:40 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Amat-2007" MODIFIED="2017-07-21 11:25:16 +0100" MODIFIED_BY="[Empty name]" NAME="Amat 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-07-21 11:25:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amat LL, Franco EM, Saavedra AH, Martinez AV</AU>
<TI>Needleless (R): a new technique for correction of urinary incontinence. Randomized controlled trial compared with TVT-O (R). Preliminary results (Abstract number 225)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S128</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334001"/><IDENTIFIER TYPE="OTHER" VALUE="27329"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843811"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Atherton-2000" MODIFIED="2008-10-30 14:42:51 +0000" MODIFIED_BY="[Empty name]" NAME="Atherton 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-10-30 14:42:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Atherton MJ, Stanton SL</AU>
<TI>TVT and colposuspension: comparisons and contrasts of possible mechanisms (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>4</NO>
<PG>396-8</PG>
<EN>19</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843814"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843813"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aurunkalaivanan-2001" MODIFIED="2010-11-19 11:53:59 +0000" MODIFIED_BY="[Empty name]" NAME="Aurunkalaivanan 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-11-19 11:53:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arunkalaivanan AS, Barrington JW</AU>
<TI>Comparison of porcine pubo vaginal sling (Pelvicol) vs tension free vaginal tape (TVT) in the surgical management of stress incontinence (Abstract)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2001</YR>
<VL>12 (Suppl 3)</VL>
<PG>S21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843816"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843815"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barrington-2003" MODIFIED="2017-07-21 11:10:49 +0100" MODIFIED_BY="[Empty name]" NAME="Barrington 2003" YEAR="2003">
<REFERENCE MODIFIED="2017-07-21 11:10:49 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 16334&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:10:49 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Barrington JW</AU>
<TI>Pelvicol implant vs TVT - a randomised prospective study</TI>
<SO>Proceedings of the BARD Satellite Symposium to the International Continence Society Annual Meeting, 7 Oct</SO>
<YR>2003</YR>
<VL>8</VL>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843818"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843817"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bruschini-2005" MODIFIED="2017-07-21 11:10:57 +0100" MODIFIED_BY="[Empty name]" NAME="Bruschini 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-07-21 11:10:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bruschini H, Nunes R, Truzzi JC, Simonetti R, Cury J, Ortiz V, et al</AU>
<TI>Low cost polypropylene sling procedure for correction of stress urinary incontinence: a possible solution for developing countries? (Abstract number 360)</TI>
<SO>Proceedings of the International Continence Society (ICS), 35th Annual Meeting, 2005 Aug 28-Sep 2, Montreal, Canada</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843822"/><IDENTIFIER TYPE="OTHER" VALUE="21055"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843821"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choe-2000" MODIFIED="2017-07-16 10:28:42 +0100" MODIFIED_BY="[Empty name]" NAME="Choe 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-07-16 10:28:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choe JM, Ogan K, Battino BS</AU>
<TI>Antimicrobial mesh versus vaginal wall sling: a comparative outcomes analysis</TI>
<SO>Journal of Urology</SO>
<YR>2000</YR>
<VL>163</VL>
<NO>6</NO>
<PG>1829-34</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334003"/><IDENTIFIER TYPE="MEDLINE" VALUE="20259643"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;ID: 11144&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choe JM</AU>
<TI>The use of synthetic materials in pubovaginal sling</TI>
<SO>Advances in Experimental Medicine &amp; Biology</SO>
<YR>2003</YR>
<VL>539</VL>
<NO>Pt A</NO>
<PG>481-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334004"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6334002"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choe-2001" MODIFIED="2017-07-21 11:11:05 +0100" MODIFIED_BY="[Empty name]" NAME="Choe 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-07-21 11:11:05 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 14377&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:11:05 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Choe JM</AU>
<TI>Sling surgery performed with and without preoperative urodynamics: a comparative outcomes analysis</TI>
<SO>Proceedings of the International Continence Society (ICS), 31st Annual Meeting, 18-21 Sept, Seoul, Korea</SO>
<YR>2001</YR>
<PG>Abstract number 175</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843824"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843823"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chong-2003" NAME="Chong 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chong C, Bane A, Corstiaans A</AU>
<TI>Intraoperative division of tensionless vaginal tape (TVT) - prospective randomized trial (Abstract)</TI>
<SO>Singapore Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2003</YR>
<VL>34 (Suppl 1)</VL>
<PG>55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843826"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843825"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Corcos-2001" MODIFIED="2017-07-16 10:28:31 +0100" MODIFIED_BY="[Empty name]" NAME="Corcos 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-07-22 10:30:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corcos J, Collet JP, Shapiro S, Herschorn S, Radomski SB, Schick E, et al</AU>
<TI>Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence</TI>
<SO>Urology</SO>
<YR>2005</YR>
<VL>65</VL>
<NO>5</NO>
<PG>898-904</PG>
<IDENTIFIERS MODIFIED="2010-07-22 10:30:45 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843828"/><IDENTIFIER MODIFIED="2010-07-22 10:30:45 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="20346"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-16 10:28:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Corcos J, Collet JP, Shappiro S, Schick E, Macramallah E, Tessier J et al
</AU>
<TI>Surgery vs collagen for the treatment of female stress urinary incontinence (SUI): results of a multicentric randomized trial (Abstract)</TI>
<SO>Journal of Urology</SO>
<YR>2001</YR>
<VL>165</VL>
<NO>5 Suppl</NO>
<PG>198</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334005"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843827"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Darai-2007" MODIFIED="2017-07-21 11:25:26 +0100" MODIFIED_BY="[Empty name]" NAME="Darai 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-07-16 10:31:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Darai E, Frobert JL, Grisard-Anaf M, Lienhart J, Fernandez H, Dubernard G, et al</AU>
<TI>Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes</TI>
<SO>European Urology</SO>
<YR>2007</YR>
<VL>51</VL>
<NO>3</NO>
<PG>795-802</PG>
<IDENTIFIERS MODIFIED="2010-07-19 11:48:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334006"/><IDENTIFIER MODIFIED="2010-07-19 11:48:23 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="22550"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:25:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>David-Montefiore E, Frobert JL, Grisard-Anaf M, Liehart J, Fernandez H, Dubernard G, et al</AU>
<TI>Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334007"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-19 11:48:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>David-Montefiore E, Frobert JL, Grisard-Anaf M, Lienhart J, Bonnet K, Poncelet C, et al</AU>
<TI>Peri-operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes</TI>
<SO>European Urology</SO>
<YR>2006</YR>
<VL>49</VL>
<NO>1</NO>
<PG>133-8</PG>
<IDENTIFIERS MODIFIED="2010-07-19 11:48:10 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843833"/><IDENTIFIER MODIFIED="2010-07-19 11:48:10 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="21623"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843830"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Debodinance-1993" MODIFIED="2017-07-21 11:25:36 +0100" MODIFIED_BY="[Empty name]" NAME="Debodinance 1993" YEAR="1993">
<REFERENCE MODIFIED="2017-07-16 10:33:10 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{50}&lt;/p&gt;" NOTES_MODIFIED="2017-07-16 10:33:10 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Debodinance P, Querleu D</AU>
<TI>Comparison of the Bologna and Ingelman-Sundber procedures for stress incontinence associated with genital prolapse: prospective randomized study
</TI>
<SO>European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology</SO>
<YR>1993</YR>
<VL>52</VL>
<NO>1</NO>
<PG>35-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334008"/><IDENTIFIER TYPE="MEDLINE" VALUE="94164373"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:25:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Debodinance P</AU>
<TI>[Comparison of the Bologna and Ingelman-Sundberg procedures for stress incontinence associated with genital prolapse: ten-year follow-up of a prospective randomized study]. [French]</TI>
<SO>Journal de Gynecologie , Obstetrique et Biologie de la Reproduction</SO>
<YR>2000</YR>
<VL>29</VL>
<NO>2</NO>
<PG>148-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843836"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843834"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Debodinance-1994" MODIFIED="2017-07-21 11:25:47 +0100" MODIFIED_BY="[Empty name]" NAME="Debodinance 1994" YEAR="1994">
<REFERENCE MODIFIED="2017-07-21 11:25:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Debodinance P, De Bievre P, Parmentier D, Dubrulle R, Querleu D, Crepin G</AU>
<TI>[The "hazards" of using a Gore-Tex sling in the treatment of stress urinary incontinence]. [French]</TI>
<SO>Journal de Gynecologie, Obstetrique et Biologie de la Reproduction</SO>
<YR>1994</YR>
<VL>23</VL>
<NO>6</NO>
<PG>665-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843838"/><IDENTIFIER TYPE="MEDLINE" VALUE="3127"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843837"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giri-2004" MODIFIED="2017-07-21 11:25:57 +0100" MODIFIED_BY="[Empty name]" NAME="Giri 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-07-21 11:25:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giri SK, Hickey JP, Macdonald J, Narasimahulu G, Cashman E, Drumm J, et al</AU>
<TI>Prospective, randomised trial of xenograft versus rectus fascia pubovaginal sling in the treatment of stress urinary incontinence (abstract number 13)</TI>
<SO>Irish Journal of Medical Science</SO>
<YR>2004</YR>
<VL>173</VL>
<NO>1 Suppl 1</NO>
<PG>18</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334009"/><IDENTIFIER TYPE="OTHER" VALUE="29716"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843841"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giri-2006" MODIFIED="2017-07-21 11:11:17 +0100" MODIFIED_BY="[Empty name]" NAME="Giri 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-11-19 12:17:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Giri SK, Hickey JP, Sil D, Mabadeje O, Shaikh FM, Narasimhulu G, et al</AU>
<TI>The long-term results of pubovaginal sling surgery using acellular cross-linked porcine dermis in the treatment of urodynamic stress incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2006</YR>
<VL>175</VL>
<NO>5</NO>
<PG>1788-92; discussion 1793</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843844"/><IDENTIFIER TYPE="OTHER" VALUE="22459"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:11:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Giri SK, Sil D, Drumm J, Mabadeje O, Narasimahulu G, Flood HD</AU>
<TI>Is acellular porcine dermis material durable for pubovaginal sling surgery? (Abstract number 349)</TI>
<SO>Proceedings of the International Continence Society (ICS), 35th Annual Meeting, 2005 Aug 28-Sep 2, Montreal, Canada</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843845"/><IDENTIFIER TYPE="OTHER" VALUE="21068"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843843"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldberg-2001" MODIFIED="2017-07-21 11:11:25 +0100" MODIFIED_BY="[Empty name]" NAME="Goldberg 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-07-21 11:11:25 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 14471&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:11:25 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Goldberg RP, Koduri S, Lobel RW, Culligan PJ, Tomezsko JE, Winkler HA, et al</AU>
<TI>Long-term effects of three different anti-incontinence procedures on the posterior compartment (Abstract)</TI>
<SO>Proceedings of the International Continence Society (ICS), 31st Annual Meeting, 18-21 Sept, Seoul, Korea</SO>
<YR>2001</YR>
<PG>Abstract number 243</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334010"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843846"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Halaska-2001" NAME="Halaska 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;{12128}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halaska M, Kolbl H, Petri E, Danes L, Voigt R, Otcenasek M et al</AU>
<TI>Preliminary results of a prospective randomized study comparing Burch colposuspension and tension-free vaginal tape - urodynamic and sexuological aspects</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>4</NO>
<PG>421-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843849"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843848"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Han-2001" MODIFIED="2010-11-19 11:55:40 +0000" MODIFIED_BY="[Empty name]" NAME="Han 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-11-19 11:55:40 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 12580&lt;/p&gt;" NOTES_MODIFIED="2010-11-19 11:55:40 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Han WHC</AU>
<TI>Burch colposuspension or tension-free vaginal tape for female stress urinary incontinence?</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>Suppl 3</NO>
<PG>S23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843851"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843850"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hung-2001" NAME="Hung 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;ID: 14359&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hung MJ</AU>
<TI>Tension free vaginal tape versus traditional polypropylene pubovaginal sling for the treatment of stress urinary incontinence (Abstract)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2001</YR>
<VL>12 (Suppl 3)</VL>
<PG>253</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843853"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843852"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ishenko-1999" NAME="Ishenko 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;ID: 12585&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ishenko AI, Slobodenyuk AI, Chushkov YV</AU>
<TI>Modified pereyra and sling procedures in combined surgical treatment in patients with uterine prolapse and stress urinary incontinence - randomized study</TI>
<SO>European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology</SO>
<YR>1999</YR>
<VL>86</VL>
<NO>Suppl</NO>
<PG>S15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843855"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843854"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kocjancic-2008" MODIFIED="2017-07-21 11:11:45 +0100" MODIFIED_BY="[Empty name]" NAME="Kocjancic 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-07-21 11:11:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Kocjancic E, Constantini E, Crivellaro S, Tosco L, Grossetti B, Frea B, et al</AU>
<TI>Mixed incontinence: the best solution for a difficult task (Abstract number 485)</TI>
<SO>Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20-24, Cairo, Egypt</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334011"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:11:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kocjancic E, Constantini E, Giannantoni A, Crivellaro S, Mearini L, Frea B, et al</AU>
<TI>Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462)</TI>
<SO>Proceedings of the American Urological Association (AUA), Annual Meeting, 19-24 May, Anaheim, CA</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843858"/><IDENTIFIER TYPE="OTHER" VALUE="23765"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843856"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuo-2001" NAME="Kuo 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;ID: 11796&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuo HC</AU>
<TI>Comparison of video urodynamic results after the pubovaginal sling procedure using rectus fascia and polypropylene mesh for stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2001</YR>
<VL>165</VL>
<NO>1</NO>
<PG>163-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843860"/><IDENTIFIER TYPE="MEDLINE" VALUE="20574918"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843859"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kwon-2002" NAME="Kwon 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;ID: 14540&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kwon C, Goldberg R, Sanjay G, Sumana K, Krotz S, Sand P</AU>
<TI>Protective effect of transvaginal slings on recurrent anterior vaginal wall prolapse after pelvic reconstructive surgery (abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>4</NO>
<PG>321-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843862"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843861"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lemieux-1991" MODIFIED="2017-07-21 11:11:55 +0100" MODIFIED_BY="[Empty name]" NAME="Lemieux 1991" YEAR="1991">
<REFERENCE MODIFIED="2017-07-21 11:11:55 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 14575&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:11:55 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Lemieux MC, Kung R, Drutz HP</AU>
<TI>Suprapubic clamping routine after anti-incontinence surgery: a randomized prospective study comparing continuous vs intermittent clamping (Abstract)</TI>
<SO>Proceedings of the American Urogynecology Society, 12th Annual Meeting, 23-26 Oct, California, USA</SO>
<YR>1991</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843864"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843863"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liapis-2002" NAME="Liapis 2002" YEAR="2002">
<REFERENCE NOTES="&lt;p&gt;{15437}&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Liapis A, Bakas P, Creatsas G</AU>
<TI>Burch colposuspension and tension-free vaginal tape in the management of stress urinary incontinence in women</TI>
<SO>European Urology</SO>
<YR>2002</YR>
<VL>41</VL>
<NO>4</NO>
<PG>469-73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843866"/><IDENTIFIER TYPE="MEDLINE" VALUE="22070093"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;{9872}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liapis A, Bakas P, Creatsas G</AU>
<TI>Comparison of open retropubic colposuspension with tension-free vaginal tape for the treatment of genuine stress incontinence in women (abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>4</NO>
<PG>385-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843867"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843865"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lim-2005" MODIFIED="2010-07-22 13:37:46 +0100" MODIFIED_BY="[Empty name]" NAME="Lim 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-07-22 13:37:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lim YN, Muller R, Corstiaans A, Dietz HP, Barry C, Rane A</AU>
<TI>Suburethral slingplasty evaluation study in North Queensland, Australia: The SUSPEND trial</TI>
<SO>Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2005</YR>
<VL>45</VL>
<NO>1</NO>
<PG>52-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843869"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843868"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meschia-2001" NAME="Meschia 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;ID: 12124&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meschia M, Spennacchio M, Amicarelli F, Pifarotti P, Cavoretto P, Stoppelli S</AU>
<TI>A randomized prospective comparison of TVT and endopelvic fascia plication in the treatment of occult stress urinary incontinence in patients with genital prolapse: preliminary data (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>4</NO>
<PG>423-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843871"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843870"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Naumann-2006" MODIFIED="2017-07-21 11:12:03 +0100" MODIFIED_BY="[Empty name]" NAME="Naumann 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-07-21 11:12:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Naumann G, Lobodasch K, Bettin S, Meyer P, Koelbl H</AU>
<TI>Tension free vaginal tape (TVTtm) vs less invasive free tape (LIFTtm) - A randomized multicentric study of suburethral sling surgery (Abstract number 481)</TI>
<SO>Proceedings of the International Continence Society (ICS), 36th Annual Meeting, 2006 Nov 27-Dec 1, Christchurch, New Zealand</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843873"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843872"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Sullivan-2000" NAME="O'Sullivan 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;ID: 11903&lt;/p&gt;" PRIMARY="NO" TYPE="OTHER">
<AU>O'Sullivan S, Avery N, Bailey A, Keane D</AU>
<TI>The effect of surgery on the collagen metabollism of paraurethral tissue in women with genuine stress incontinence</TI>
<SO>International Urogynaecology Journal</SO>
<YR>2000</YR>
<VL>11</VL>
<NO>Suppl 1</NO>
<PG>S5</PG>
<EN>11</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843875"/><IDENTIFIER TYPE="MEDLINE" VALUE="11903"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843874"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Obrink-1978" NAME="Obrink 1978" YEAR="1978">
<REFERENCE NOTES="&lt;p&gt;ID: 12889&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Obrink A, Bunne G</AU>
<TI>The margin to incontinence after three types of operation for stress incontinence</TI>
<SO>Scandinavian Journal of Urology and Nephrology</SO>
<YR>1978</YR>
<VL>12</VL>
<NO>3</NO>
<PG>209-14</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843877"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843876"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schostak-2001" NAME="Schostak 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;ID: 16375&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schostak M, Gottfried HW, Heicappell R, Muller M, Sauter T, Steiner U et al</AU>
<TI>Minimally invasive bone anchoring for female stress incontinence: a treatment with moderate results (Abstract)</TI>
<SO>European Urology</SO>
<YR>2001</YR>
<VL>39</VL>
<NO>Suppl 5</NO>
<PG>3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843883"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843882"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seo-2007" MODIFIED="2017-07-21 11:12:12 +0100" MODIFIED_BY="[Empty name]" NAME="Seo 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-07-21 11:12:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Seo JH, Lee JW, Kim DY, Lee YG, Seo YJ, Kwon TG, et al</AU>
<TI>Treatment of obstructive voiding dysfunction after transobturator sling surgery: results of multicenter study (Abstract number 287)</TI>
<SO>Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 20-24 Aug, Rotterdam, the Netherlands</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843885"/><IDENTIFIER TYPE="OTHER" VALUE="23762"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843884"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trezza-2001" MODIFIED="2017-07-21 11:26:09 +0100" MODIFIED_BY="[Empty name]" NAME="Trezza 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-07-21 11:26:09 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 13713&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:26:09 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trezza G, Rotondi M, Palmisano B, Iervolino P</AU>
<TI>Uterovaginal prolapse and occult urinary incontinence: a prospective randomized study on the necessity to associate reconstructive surgery and antiincontinence procedure</TI>
<SO>Urogynaecologia International Journal</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>1 Suppl</NO>
<PG>152-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334012"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843886"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-1999" NAME="Wang 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;ID: 9838&lt;/p&gt;" PRIMARY="NO" TYPE="OTHER">
<AU>Wang AC</AU>
<TI>Local anesthesia is superior to epidural blockade in tension-free vaginal tape installation</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>1999</YR>
<VL>10</VL>
<NO>Suppl 1</NO>
<PG>S13</PG>
<EN>10</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843889"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843888"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ward-2002a" MODIFIED="2017-07-21 11:26:40 +0100" MODIFIED_BY="[Empty name]" NAME="Ward 2002a" YEAR="2002">
<REFERENCE MODIFIED="2017-07-21 11:12:29 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{9954}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:12:29 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Abrams P, Martin K, Bulmer P, Donovan J, Hilton P</AU>
<TI>Responsiveness of the Bristol female lower urinary tract symptoms questionnaire (BFLUTS-Q) to surgical intervention in a randomised controlled trial</TI>
<SO>Proceedings of the International Continence Society (ICS), 30th Annual Meeting, 28-31 Aug, Tampere, Finland</SO>
<YR>2000</YR>
<PG>A173</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334014"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:26:20 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{9871}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:26:20 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Sculpher MJ, Ward KL, Hilton P; on behalf of the UK &amp; Ireland TVT trial group</AU>
<TI>A comparison of the hospital costs of tension free vaginal tape (TVT) and colposuspension</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2000</YR>
<VL>19</VL>
<NO>4</NO>
<PG>333-4</PG>
<EN>19</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334015"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:26:29 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{12573}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:26:29 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ward K, Hilton P; on behalf of the UK &amp; Ireland TVT trial group</AU>
<TI>A randomised trial of colposuspension and tension-free vaginal tape (TVT) for primary genuine stress incontinence - 2 yr follow-up (Abstract)</TI>
<SO>International Urogynaecological Association, Pelvic Floor Dysfunction</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>Suppl 3</NO>
<PG>S7</PG>
<EN>12</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334016"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-21 11:26:40 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;{14365}&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:26:40 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ward K, Hilton P; on behalf of the United Kingdom and Ireland Tension-free Vaginal Tape Trial Group</AU>
<TI>Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>325</VL>
<NO>7355</NO>
<PG>67-73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334017"/><IDENTIFIER TYPE="MEDLINE" VALUE="22109204"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;{9869}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ward KL, Hilton P, Browning J</AU>
<TI>A randomized trial of colposuspension and tension-free vaginal tape (TVT) for primary genuine stress incontinence</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2000</YR>
<VL>19</VL>
<PG>386-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334018"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;{9870}&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ward KL, Hilton P, Browning J</AU>
<TI>Urodynamic variables in a randomised comparison of colposuspension and tension-free vaginal tape (TVT) for primary GSI</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>2000</YR>
<VL>19</VL>
<PG>388-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334019"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6334013"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoo-2007" MODIFIED="2017-07-21 11:12:39 +0100" MODIFIED_BY="[Empty name]" NAME="Yoo 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-07-21 11:12:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Yoo ES, Jung HC, Shin HS, Seo JH, Seo YJ</AU>
<TI>Comparison of the two different approaches for the treatment of female stress urinary incontinence (Abstract number 282)</TI>
<SO>Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 20-24 Aug, Rotterdam, the Netherlands</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334020"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843897"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2010-07-24 12:53:04 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2010-07-23 15:59:27 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Hilton-2000" MODIFIED="2008-10-30 14:53:48 +0000" MODIFIED_BY="[Empty name]" NAME="Hilton 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-10-30 14:53:48 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 16383&lt;/p&gt;" NOTES_MODIFIED="2008-10-30 14:53:48 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Hilton P</AU>
<TI>A prospective randomised comparative trial of a tension-free vaginal tape (TVT) and fascial sling procedure for "secondary" genuine stress incontinence</TI>
<SO>UK National Research Register</SO>
<YR>2002</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2843900"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2843899"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Lucas-2001" MODIFIED="2008-10-30 14:52:57 +0000" MODIFIED_BY="[Empty name]" NAME="Lucas 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-10-30 14:52:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lucas M</AU>
<TI>Sling operation for stress urinary incontinence: randomized trial of three operative procedures</TI>
<SO>UK National Research Register</SO>
<YR>2001</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6334022"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6334021"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-07-21 11:48:50 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-07-21 11:48:50 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Berman-1997" MODIFIED="2017-07-21 11:28:37 +0100" MODIFIED_BY="[Empty name]" NAME="Berman 1997" TYPE="JOURNAL_ARTICLE">
<AU>Berman CJ, Kreder KJ</AU>
<TI>Comparative cost analysis of collagen injection and fascia lata sling cystourethropexy for the treatment of type III incontinence in women</TI>
<SO>The Journal of Urology</SO>
<YR>1997</YR>
<VL>157</VL>
<NO>1</NO>
<PG>122-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Birnbaum-2004" MODIFIED="2017-07-10 09:36:50 +0100" MODIFIED_BY="[Empty name]" NAME="Birnbaum 2004" TYPE="JOURNAL_ARTICLE">
<AU>Birnbaum HG, Leong SA, Oster EF, Kinchen K, Sun P</AU>
<TI>Cost of stress urinary incontinence: a claims data analysis</TI>
<SO>Pharmacoeconomics</SO>
<YR>2004</YR>
<VL>22</VL>
<NO>2</NO>
<PG>95-105</PG>
<IDENTIFIERS MODIFIED="2017-07-10 09:36:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="14731051"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blaivas-1988" NAME="Blaivas 1988" NOTES="&lt;p&gt;Blaivas JG, Olsson CA. Stress incontinence: classification and surgical approach.  J Urol  1988;139(4):727-31. {7746}&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Blaivas JG, Olsson CA</AU>
<TI>Stress incontinence: classification and surgical approach</TI>
<SO>Journal of Urology</SO>
<YR>1988</YR>
<VL>139</VL>
<NO>4</NO>
<PG>727-31</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="88172649"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blaivas-1997a" NAME="Blaivas 1997a" NOTES="&lt;p&gt;Blaivas JG, Appell RA, Fantl JA, Leach G, McGuire EJ, Resnick NM et al. Definition and classification of urinary incontinence: recommendations of the Urodynamic Society.  Neurourol Urodyn  1997;16:149-51. {5727}&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Blaivas JG, Appell RA, Fantl JA, Leach G, McGuire EJ, Resnick NM et al</AU>
<TI>Definition and classification of urinary incontinence: recommendations of the Urodynamic Society</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>1997</YR>
<VL>16</VL>
<NO>3</NO>
<PG>149-51</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="97281840"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chong-2011" MODIFIED="2017-07-21 11:28:47 +0100" MODIFIED_BY="[Empty name]" NAME="Chong 2011" TYPE="JOURNAL_ARTICLE">
<AU>Chong E, Khan A, Anger J</AU>
<TI>The financial burden of stress urinary incontinence among women in the United States</TI>
<SO>Current Urology Reports</SO>
<YR>2011</YR>
<VL>12</VL>
<NO>5</NO>
<PG>358-62</PG>
<IDENTIFIERS MODIFIED="2017-07-10 09:36:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="DOI" VALUE="10.1007/s11934-011-0209-x."/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cody-2003" MODIFIED="2017-07-21 11:28:58 +0100" MODIFIED_BY="[Empty name]" NAME="Cody 2003" TYPE="JOURNAL_ARTICLE">
<AU>Cody J, Wyness L, Wallace S, Glazener C, Kilonzo M, Stearns S, et al</AU>
<TI>Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence</TI>
<SO>Health Technology Assessment</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>21</NO>
<PG>iii, 1-189</PG>
<IDENTIFIERS MODIFIED="2017-07-13 12:20:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-13 12:20:11 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="13678548"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dean-2006" MODIFIED="2017-07-13 12:25:20 +0100" MODIFIED_BY="[Empty name]" NAME="Dean 2006" TYPE="COCHRANE_REVIEW">
<AU>Dean N, Ellis G, Herbison GP, Wilson D</AU>
<TI>Laparoscopic colposuspension for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2017-07-13 12:25:20 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-13 12:25:20 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002239.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Debodinance-2000" MODIFIED="2017-07-21 11:46:18 +0100" MODIFIED_BY="[Empty name]" NAME="Debodinance 2000" TYPE="JOURNAL_ARTICLE">
<AU>Debodinance P</AU>
<TI>[Comparison of the Bologna and Ingelman-Sundberg procedures for stress incontinence associated with genital prolapse: ten-year follow-up of a prospective randomized study]. [French]</TI>
<SO>Journal de Gynecologie , Obstetrique et Biologie de la Reproduction</SO>
<YR>2000</YR>
<VL>29</VL>
<NO>2</NO>
<PG>148-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fantl-1996" MODIFIED="2017-07-16 10:49:53 +0100" MODIFIED_BY="[Empty name]" NAME="Fantl 1996" NOTES="&lt;p&gt;Fantl JA, Newman DK., Colling J, et al . Urinary Incontinence in Adults: Acute and Chronic Management. Cinical Practice Guideline, No. 2, 1996 Update. Rockville, MD: US Department of Health and Human Services.  Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96-0682. March 1996. {6687}&lt;/p&gt;" NOTES_MODIFIED="2017-07-16 10:49:53 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK">
<AU>Fantl JA, Newman DK, Colling J, DeLancey JOL, Keeys C, Loughery R, et al</AU>
<SO>Urinary incontinence in adults: acute and chronic management. Clinical practice guideline. No. 2, 1996 update</SO>
<YR>1996 Mar. AHCPR Publication No.: 96-0682</YR>
<NO>2</NO>
<PG>1-154</PG>
<PB>US Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research</PB>
<CY>Rockville (MD)</CY>
<IDENTIFIERS><IDENTIFIER TYPE="OTHER" VALUE="AHCPR Publication No. 96-0682"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Glazener-2001" MODIFIED="2017-07-13 12:25:37 +0100" MODIFIED_BY="[Empty name]" NAME="Glazener 2001" TYPE="COCHRANE_REVIEW">
<AU>Glazener CMA, Cooper K</AU>
<TI>Anterior vaginal repair for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2017-07-13 12:25:37 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-13 12:25:37 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001755"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Glazener-2004" MODIFIED="2017-07-13 12:25:48 +0100" MODIFIED_BY="[Empty name]" NAME="Glazener 2004" TYPE="COCHRANE_REVIEW">
<AU>Glazener CMA, Cooper K</AU>
<TI>Bladder neck needle suspension for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2017-07-13 12:25:48 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-13 12:25:48 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003636.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" NOTES="&lt;p&gt;ID: 20302&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2010-08-02 15:47:58 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated Sep 2008)</SO>
<YR>2008</YR>
<PB>The Cochrane Collaboration</PB>
<CY>Available from: www.cochrane-handbook.org</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hunskaar-2002" NAME="Hunskaar 2002" TYPE="BOOK_SECTION">
<AU>Hunskaar S, Burgio K, Diokno AC, Herzog AR, Hjalmas K, Lapitan MC</AU>
<TI>Epidemiology and natural history of urinary incontinence (UI)</TI>
<SO>Incontinence: 2nd International Consultation on Incontinence. Recommendations of the International Scientific Committee: the evaluation and treatment of urinary incontinence. Paris, 1-3 July 2001</SO>
<YR>2002</YR>
<ED>Abrams P, Cardozo L, Khoury S, Wein A</ED>
<PB>Health Publication Ltd</PB>
<CY>Plymouth, UK</CY>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="20304"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jackson-1996" NAME="Jackson 1996" NOTES="&lt;p&gt;8058&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P</AU>
<TI>The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing</TI>
<SO>British Journal of Urology</SO>
<YR>1996</YR>
<VL>77</VL>
<NO>6</NO>
<PG>805-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keegan-2007" MODIFIED="2017-07-13 12:25:58 +0100" MODIFIED_BY="[Empty name]" NAME="Keegan 2007" TYPE="COCHRANE_REVIEW">
<AU>Keegan PE, Atiemo K, Cody JD, McClinton S, Pickard R</AU>
<TI>Periurethral injection therapy for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2017-07-13 12:25:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-13 12:25:58 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003881.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kilonzo-2004" MODIFIED="2017-07-10 09:36:50 +0100" MODIFIED_BY="[Empty name]" NAME="Kilonzo 2004" TYPE="JOURNAL_ARTICLE">
<AU>Kilonzo M, Vale L, Stearns S, Grant A, Cody J, Glazener C, et al</AU>
<TI>Cost effectiveness of tension-free vaginal tape for the surgical management of female stress incontinence</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>4</NO>
<PG>455-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kunkle-2015" MODIFIED="2017-07-21 11:29:08 +0100" MODIFIED_BY="[Empty name]" NAME="Kunkle 2015" TYPE="JOURNAL_ARTICLE">
<AU>Kunkle C, Hallock J, Hu X, Blomquist J, Thung S, Werner E</AU>
<TI>Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence</TI>
<SO>Female Pelvic Medicine &amp; Reconstructive Surgery</SO>
<YR>2015</YR>
<VL>21</VL>
<NO>3</NO>
<PG>154-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lapitan-2003" MODIFIED="2017-07-21 11:29:16 +0100" MODIFIED_BY="[Empty name]" NAME="Lapitan 2003" TYPE="COCHRANE_REVIEW">
<AU>Lapitan MC, Cody DJ</AU>
<TI>Open retropubic colposuspension for urinary stress incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2017-07-13 12:28:10 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-13 12:28:10 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002912"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lapitan-2009" MODIFIED="2010-11-19 11:00:19 +0000" MODIFIED_BY="[Empty name]" NAME="Lapitan 2009" TYPE="COCHRANE_REVIEW">
<AU>Lapitan MCM, Cody JD, Grant A</AU>
<TI>Open retropubic colposuspension for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2010-11-19 11:00:19 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2010-11-19 11:00:19 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002912.pub4"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lucas-2004" MODIFIED="2017-07-21 11:48:50 +0100" MODIFIED_BY="[Empty name]" NAME="Lucas 2004" TYPE="CONFERENCE_PROC">
<AU>Lucas M, Emery S, Alan W, Kathy W</AU>
<TI>Failure of porcine xenograft sling in a randomised controlled trial of three sling materials in surgery for stress incontinence (Abstract)</TI>
<SO>Proceedings of the International Continence Society (34th Annual Meeting) and the International UroGynecological Association, 23-27 August, 2004, Paris</SO>
<YR>2004</YR>
<PG>Abstract number 309</PG>
<IDENTIFIERS><IDENTIFIER TYPE="OTHER" VALUE="19056"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McGuire-1993" NAME="McGuire 1993" NOTES="&lt;p&gt;McGuire EJ, Fitzpatrick CC, Wan J, Bloom D, Sanvordenker J, Ritchey et al. Clinical assessment of urethral sphincter function.  J Urol  1993;150(5 Pt 1):1452-4.{5868}&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>McGuire EJ, Fitzpatrick CC, Wan J, Bloom D, Sanvordenker J, Ritchey M et al</AU>
<TI>Clinical assessment of urethral sphincter function</TI>
<SO>Journal of Urology</SO>
<YR>1993</YR>
<VL>150</VL>
<NO>5 Pt 1</NO>
<PG>1452-4</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="94016914"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moehrer-2002" MODIFIED="2017-07-21 11:37:44 +0100" MODIFIED_BY="[Empty name]" NAME="Moehrer 2002" NOTES="&lt;p&gt;&lt;span class=&quot;inserted&quot; modified=&quot;2017-07-13 13:17:00 +0100&quot; modified_by=&quot;[Empty name]&quot;&gt;first published 2000, iss&lt;/span&gt;&lt;span class=&quot;inserted&quot; modified=&quot;2017-07-13 13:18:00 +0100&quot; modified_by=&quot;[Empty name]&quot;&gt;ue 1 but they want to refer to this particular version, which was a minor update with an updated search&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2017-07-21 11:37:44 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Moehrer B, Ellis G, Carey M, Wilson PD</AU>
<TI>Laparoscopic colposuspension for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2017-07-13 13:15:16 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-13 13:15:16 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002239"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Donnell-1994" NAME="O'Donnell 1994" NOTES="&lt;p&gt;O'Donnell P. Goals of Therapy and Mechanisms of Urethral Incontinence.  1994;175-201. {7747}&lt;/p&gt;" TYPE="BOOK_SECTION">
<AU>O'Donnell P</AU>
<TI>Goals of Therapy and Mechanisms of Urethral Incontinence</TI>
<SO>Female Urology</SO>
<YR>1994</YR>
<PG>175-201</PG>
<EN>1st</EN>
<ED>McGuire EJ, Kursh ED</ED>
<PB>J. B. Lippincott Company</PB>
<CY>Philadelphia, Pensylvania, USA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ogah-2010" MODIFIED="2010-11-19 11:02:16 +0000" MODIFIED_BY="[Empty name]" NAME="Ogah 2010" TYPE="COCHRANE_REVIEW">
<AU>Ogah J, Cody JD, Rogerson L</AU>
<TI>Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2010-11-19 11:02:16 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2010-11-19 11:02:16 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006375.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Reference-Manager-2012" MODIFIED="2017-07-21 09:58:23 +0100" MODIFIED_BY="[Empty name]" NAME="Reference Manager 2012" TYPE="COMPUTER_PROGRAM">
<TI>Reference Manager Professional Edition Version 12</TI>
<YR>2012</YR>
<PB>Thomson Reuters</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2017-07-21 11:37:54 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review manager 5 (RevMan 5)</TI>
<YR>2014</YR>
<PB>Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schultz-2010" MODIFIED="2017-07-21 11:38:04 +0100" MODIFIED_BY="[Empty name]" NAME="Schultz 2010" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Altman DG, Moher D, for the CONSORT Group</AU>
<TI>CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials</TI>
<SO>PLoS Medicine</SO>
<YR>2010</YR>
<VL>7</VL>
<NO>3</NO>
<PG>e1000251</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-2002" MODIFIED="2017-07-16 10:53:29 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 2002" NOTES="&lt;p&gt;15581&lt;/p&gt;" NOTES_MODIFIED="2017-07-16 10:53:29 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK_SECTION">
<AU>Smith ARB, Daneshgari F, Dmochowski R, Ghoniem G, Jarvis GJ, Nitti V, et al</AU>
<TI>Surgical treatment of incontinence in women</TI>
<SO>Incontinence. 2nd International Consultation on Incontinence</SO>
<YR>2002</YR>
<PB>Health Publication Ltd</PB>
<CY>Plymouth, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Subak-2008" MODIFIED="2017-07-21 11:38:13 +0100" MODIFIED_BY="[Empty name]" NAME="Subak 2008" TYPE="JOURNAL_ARTICLE">
<AU>Subak L, Brubaker, L, Chai T, Creasman J, Diokno A, et al</AU>
<TI>High costs of urinary incontinence among women electing surgery to treat stress incontinence</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2008</YR>
<VL>111</VL>
<NO>4</NO>
<PG>899-907</PG>
<IDENTIFIERS MODIFIED="2017-07-10 09:36:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="DOI" VALUE="10.1097/AOG.0b013e31816a1e12"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wagner-1998" MODIFIED="2017-07-16 10:46:15 +0100" MODIFIED_BY="[Empty name]" NAME="Wagner 1998" TYPE="JOURNAL_ARTICLE">
<AU>Wagner T, Hu T
</AU>
<TI>Economic costs of urinary incontinence in 1995</TI>
<SO>Urology</SO>
<YR>1998</YR>
<VL>51</VL>
<NO>3</NO>
<PG>355-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ward-2002b" MODIFIED="2017-07-21 11:38:21 +0100" MODIFIED_BY="[Empty name]" NAME="Ward 2002b" TYPE="JOURNAL_ARTICLE">
<AU>Ward K, Hilton P; on behalf of the UK &amp; Ireland TVT trial group</AU>
<TI>Prospective multicentre randomised trial of tension-free vaginal tape and open colposuspension as primary treatment for stress incontinence</TI>
<SO>BMJ</SO>
<YR>2002</YR>
<VL>325</VL>
<PG>67-69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ware-1993" NAME="Ware 1993" NOTES="&lt;p&gt;Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide.  The Health Institute, New England Medical Centre, Boston, Massachusetts 1993. {9004}&lt;br&gt;&lt;/p&gt;" TYPE="BOOK">
<AU>Ware JE, Snow KK, Kosinski M, Gandek B</AU>
<SO>SF-36 Health survey manual and interpretation guide</SO>
<YR>1993</YR>
<PB>The Health Institute, New England Medical Centre</PB>
<CY>Boston (MA)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilson-1996" NAME="Wilson 1996" NOTES="&lt;p&gt;Wilson PD, Herbison RM, Herbison GP. Obstetric practice and the prevalence of urinary incontinence three months after delivery.  Br J Obstet Gynaecol  1996;103:154-61. {3348}&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Wilson PD, Herbison RM, Herbison GP</AU>
<TI>Obstetric practice and the prevalence of urinary incontinence three months after delivery</TI>
<SO>British Journal of Obstetrics &amp; Gynaecology</SO>
<YR>1996</YR>
<VL>103</VL>
<NO>2</NO>
<PG>154-61</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="96199090"/></IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2010-08-02 15:47:58 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-07-21 11:52:57 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-07-21 11:52:57 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-07-21 11:07:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Albo-2007">
<CHAR_METHODS MODIFIED="2017-07-21 11:07:07 +0100" MODIFIED_BY="[Empty name]">
<P>RCT by electronic treatment assignment. 2 arms. Unblinded<BR/>Follow up at 24 months. Analysis with ITT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:07:07 +0100" MODIFIED_BY="[Empty name]">
<P>N = 655<BR/>4 ineligible after randomisation (3-Burch, 1-Sling), 1 did not undergo allocated treatment. Only 520 assessed at end of trial (255-Burch, 265-sling)</P>
<P>Symptom-based diagnosis, confirmed by standard stress test</P>
<P>Inclusion criteria: documented pure or predominant symptom of SUI for at least 3 months, positive standardised urinary stress test<BR/>Exclusion criteria: age &lt; 21 years, nonambulatory, pregnancy, current cancer chemo- or radiotherapy, systemic disease affecting bladder function, urethral diverticulum, prior augmentation cystoplasty or artificial urethral sphincter, recent pelvic surgery</P>
<P>Groups similar in age, ethnic group, marital status, BMI, vaginal deliveries, hormone treatment, smoking, mixed UI, POP, UDS, concomitant surgery</P>
<P>Multicentre. Tertiary referral centres. USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:07:07 +0100" MODIFIED_BY="[Empty name]">
<P>A (326): Sling</P>
<P>B (329): Burch<BR/>
</P>
<P>Burch as modified by Tanagho</P>
<P>Sling procedure using autologous rectus fascia at level of the bladder neck and proximal urethra</P>
<P>Interventions standardised across the centres</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:07:07 +0100" MODIFIED_BY="[Empty name]">
<P>Number with overall success, number with SUI-specific success, pad test, number of incontinence episodes in a 3-d voiding diary, POP, adverse events, voiding dysfunction (use of a catheter), postoperative UUI</P>
<P>Overall success defined as no self-reported symptoms of UI, no incontinence on 3-d diary, negative stress test, no re treatment</P>
<P>SUI-specific success defined as no symptoms, negative stress test and no re treatment for SUI</P>
<P>All outcomes reported at 2-year follow-up</P>
<P>Failure (symptoms) at 24 months: A: 101/265, B: 130/255</P>
<P>Failure (pad test) at 24 months: A: 37/265, B: 38/255</P>
<P>Complications: any complications: A: 206/326, B: 156/329; any voiding dysfunction: A: 46/326, B: 7/329; post-operative cystitis: A: 247/326, B: 166/329; bladder perforation: A: 2/326, B: 10/329</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:07:07 +0100" MODIFIED_BY="[Empty name]">
<P>Full text with several other reports in full-text and abstract form</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Amaro-2007">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of autologous fascial sling with TVT. Single blind. Follow-up assessment carried out at 1, 6, 12 and 36 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>Women with involuntary detrusor contractions or pre-existing bladder outlet obstruction during urodynamic study were excluded</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>A (21): autologous fascial sling</P>
<P>B (20): TVT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>Cure rates (defined as complete dryness with no usage of pads, operative-room time, postoperative analgesia, complications, time of hospital stay, postoperative catheterisation, time to return to normal activities. 60-min pad test used and QoL evaluated using a validated Portuguese version of King's Health Questionnaire</P>
<P>Incontinent at 12 months: A: 9/21, B: 7/20</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract and poster</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arunkalaivanan-2003">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>RCT, randomisation method unclear. Participants' demographics were well reported. Procedures were standardised. Follow-up was 2-6 months, 12 and 24 months (median 12 months)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>142 women with urodynamic-proven SUI were recruited. Women with detrusor instability excluded. Groups comparable</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>A (74): Pelvicol</P>
<P>B (68): TVT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome measures: cure rates (subjective, questionnaire-based; pad used - not weighed), levels of morbidity and impact on QoLand symptom severity</P>
<P>Failure at 12 months (incontinence): A: 8/74, B: 10/68</P>
<P>Not Improved at 12 months: A:6/74, B: 4/68</P>
<P>Failure at 36 months (incontinence): A: 12/68, B: 7/60</P>
<P>Not improved at 36 months: A: 5/68, B: 4/60</P>
<P>Complications: any complications: A: 17/74, B: 13/68; any voiding dysfunction: A: 8/74, B: 6/68; Retention up to 6 weeks A: 6/74, B: 1/68; Release of sling required A: 5/74, B: 2/68; Bladder perforations: A: 0/74, B: 0/68</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>Surgery was only offered after conservative therapy had proved unsuccessful</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bai-2005">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Method not described. 3 arms. Blinding not mentioned. Unclear if ITT. Follow-up at 1 year with assessments at 3, 6, 9 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>UDS confirmed. No mixed incontinence</P>
<P>Groups comparable as to age, parity, BMI, menopausal status, MUCP, VLPP, functional urethral length and peak flow rates at baseline</P>
<P>Inclusion criteria : USI grade 1 and 2</P>
<P>Exclusion criteria: grade III incontinence, detrusor overactivity, UTI, ISD, POP &gt; grade II</P>
<P>Ob&amp;Gyne. South Korea</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-20 23:15:20 +0100" MODIFIED_BY="[Empty name]">
<P>A (28): Sling<BR/>B (33): Burch <BR/>C (31): TVT </P>
<P>Sling procedure was a pubovaginal sling using autologous rectus muscle fascia</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>Number cured (3, 6, 12 months); complication rate (number with idiopathic detrusor overactivity, hesitancy, urinary retention)</P>
<P>Cure defined as absence of subjective complaints of leakage and absence of urinary leakage on stress test</P>
<P>Not cured (6 months): A: 2/28, B: 3/33, C: 2/31</P>
<P>Not cured (12 months): A: 2/28, B: 4/33, C: 4/31</P>
<P>De novo detrusor overactivity: A: 0/28, B: 3/33, C: 0/31</P>
<P>Voiding dysfunction: A: 2/28, B: 1/33, C: 4/31</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>TVT technique according to Ulmsten</P>
<P>All procedures performed by one surgeon</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barbalias-1997">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Follow-up at 6 and 30 months. Women allocated to 1/2 interventions by a computer-generated random table in a 2:1 ratio. All women available at follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>48 consecutive women. Inclusion and exclusion criteria not clearly stated, but some participants with mixed incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>A (32): rectus fascia sling</P>
<P>B (16): Gore-Tex sling operation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>Cure defined as complete freedom from SUI (clinically accessed) or improved (persistence or recurrence of SUI, but in lesser intensity)</P>
<P>Failure rates at 6 months: A: 6/32, B: 2/16</P>
<P>Failure rates at 30 months: A:11/32, B: 2/16</P>
<P>Complications: B: 2 cases of erosion of sling and 3 other cases of recurrent UTI</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>Pre-operative characteristics reported but no comparisons between groups made; statistical analysis reported for urodynamic parameters pre and post operation. No other statistical comparison between groups reported. Some participants with mixed incontinence, but results not stratified by groups or type of incontinence</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Basok-2008">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Details of randomisation not given. Two arms. Follow-up 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>139 women randomised. Baseline comparison made: number of participants, mean age (years), mean daily pad usage, mean parturition, mean BMI, mixed urinary incontinence.  No statistical difference</P>
<P>Inclusion criteria: stress urinary incontinence due to urethral hypermobility</P>
<P>Exclusion criteria: participants with ISD, uterine prolapse, rectocele, enterocele, grade III or IV cystocele</P>
<P>Concomitant urinary urge incontinence was present in some women with mixed urinary incontinence present in 49 participants (73%) in the fascia lata sling group and in 44 participants (61%) in the intravaginal slingplasty group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-24 12:49:57 +0100" MODIFIED_BY="[Empty name]">
<P>A (67) Cadaveric fascia lata</P>
<P>B (72) Intravaginal slingplasty</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]">
<P>Objective cure rate was evaluated by the pad test, and participant-satisfaction rate was assessed by a subjective questionnaire. A cure and an improvement were defined as a totally dry participant and 1 pad/d, respectively. Usage of more than 1 pad/d was accepted as surgical failure. The sum of cure and improvement rates was conceded as a total success rate.</P>
<P>Other outcomes measured were: mean operating time, bladder perforation, urinary retention, erosion, sling revision, haematoma, persistent urge urinary incontinence,  defective vaginal wall, de novo detrusor overactivity.</P>
<P>Total success: A: 79.0%, B: 70.8</P>
<P>Satisfaction at 12 months: A: 82.0%, B: 87.5%</P>
<P>Incontinent at 12 months: A: 32/67, B: 38/72</P>
<P>Not improved at 12 months: A: 14/67, B: 21/72</P>
<P>Daily mean pad usage (SD): A: 4.1 (3.5), B: 2.9 (1.7)</P>
<P>Operative time: A: 50, B: 25 min</P>
<P>Adverse events: de novo detrusor overactivity: A: 15/67, B: 5/72; bladder perforation: A: 3/67, B: 8/72; urinary retention: A: 8/67, B: 8/72; vaginal erosion: A: 0/67, B: 0/72; sling revision: A: 2/67, B: 0/72</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]">
<P>Preoperative evaluation of all participants included: urogynaecological history, previous pelvic surgery, voiding diary, parturition and daily pad usage</P>
<P>The abstract indicated that the QOL was significantly improved in the study, the full article showed that measurement was carried out by participant-satisfaction questionnaire. No comment was made on the validity and reliability of this questionnaire</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Demirci-2001">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Follow-up 12 months. No details of allocation method given. Not all women available in follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]">
<P>46 women recruited, 23 in each arm of the study. 34 women available for follow-up, reasons for loss to follow-up not reported. Inclusion and exclusion criteria were well defined</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]">
<P>A (23): rectus fascia sling</P>
<P>B (23): Burch colposuspension<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]">
<P>Cure defined as dry, symptom-free (subjective based on history and objective on ultrasonography)</P>
<P>Failure rate: A:0/17, B: 1/17</P>
<P>Late complications (1-year follow-up): A: 1 instability; 3 suprapubic pain and 1 dyspareunia; B: 1 instability, 2 dyspareunia and 2 genital prolapse (enterocele)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Ultrasonography for measurement of bladder neck mobility was tested in both groups pre and post operatory and showed significant improvement but no significant differences between the groups</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Enzelsberger-1996">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Follow-up at 32-48 months. Women allocated to 1/2 interventions by open random-number chart. All women available to follow up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]">
<P>72 women recruited, 36 in each arm of the study.</P>
<P>Inclusion criteria: all participants with GSI (urodynamic and sonographic diagnosis) had a vaginal hysterectomy and, at least, one previous anterior repair; 57 were postmenopausal without hormone replacement therapy.</P>
<P>Exclusion criteria: urinary tract infection, unstable bladder, voiding difficulty and severe cystocele and/or rectocele.</P>
<P>Groups were comparable for age, weight, parity, menopausal status, previous surgery and time of follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]">
<P>A (36) Group II: lyophilised dura mater sling operation</P>
<P>B (36) Group I: modified Burch colposuspension (two pairs of sutures instead of three)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>Cure defined as dry, symptom-free without objective urine loss during stress with bladder filled to 300 mL or positive urethral-closure pressure during stress provocation.</P>
<P>Failure rate at follow-up at 32-48 months: A: 3/36, B: 5/36</P>
<P>Urodynamic results reported before and at follow-up. Reported longer hospital stay and suprapubic catheter permanence for A. Equal frequency pyrexia and bladder laceration</P>
<P>Late complications: enterocele or rectocele: A: 1/36, B: 5/36; voiding difficulty A: 5/36, B: 1/36. Both differences statistically significant. Other problems not statistically significant: urgency/urge incontinence (A: 6/36, B: 3/36). 4 participants reported in control because of residual urine for B. Equal good results in sonographic investigation at follow-up.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fischer-2001">
<CHAR_METHODS>
<P>RCT. Details not given. Follow-up at 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>22 women with intrinsic sphincter deficiency, 11 in each arm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-20 23:27:03 +0100" MODIFIED_BY="[Empty name]">
<P>A (11): suburethral sling</P>
<P>B (11): Burch retropubic urethropexy<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>Cure assessed using IIQ, UDI, stress test, voiding dysfunction</P>
<P>Success rate reported as: A: 100% (11/11), B: 77.8% (7/9) P = 0.1</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only<BR/>Aim to evaluate the prognostic value of urethral electrodiagnosis</P>
<P>Two participants in the Burch group were found to have recurrent urethrovisical junction hypermobility or displacement and not included in the final analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guerrero-2008">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.  Details not given in abstract of trial. 3 treatment arms. 4 centres. Follow-up 6 months and 1 year</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>201 women randomised (mean age 52 years) to Pelvicol-50, TVT-72, autologous sling-79. 85% were available for follow-up at 1 year</P>
<P>Inclusion criteria: women requiring primary surgical treatment for urodynamic SUI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-23 10:17:36 +0100" MODIFIED_BY="[Empty name]">
<P>A (79) autologous sling</P>
<P>B (50) Pelvicol</P>
<P>C (72) TVT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>Success and improvement rates were described</P>
<P>Other outcome measures included: operative details, complications, dry/ improved rates, QoL assessment, catheterisation and re-operation rates</P>
<P>Median theatre time (min): A: 50, B: 35, C: 30</P>
<P>Median length post-op stay (days): A: 4, B: 4, C: 2</P>
<P>Incontinent at 6 months: A: 41/79, B: 28/50, C: 35/72</P>
<P>Incontinent at 12 months : A: 41/79, B: 39/50, C: 32/72</P>
<P>Not improved at 6 months: A: 4/79, B: 13/50, C: 6/72</P>
<P>Not improved at 12 months: A: 8/79, B: 19/50, C: 5/72</P>
<P>Re-operation rate: A: 0%, B: 0%, C: 0%</P>
<P>Self-catherterisation at 12 months: A: 1/79, B: 0/50, C: 0/72</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>High re-operation rates (1 in 5) in Pelvicol group so arm closed.  Study closed at 6 years before target number reached.  Interim analysis after the first 50 participants in each group</P>
<P>No mention of how success rate was assessed in the abstract, on contacting a listed author, we were informed that the figures were patient-reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Henriksson-1978">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Details not given. Follow-up at 4-6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>30 women randomised, 15 in each arm of the study, all with genuine stress incontinence. All age groups of participants but menopausal status not reported. Exclusion criteria: cystocele, uterine prolapse, urge incontinence, neurogenic bladder, UTIs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>A (15): Teflon sling (Zoedler urethroplasty)</P>
<P>B (15): MMK urethrocystopexy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>Cure defined as complete freedom from SUI (subjective and objective demonstration). All participants cured in both groups. Complications not reported. Main differences observed in stress closing pressure of urethra, which became positive after surgery in both groups</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>Groups stated similar but no comparisons made at baseline. Short follow-up</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hilton-1989">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Follow-up at 2, 3, 12 and 24 months. Women allocated to 1/2 interventions by random tables. All women available at follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>20 women recruited, 10 in each arm of the study.</P>
<P>Inclusion criteria: GSI (urodynamic diagnosis), vaginal narrowing, post surgical scar, unsuitable for colposuspension.</P>
<P>Exclusion criteria: not stated.</P>
<P>Groups comparable for age, parity and number of previous surgical incontinence procedures. Menopausal status not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>A (10): porcine dermis sling operation</P>
<P>B (10): Stamey bladder-neck (needle) suspension</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>Cure stated as objective (urodynamic diagnosis, pad test) at 3 months and subjective at 24 months of follow-up.</P>
<P>Failure rates at 3 months: A: 1/10, B: 2/10</P>
<P>Failure rates at 24 months: A: 1/10, B: 3/10</P>
<P>Differences not statistically significant at 3 and 24 months</P>
<P>Post op. complications: A: 9/10, B: 2/10 (operative blood loss, pyrexia, infective complications, supra pubic catheter permanence). Hospital stay: A: 20 (12.9), B: 7 (0.3). Late complications not reported. Voiding problems at 3 months: A: 4/10, B:2/10. Detrusor instability: A: 2/10, B: 1/10. Urge incontinence: A: 5/10, B: 3/10.<BR/>No difference in frequency of uninhibited detrusor contractions, residual volume and maximum voiding pressure. Peak flow significantly reduced for A, although &gt; 15 mL/s</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>Pad test at 12 and 24 months stated but not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kondo-2006">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>RCT randomisation by date of birth method. 2 arms. Odd days assigned to TVT arm, even days PVS. Follow-up 3, 12 and 24 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>63 women who complained of SUI were recruited, 3 eventually declined to undergo surgery, therefore a total of 60 women (29-PVS, 31-TVT) with urodynamic stress or mixed incontinence were included. Diagnosis made by a cough-stress test, a 60 min pad-weighing test, and urodynamic studies</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-20 23:46:20 +0100" MODIFIED_BY="[Empty name]">
<P>A (29): PVS</P>
<P>B (31): TVT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>The primary outcome measure was cure of SUI. Objective cure was defined as the complete absence of leakage during the cough-stress test with 250 or 300 mL of water in the bladder. Subjective cure was consistent with complete dryness or a few drops of water with strong exercises.</P>
<P>Other outcome measures (6-parameter analysis): operation time, numbers of analgesics required in a perioperative period, , changes in haematocrit, length of a Foley catheter, and length of stay</P>
<P>Not cured at 24 months (subjective): A: 7/21, B: 4/23</P>
<P>Not cured at 24 months (objective): A: 11/21, B: 7/23</P>
<P>Operative time (mean (SD)): A: 87.1 (13.3), B: 43.9 (17.3) min</P>
<P>Length of hospital stay (mean (SD)): A: 9.2 (0.9), B: 9.2 (0.6) days</P>
<P>Time to catheter removal (mean (SD)): A: 1.4 (0.5), B: 1.3 (0.1) days</P>
<P>Complications: all complications: A: 11/29, B: 9/31; bladder perforation: A: 7/29, B: 7/31; urethral injury: A:0/29, B: 1/31; subcutaneous haematoma: A: 0/29, B: 1/31; voiding dysfunction: A: 4/29, B: 0/31; release of sling surgery: A: 4/29, B: 0/31; de novo detrusor urgency: A: 3/29, B: 2/31</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up 24 months. Women who underwent concomitant surgery (5-PVS, 8-TVT) and/or had revision surgery were excluded from the 6-parameter analysis because extra interventions made a comparison difficult. Participants for the assessment reduced to 23 women in the TVT and 21 in the PVS group</P>
<P>Data updated from new publication</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lucas-2000">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Follow-up at 3, 6 and 12 months. Women allocated to each arm by a central telephone randomisation system. Not blinded ? operation obvious to all medical and nursing personnel. 3 hospitals</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]">
<P>165 women randomly assigned to 2 groups.  Baseline demographics and symptomology were similar: age, height, weight, symptom years, previous surgery, number and type of concurrent problems between both groups</P>
<P>Inclusion criteria: participants &gt; 18 years and urodynamically proven SUI</P>
<P>exclusion criteria: evidence of neurological disease; urodynamic evidence of detrusor instability and hypocompliance</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>A (81): standard sling insertion (long)</P>
<P>B (84):  sling on a string (short)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome was to compare QoL scores in both groups over time.  Success rate was measured by recurrence of stress leakage as reported in participant questionnaire</P>
<P>Secondary outcomes were measured by participant's QoL, clinical indicators (such as immediate post-operative complications, time to first void, pad tests); administrative indicators, pain scores and participant satisfaction</P>
<P>Participant satisfaction at 12 months: A: 57/73, B: 62/82</P>
<P>Stress leakage at 12 months: A: 14/72, B: 16/72</P>
<P>Stress leakage at 3 years: A: 35/75, B: 30/70</P>
<P>Stress leakage at 6 years: A: 42/73, B: 34/69</P>
<P>De novo urgency: A: 6/81,B: 2/84</P>
<P>Pad test volumes (mL): A: 7.71, B: 4.61; P = 0.56</P>
<P>Mean operative time (min): A: 62 (range 38-135), B: 54 (25 to 140) P = 0.001, (P used to calculate SD: 15.33 in each group)</P>
<P>Mean blood loss (mL): A: 274 (50-800), B: 230 (50-700) P = 0.07</P>
<P>Length of stay (ds): A: 6.48, B: 6.73</P>
<P>Voiding dysfunction 12 months: A: 19/81, B: 17/84</P>
<P>Readmission within 3 months: A: 19/79, B: 9/83</P>
<P>Surgery to release sling: A: 1/81, B: 4/84</P>
<P>Further continence surgery: A: 2/56, B: 5/69</P>
<P>Pain at 3 months: A: 52/78, B: 42/82</P>
<P>Adverse effects: perioperative surgical complications: A: 34/81, B: 31/84; bladder perforation A 2/81, B 3/84; UTI A 10/81, B 6/84</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>Detailed outcome measures at 3, 6 and 12 months were provided. Both groups showed improvement in their QoL with no significant statistical difference between allocated operation.</P>
<P>46 participants had previously undergone one or more forms of incontinence surgery.</P>
<P>Data updated from new publication</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maher-2005">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of pubovaginal sling vs Macroplastique. Follow-up 6 months and 1 year.  ITT analysis performed</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>45 women randomised. 1 from each arm lost to follow-up by 1 year</P>
<P>Inclusion criteria: women with USI and ISD diagnosed by a MUCP less than or equal to 20 cm H2O, who failed to respond to conservative treatment</P>
<P>Exclusion criteria: required prolapse surgery, had undergone a sling procedure or were unsuitable for general anaesthesia</P>
<P>Baseline comparison included: age (years), BMI (kg/m<SUP>2</SUP>), menopause status, parity, previous surgery (abdominal hysterectomy, vaginal hysterectomy/repair, retropubic continence surgery, needle suspension)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>A (22) pubovaginal Sling</P>
<P>B (23) transurethral Macroplastique</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>Objective success: no leakage due to SUI on repeat urodynamic study</P>
<P>Subjective success: no or occasional (less than once a week) stress incontinence</P>
<P>Other outcome measures included: voiding dysfunction, participant satisfaction, operating time, blood loss, inpatient days, duration of catheterisation, time to resume normal activities</P>
<P>Incontinent within 1st year: A: 2/21, B: 5/22 P = 0.41</P>
<P>Incontinent after 1st year: A: 0/13, B: 4/14 P = 0.1</P>
<P>Incontinent within 1st year (obj): A: 4/21, B: 20/22  P = &lt; 0.0001</P>
<P>Patient satisfaction (self-reported at 6 months): A: 7/21, B: 13/22 P = 0.41</P>
<P>Patient satisfaction (self-reported at 5 years): A: 9/13, B: 4/14 P = 0.057</P>
<P>Operative time (mins): A: 60 (25-105), B: 22 (10-41)  P = &lt; 0.0001</P>
<P>Length of hospital stay (days): A: 4 (3-81), B: 1 (1-2) P = &lt; 0.0001</P>
<P>Time to normal activity (weeks): A: 4 (0-42), B: 28 (0-35) P = &lt; 0.0001</P>
<P>Time to catheter removal (days): A: 5 (2-42), B: 1 (0-7) P = &lt; 0.0001</P>
<P>Further continence surgery: A: 1/21, B: 2/22</P>
<P>Complications: UTI: A: 3/21, B: 2/22; De novo detrusor overactivity: A: 1/21, B: 0/22; voiding dysfunction: A: 4/21, B: 1/22</P>
<P/>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>Tertiary referral centres</P>
<P>Macroplastique (uroplasty, Minneapolis, Minnesota, USA) is a vulcanised silicone microimplant (polydiamethylsiloxone) suspended in a povidine gel designed to provided urethral bulking for the treatment of SUI</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Osman-2003">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>RCT (block-randomisation technique). Follow-up reported at 6 months. Selection criteria were well reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>75 women with mixed incontinence symptoms and a negative cystometrogram for motor detrusor overactivity. All had proven stress urinary incontinence. No details on demographic data were reported</P>
<P>21 participants (anticholinergic) and 24 (sling) were available to follow up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>A (50): surgery (Ai (24) Burch colposuspension, Aii (26) rectus fascia sling)</P>
<P>B (25): anticholinergic treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were evaluated by SEAPI score (subjective and objective) and underwent urodynamic examination pre and post treatment</P>
<P>Cure for urge symptoms: Aii: 88%; B:57%</P>
<P>Cure for SUI: Aii: 83%; B: 0</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>The study was designed to investigate anticholinergic therapy in comparison with surgery. Participants allocated to surgery had a sling procedure if the Valsalva leak point pressure was &lt; 90 cm H2O. We extracted only data on sling in comparison with anticholinergics</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pacetta-2005">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Abstract. Randomisation 2:1. 2 arms. Follow-up 1 year</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>34 women randomised. No mention of baseline comparison</P>
<P>Inclusion criteria: women 30-77 years old with SUI due to hypermobility or ISD underwent surgical correction</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>A (10): autologous fascia</P>
<P>B (24):  FortaPerm</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>Objective outcome assessment was urine loss using a provocative pad test</P>
<P>Subjective participant evaluations included QoL questionnaire, incontinence diary, pain and global outcome assessments</P>
<P>Biopsies were taken at 1 year from FortaPerm implant sites adjacent to urethra for histology</P>
<P>Incontinent within 1st year: A: 1/10, B: 5/24</P>
<P>Not improved within 1st year (subjective): A: 0/10, B: 2/24</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>FortaPerm is absorbable biomaterial composed of laminated sheets of purified porcine collagen matrix</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sand-2000">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>RCT by random number table. Follow-up at 3 months and at 72.6 months (mean)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>36 women with genuine stress incontinence and a maximum urethral closure pressure &#8804; 20 cm H2O. Groups comparable in terms of age, parity, and urodynamic variables, except for detrusor instability (&gt; Burch vs sling) and residual volume (&gt; Burch vs sling)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>A (17): Polytetrafluoroethylene sling operation</P>
<P>B (19): modified (overcorrection) Burch colposuspension</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>Cure defined as objective (urodynamic) and subjective (history)</P>
<P>Objective cure (long-term): A: 100% 13/13, B: 86% 13/15</P>
<P>Subjective cure (long-term): A: 84% 11/13, B: 93% 14/15</P>
<P>There were no statistically significant differences in outcome measures</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>The first publication (2000) reported the short-term follow-up and was considered the primary reference. The last publication (2003) reported the long-term results</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sharifiaghdas-2008">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT with autologous rectus fascia sling. Randomisation by sealed, opaque envelopes. Follow-up 1, 3, 6 and 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>100 women randomised into 2 groups. However only 61 followed up to 1 year. 16 were lost due to distance and expense of travel, 12 were age-related and 11 because  of dissatisfaction with surgical result (6-Sling, 5-TVT)</P>
<P>Inclusion criteria: history of USI, 1-h pad-test (&gt; 2 g of leakage), objective positive cough (effort or exertion) ? induced stress test, normal cystourethroscopy and urodynamic confirmation of SI, urethral hypermobility and competent bladder neck</P>
<P>Exclusion criteria: history of &gt; 3 episodes of UTI in past 2 years, other gynaecological problems such as high grade uterine prolapse, high grade rectocele and enterocele, cystocele &#8805; grade 2, abnormal filling phase of urodynamic study, low flow rates (&lt; 15 mL/s), residual urine of more than 100 mL, trabeculated bladder mucosa on cystourethroscopy, a history of major pelvic trauma, and fractures that might negatively affect urethral function</P>
<P>Mixed incontinence was included provided urodynamics showed normal capacity, normal compliance and stable bladder</P>
<P>The 2 groups had similar characteristics with respect to age, parity, hysterectomy, previous incontinence surgery, sensory urge incontinence, preoperative IIQ score</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>A (52) pubovaginal sling</P>
<P>B (48) TVT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>Objective cure defined as negative cough-induced stress test with full bladder (at least 250 mL filled) in the lithotomy and standing position and a 1-h pad-test &#8804; 2 g</P>
<P>Subjective cure defined by mean IIQ score in each group</P>
<P>Also assessed were: type of anaesthesia, operative time, estimated blood loss, bladder penetration and satisfaction with procedure</P>
<P>Incontinent within 1 year (stress test): A: 6/36, B: 3/25  P = 0.9</P>
<P>Incontinent within 1 year (1-h pad test): A: 10/36, B: 6/25  P = 0.83</P>
<P>Participantsatisfaction at 12 months: A: 20/36, B: 15/25</P>
<P>Operative time (min): A: 80 (50-180), B: 45 (30-70) P = 0.01</P>
<P>Length of hospital stay (days): A: 5 (3-7), B: 2 (1-5) P = 0.001</P>
<P>Time to catheter removal (days): A: 4.6 (3-6), B: 1.3 (1-5) P = 0.001</P>
<P>Complications: de novo urge symptoms: A: 8/36, B: 1/25;  voiding dysfunction: A: 11/36, B: 5/25; bladder perforation: A: 2/36, B: 6/25  P = 0.05; bleeding (&gt; 250mL): A: 1/36, B: 1/25 P = 1.00; suprapubic incisional hernia after 8 months: A: 1/36, B: 1/25</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>Procedures performed by single surgeon</P>
<P>All participants were preoperatively evaluated by, physical examination, plain abdominal X-ray, urinary tract ultrasound, cystourethroscopy and urodynamic study</P>
<P>Physical examination assessed degree of prolapsed, basal lab tests (FBC, renal and liver function tests, serum electrolytes, urine analysis, culture)</P>
<P>Assumption was made that t-test was used for operative time, catheterisation and hospital stay</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shin-2001">
<CHAR_METHODS>
<P>RCT stated. Details not given in the abstract of trial. Follow-up after first year reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>57 women with various types of SUI. Participants' characteristics were not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>A (33): autologous dermal graft patch</P>
<P>B (24): cadaveric fascia lata</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome measures reported were success rate (dry/improved), de novo detrusor instability</P>
<P>Success rate: A: 91, 6%, B: 93, 2%</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Silva-Filho-2006">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of SAFYRE TOT with autologous pubovaginal sling. Randomisation method unclear.  Follow-up 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>20 women (average age of 52.5 years ± 11.8 years) with both USI and SUI but without detrusor overactivity</P>
<P>The 2 groups had similar characteristics with respect to age, parity, BMI, menopausal status, presence of pelvic floor defects, and mean Valsalva leak point pressure in the preoperative UDS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]">
<P>A (10): pubovaginal sling</P>
<P>B (10): SAFYRE TOT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>Cure rates and intraoperative and postoperative morbidity. Women were declared objectively cured when they had a postoperative pad test of &#8804; 8 g</P>
<P>All participants were preoperatively evaluated by history, physical examination, QoL questionnaire (King's Health Questionnaire), a 24-h pad weight test, a 2-d voiding diary, and a multichannel urodynamic study that included uroflowmetry, post-void residual volume measurement by urethral catheter, and a cystometrogram. The objective quantification of the severity of incontinence was done by the mean stress leaking point pressure in the urodynamic study. Preoperative measurements included the type of anaesthesia, duration of surgery, intraoperative complications, occurrence of combined procedures, and hospital stay.</P>
<P>At 6-month follow-up the aforementioned measurements were carried out excluding UDS.</P>
<P>Post operative pad test (mean (SD)): A: 8.4 (16.44), B: 39.4 (39.53) g; P = 0.01</P>
<P>Operative time (mean (SD)): A: 69.5 (23.7), B: 21.1 (3.8) min; P &lt; 0.001</P>
<P>Length of hospital stay (mean (SD)): A: 44.4 (5.8), B: 28.8 (8.4) h; P &lt; 0.001</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>SAFYRE consists of a monofilament polypropylene mesh between two silicone columns that are made of multiple cone-shaped soft tissue anchors. The two columns are fixed to the obturator muscle. The pubovaginal sling uses rectus fascia</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Song-2004">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT compared with autologous fascia lata pubovaginal sling. Single centre</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>67 women with SUI were randomised. Basline comparison of age, menopause status, parity, SUI, mixed incontinence and intrinsic sphincter dysfunction were made</P>
<P>Inclusion criteria: type II-IV SUI, mixed SUI, intrinsic sphincter dysfunction, or failed previous operations</P>
<P>Mixed incontinence was included in this study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>A (19): autologous fascia lata pubovaginal sling</P>
<P>B (48): TVT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>Cure rates and operative morbidity</P>
<P>Damage to bladder, urinary retention, difficulty voiding</P>
<P>Incontinent at 3 months: A: 1/19, B: 3/48</P>
<P>Not improved at 3 months A: 0/19, B: 0/48</P>
<P>Operative time (SD): A: 125 (13), B: 27 (5) min</P>
<P>Mean length of hospital stay: A: 7.2, B: 1.8 ds</P>
<P>Mean time to catheter removal: A: 5.3, B: 1 ds</P>
<P>Complications: voiding dysfunction: A: 3/19, B: 3/48; urinary retention: A: 2/19, B: 0/48; bladder injury: A: 0/19, B: 2/48; detrusor overactivity: A: 1/19, B: 3/48</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up on average was between 20-37 months. Cure rates assessed at 3 months</P>
<P>Full text was translated from Chinese</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tcherniakovsky-2009">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Follow-up 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>41 women randomly distributed into two groups. Participants had similar baseline characteristics (age, BMI, parity, vaginal births, postmenopausal conditions, hormone replacement therapy, previous SUI surgery, genital prolapse, previous surgery/previous hysterectomy, disease duration)</P>
<P>Inclusion criteria: USI, confirmed through medical history, physical exam, and urodynamic investigation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>A (20): retropubic sling</P>
<P>B (21): SAFYRE TOT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>Cure was reported absence of SUI and no urinary loss during effort manoeuvres at 12-month follow-up re-evaluation.</P>
<P>Failure at 12 months: A: 1/20, B: 2/21</P>
<P>Operative time (mean (SD)): A: 59.7 (10.3), B: 12.8 (2.4) mins</P>
<P>Time to catheter removal: A: 2, B: 1 ds</P>
<P>Complications: all complications: A: 12/20, B: 3/21; UTI: A: 2/20 B: 0/21; bladder perforation: A: 1/20, B: 0/21; urinary retention: B: 3/20, A: 2/21; vaginal mesh erosion (isolated): A: 0/20, B: 1/21</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>Physical exam specifically evaluated urinary loss through Valsalva manoeuvre and presence of other concurrent dystopias of pelvic floor (anterior, posterior, and apical), using POP-Q classification.</P>
<P>VLPP standardised in this study at 200 mL of vesical repletion</P>
<P>Urodynamic study performed on every participant included </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Teixeira-2008">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Details not given in abstract. Follow-up 24 h and 90 ds</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>42 participants were randomised (porcine collagen-21, polypropylene tapes-21)</P>
<P>Inclusion criteria: stress urinary incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-20 11:12:32 +0100" MODIFIED_BY="[Empty name]">
<P>A (21) porcine collagen</P>
<P>B (21) polypropylene tapes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>No outcome measure relevant to this review</P>
<P>C reactive protein and white blood count measured previous day and at 24 h after surgery</P>
<P>Biopsy at 90ds post operation for local inflammatory markers (polymorphonuclear cells, mononuclear cells, giant cells and neovascularisation) and collagen reaction (collagen amount, composition and organisation)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>Trial assessing systemic and local inflammatory response in different sling materials</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Viseshsindh-2003">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Method not clarified. Only the short-term follow-up reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>26 women with stress urinary incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-07-21 00:19:27 +0100" MODIFIED_BY="[Empty name]">
<P>A (15): fascial sling</P>
<P>B (11): vaginal wall sling</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>Measures of outcome included SEAPI-QMN questionnaire, presence of SUI at postoperative period, urinary symptoms and hospital stay.</P>
<P>Cure rates: SEAPI scores decreased from 6.1 to 0.9 for B and from 6.3 to 0.8 for A</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>All procedures performed by same surgeon</P>
<P>No useable data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wadie-2005">
<CHAR_METHODS MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>RCT randomised by closed envelope delivered to surgeon by a third party. Procedures by one surgeon. Follow-up 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>53 women (mean age 45.12 years) with SUI were randomised, all had similar background characteristics (age, BMI, parity, grade of associated cystocoele)</P>
<P>Inclusion criteria were age &gt; 21 years, Predominant symptom of SUI, willing to give informed consent, life expectancy &gt; 1 year, normal upper urinary tract and normal manual dexterity</P>
<P>Exclusion: pelvic or vaginal surgery within 6 months, urge incontinence as predominant symptom, &gt; grade 2 cystocele, associated urethral pathology e.g. diverticulum, associated bladder pathology e.g. fistula, culture proven, active urinary tract infection</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>A (25): autologous fascial sling</P>
<P>B (28): TVT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>Cure, i.e. complete dryness with no usage of pad and negative cough-stress test</P>
<P>Not cured at 6 months: A: 2/25, B: 2/28</P>
<P>Operative time (mean (SD)): A: 68 (23), B: 48 (25) min</P>
<P>Time to catheter removal (mean (SD)): A: 6.6 (5.3), B: 4.3 (2.6) d</P>
<P>Complications: bladder perforation: A: 1/25, B: 2/28; de novo detrusor overactivity at 6 months: A: 1/23, B: 0/24; stitch sinus at 1 week: A: 0/25, B 1/28; vaginal erosion: A: 0/25, B: 0/28; wound pain at 6 months: A: 7/25, B: 2/28; voiding dysfunction: A: 7/25, B: 3/28</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-07-15 10:25:25 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BMI = body mass index<BR/>IIQ = Incontinence Impact Questionnaire<BR/>ISD = Intrinsic sphincter dysfunction<BR/>ITT = intention to treat<BR/>MMK = Marshall-Marchetti-Krantz<BR/>MUCP = maximum urethral closure pressure<BR/>POP = pelvic organ prolapse<BR/>QoL = quality of life<BR/>RCT = randomised controlled trial<BR/>SEAPI = SEAPI QMM incontinence classification system<BR/>SUI = stress urinary incontinence<BR/>TVT = tension-free vaginal tape<BR/>UDI = Urinary Distress Inventory<BR/>UDS = urodynamics<BR/>UI = urinary incontinence<BR/>USI = urodynamic stress incontinence<BR/>UTI = urinary tract infection<BR/>UUI = urge urinary incontinence<BR/>VLPP = Valsava leak point pressure<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-07-21 11:46:55 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Amat-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. One minimally invasive sling versus another</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Atherton-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aurunkalaivanan-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>We are not sure about the population studied and it could be the same population as <LINK REF="STD-Barrington-2003" TYPE="STUDY">Barrington 2003</LINK> and <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK> (included in the review); we have written to the trial authors to clarify this point.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barrington-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>We are not sure about the population studied and it could be the same population as <LINK REF="STD-Aurunkalaivanan-2001" TYPE="STUDY">Aurunkalaivanan 2001</LINK> and <LINK REF="STD-Arunkalaivanan-2003" TYPE="STUDY">Arunkalaivanan 2003</LINK> (included in the review); we have written to the trial authors to clarify this point.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bruschini-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT, no comparator group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Choe-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation score C (participants randomised by alternating fashion). Trial comparing slings made of vaginal wall and of polytetrafluorethylene mesh impregnated with chorhexidine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Choe-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>All participants were randomised to undergo preoperative urodynamic evaluation or not. They then had implantation of suburethral mycromesh sling. Therefore the study analyses the impact on effectiveness of sling if the diagnosis of SUI is made with or without urodynamic evaluation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chong-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Participants all had TVT operation, were randomised to division/no division of tape</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Corcos-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were randomised to surgery or collagen injection but those in the surgery arm were selected to sling by participant's option. Three types of operation could be chosen in the surgery group: Burch, sling or bladder neck suspension. Results were reported in terms of collagen versus surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Darai-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>1 minimally invasive sling versus another</P>
<P>Inlcuded in Minimally Invasive Sling Cochrane Review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:46:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Debodinance-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:46:55 +0100" MODIFIED_BY="[Empty name]">
<P>Not all participants had stress incontinence (and allocation score C - participants randomised by birth date). <LINK REF="REF-Debodinance-2000" TYPE="REFERENCE">Debodinance 2000</LINK> is a 10-year follow-up of the first published study. The trial is a comparative study between Bologna (a sling made of strips of vaginal wall) and Ingelman-Sundberg procedure (anterior colporrhaphy with pubococcygeus muscle)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Debodinance-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Not clear how participants allocated. Paper in French, need translation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Giri-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>We are not sure about the population studied and it could be the same population as <LINK REF="STD-Giri-2006" TYPE="STUDY">Giri 2006</LINK>, which has been excluded as it was a non-randomised study. We have made attempts to contact the study authors.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Giri-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Non-randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldberg-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Prolapse surgery rather than incontinence surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Halaska-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Study comparing transvaginal tape with colposuspension; will be included in a separate review on self-fixing slings</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Han-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Study comparing transvaginal tape with colposuspension; will be included in a separate review on self-fixing slings.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hung-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Not clear how participants were allocated, we have written to the study authors</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ishenko-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Randomisation and groups unclear ('randomised by age'). Excluded as attempts to contact study authors unsuccessful and insufficient information given in abstract. Interventions: vaginal hysterectomy, modified Pereyra procedure, anterior and posterior repair vs vaginal hysterectomy, sling procedure with Mersilene mesh, anterior and posterior repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kocjancic-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Study comparing transvaginal tape procedures; will be included in a separate review on self-fixing slings.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuo-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation score C (participants randomised by consecutive study entry). Comparison between rectus fascia and polypropylene mesh</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kwon-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Not all participants had stress incontinence; all participants were treated for prolapse but one group received concomitant transvaginal sling (processed fascia lata), one group received an alternate surgery for SUI and the last group, didn't have SUI and were submitted only to treatment of prolapse</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lemieux-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Interventions were on clamping versus non-clamping of catheters post-anti-incontinence surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liapis-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Study comparing transvaginal tape with colposuspension; will be included in a separate review on self-fixing slings</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lim-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>This study is comparing minimally invasive sling procedures and will be included in that Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meschia-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Surgery for prolapse rather than incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Naumann-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>This study is comparing tape procedures and will be included in the minimally invasive slings Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Sullivan-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. Participants randomised to colposuspension or transvaginal tape. Outcome measures (collagen metabolism) reported not included in this review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Obrink-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:17 +0100" MODIFIED_BY="[Empty name]">
<P>Not clear how participants were allocated. Study author written to in October 2001, no reply received</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schostak-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear how participants were allocated. Bone anchoring used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seo-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>RCT. One minimally invasive sling versus another</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trezza-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>Occult incontinence treated at same time as prolapse repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised to different types of anaesthetic</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ward-2002a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>Study comparing transvaginal tape with colposuspension; will be included in a separate review on self-fixing slings</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yoo-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>This study is comparing tape procedures and will be added to the minimally invasive slings Cochrane Review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2010-07-24 12:53:04 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-07-21 11:49:10 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hilton-2000">
<CHAR_STUDY_NAME MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>A prospective randomised comparative trial of a tension free vaginal tape (TVT) and fascial sling procedure for 'secondary' genuine stress incontinence</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS>
<P>146 planned recruitment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>TVT versus fascial sling</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>No information</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-07-21 11:49:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lucas-2001">
<CHAR_STUDY_NAME MODIFIED="2008-10-24 08:40:36 +0100" MODIFIED_BY="[Empty name]">
<P>Sling operation for stress urinary incontinence: randomised trial of three operative procedures</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS>
<P>TVT versus Pelvicol versus sling on a string</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES/>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES MODIFIED="2017-07-21 11:49:10 +0100" MODIFIED_BY="[Empty name]">
<P>Possibly same as <LINK REF="REF-Lucas-2004" TYPE="REFERENCE">Lucas 2004</LINK>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:07:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Albo-2007">
<DESCRIPTION>
<P>Use of permuted-block randomisation schedule with stratification according to clinical site</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 16:26:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Amaro-2007">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Arunkalaivanan-2003">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:32:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbalias-1997">
<DESCRIPTION>
<P>Computer randomised numbers, assigning 2 successive numbers to the fascial group and following number to Gore-Tex group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:23:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Basok-2008">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:45:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Demirci-2001">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-29 14:19:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Enzelsberger-1996">
<DESCRIPTION>
<P>Random number chart, even numbers underwent colposuspension; odd numbers underwent sling procedure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 17:27:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fischer-2001">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 16:54:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guerrero-2008">
<DESCRIPTION>
<P>Insufficient information to make judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 21:36:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Henriksson-1978">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 17:23:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilton-1989">
<DESCRIPTION>
<P>Random number chart</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kondo-2006">
<DESCRIPTION>
<P>Date-of-birth method</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 14:43:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lucas-2000">
<DESCRIPTION>
<P>Computer-generated randomisation schedule</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maher-2005">
<DESCRIPTION>
<P>Computer randomisation software, no description given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Osman-2003">
<DESCRIPTION>
<P>Block randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-22 15:01:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pacetta-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 17:17:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sand-2000">
<DESCRIPTION>
<P>Random number table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharifiaghdas-2008">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:55:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shin-2001">
<DESCRIPTION>
<P>Insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Silva-Filho-2006">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-26 10:26:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2004">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tcherniakovsky-2009">
<DESCRIPTION>
<P>Participants "randomly distributed". No detail provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 14:31:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Teixeira-2008">
<DESCRIPTION>
<P>No details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:49:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Viseshsindh-2003">
<DESCRIPTION>
<P>Insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-23 15:16:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wadie-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:07:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Albo-2007">
<DESCRIPTION>
<P>Insufficient information to permit judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 16:26:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Amaro-2007">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 16:40:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Arunkalaivanan-2003">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbalias-1997">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:23:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Basok-2008">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:42:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Demirci-2001">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-29 14:19:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Enzelsberger-1996">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 17:27:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fischer-2001">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 16:54:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guerrero-2008">
<DESCRIPTION>
<P>Insufficient information to make judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 21:36:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Henriksson-1978">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 17:24:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hilton-1989">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 15:57:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kondo-2006">
<DESCRIPTION>
<P>Date of birth</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 14:43:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lucas-2000">
<DESCRIPTION>
<P>Remote telephone randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 13:15:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maher-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 17:10:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Osman-2003">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-22 15:01:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pacetta-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-29 14:34:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sand-2000">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharifiaghdas-2008">
<DESCRIPTION>
<P>Sealed, opaque envelopes, no mention of numbering</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:54:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shin-2001">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Silva-Filho-2006">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-26 10:26:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2004">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tcherniakovsky-2009">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-20 14:31:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Teixeira-2008">
<DESCRIPTION>
<P>"blindly randomised" no details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-07-21 16:49:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Viseshsindh-2003">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wadie-2005">
<DESCRIPTION>
<P>Closed, opaque envelopes held by a non-involved 3rd party who revealed the allocation after participant had been anaesthetised, just before start of surgery</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:07:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Albo-2007">
<DESCRIPTION>
<P>Participants were aware of study-group assignments postoperatively. Independent data and safety monitoring board oversaw the progress, interim results, and safety of the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:15:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Amaro-2007">
<DESCRIPTION>
<P>"Single blinded" mentioned in abstract, but no description given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Arunkalaivanan-2003">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 16:32:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 16:38:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barbalias-1997">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 16:23:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Basok-2008">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 16:42:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Demirci-2001">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 21:50:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Enzelsberger-1996">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 17:27:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fischer-2001">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-20 16:54:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Guerrero-2008">
<DESCRIPTION>
<P>Insufficient information to make judgement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 21:37:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Henriksson-1978">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 17:24:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hilton-1989">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kondo-2006">
<DESCRIPTION>
<P>No mention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lucas-2000">
<DESCRIPTION>
<P>Not blinded. Operation performed obvious to all medical and nursing personnel involved in the assessment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-20 13:15:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Maher-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 17:10:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Osman-2003">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-22 15:01:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pacetta-2005">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-29 14:34:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sand-2000">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sharifiaghdas-2008">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 16:54:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shin-2001">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Silva-Filho-2006">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-26 10:26:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Song-2004">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tcherniakovsky-2009">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 16:51:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Teixeira-2008">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2010-07-21 16:49:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Viseshsindh-2003">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wadie-2005">
<DESCRIPTION>
<P>No details provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:07:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Albo-2007">
<DESCRIPTION>
<P>135 women were lost to follow-up at 2 years. 61 from the sling group and 74 from Burch failed to attend clinic</P>
<P>To allow for attrition and missed visits, 655 women had been recruited following power calculation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-07-20 16:27:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Amaro-2007">
<DESCRIPTION>
<P>All outcome data assessed. No women lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arunkalaivanan-2003">
<DESCRIPTION>
<P>No participants lost to follow-up at 12 months. All outcome data assessed. At 36 months, in the Pelvicol arm 2 participants died and 4 lost to follow-up; in the TVT arm 1 died, and 7 lost to follow-up. Statistical analysis failed to detect significant differences</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bai-2005">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-07-21 16:34:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barbalias-1997">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-07-21 16:41:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Basok-2008">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Demirci-2001">
<DESCRIPTION>
<P>12 women missing lost to follow-up, reason not reported. No mention of whether loss had impact on final analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Enzelsberger-1996">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fischer-2001">
<DESCRIPTION>
<P>Two participants in the Burch group were found to have recurrent urethrovesical junction hypermobility considered surgical failures and excluded from final analysis. Insufficient information to judge whether appropriately addressed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guerrero-2008">
<DESCRIPTION>
<P>No missing outcome data at 12 months. Study closed after 6 years due to failure to recruit target numbers and high reoperation rate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Henriksson-1978">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-07-21 17:25:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilton-1989">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kondo-2006">
<DESCRIPTION>
<P>Similar loss across groups at follow-up, 72% remained in sling arm and 74% in Burch</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lucas-2000">
<DESCRIPTION>
<P>Ouctome data were analysed according to the randomised group, per protocol and best possible. 21 women lost to follow-up by 12 months, 23 lost by 3 years. The similar losses from each arm were unlikely to affect the final analysis. Actual numbers with outcome reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Maher-2005">
<DESCRIPTION>
<P>Ouctome data were analysed according to the randomised group. One woman in each group failed to return or complete any review. Actual numbers with outcome reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Osman-2003">
<DESCRIPTION>
<P>Of 75 women randomised, 68 evaluated at 6 months. Four lost in anticholinergic arm and 3 in surgical arm. Insufficient information to determine whether appropriately addressed or not</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pacetta-2005">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sand-2000">
<DESCRIPTION>
<P>Similar losses in both groups at long-term assessment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sharifiaghdas-2008">
<DESCRIPTION>
<P>All outcomes assessed in randomised groups. 39 participants lost to follow-up. Similar losses in each group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-07-21 16:55:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shin-2001">
<DESCRIPTION>
<P>No missing outcome data. (based on abstract)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Silva-Filho-2006">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Song-2004">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tcherniakovsky-2009">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Teixeira-2008">
<DESCRIPTION>
<P>2 participants with missing outcome data. No detail provided on whether losses were similar in both groups, or from a single arm of the trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-07-21 16:50:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Viseshsindh-2003">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-21 11:15:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wadie-2005">
<DESCRIPTION>
<P>No missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-07-20 11:37:24 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-07-20 11:38:15 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2010-12-07 17:29:55 +0000" MODIFIED_BY="Grade Profiler">Traditional suburethral slings compared to injectable treatment for stress urinary incontinence</TITLE>
<TABLE COLS="7" ROWS="5">
<TR>
<TD COLSPAN="7">
<P>
<B>Traditional suburethral slings compared to injectable treatment for stress urinary incontinence</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> women with stress urinary incontinence<BR/>
<B>Settings:</B> secondary care<BR/>
<B>Intervention:</B> traditional suburethral slings<BR/>
<B>Comparison: </B>injectable treatment</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Injectable treatment</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Traditional suburethral slings</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>4.1 Number with incontinence (worse, unchanged or improved) within the first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>227 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>95 per 1000</B>
<BR/>(20 to 438)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.42 </B>
<BR/>(0.09 to 1.93)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>43<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Single trial with few participants</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>4.2 Number with incontinence (worse, unchanged or improved) after first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>286 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>34 per 1000</B>
<BR/>(3 to 578)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.12 </B>
<BR/>(0.01 to 2.02)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>27<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3,4,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Single trial with few participants</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>4.4 Voiding dysfunction </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>45 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>189 per 1000</B>
<BR/>(23 to 1000)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 4.19 </B>
<BR/>(0.51 to 34.5)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>43<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3,4,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Single trial with few participants</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Illustrative comparative risks were based upon the mean risk on control intervention in the studies included in the meta-analysis.<BR/>
<SUP>2</SUP>Single trial with few participants.<BR/>
<SUP>3</SUP>Uncertainty about method of sequence generation and allocation concealment.<BR/>
<SUP>4</SUP>Single trial thus unable to determine inconsistency.<BR/>
<SUP>5</SUP>Single small trial with large confidence intervals.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2017-07-16 09:10:41 +0100" MODIFIED_BY="[Empty name]">Traditional suburethral sling operation compared to open abdominal retropubic suspension for stress urinary incontinence</TITLE>
<TABLE COLS="7" ROWS="8">
<TR>
<TD COLSPAN="7">
<P>
<B>Traditional suburethral sling operation compared to open abdominal retropubic suspension for stress urinary incontinence</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> women with stress urinary incontinence<BR/>
<B>Settings:</B> secondary care<BR/>
<B>Intervention:</B> traditional suburethral sling operation<BR/>
<B>Comparison: </B>open abdominal retropubic suspension</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Open abdominal retropubic suspension</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Traditional suburethral sling operation</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>5.1 Number with incontinence (worse, unchanged or improved) within the first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>92 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>37 per 1000</B>
<BR/>(10 to 130)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.4 </B>
<BR/>(0.11 to 1.41)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>147<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Fischer trial did not account for incomplete outcome data</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>5.3 Number with incontinence (worse, unchanged or improved) after first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>399 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>299 per 1000</B>
<BR/>(247 to 359)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.75 </B>
<BR/>(0.62 to 0.9)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>715<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Demirci did not account for incomplete outcome data</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>5.14 Peri-operative surgical complications </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>407 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>533 per 1000</B>
<BR/>(464 to 615)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 1.31 </B>
<BR/>(1.14 to 1.51)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>792<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>5.15 Bladder perforation </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>30 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>0 per 1000</B>
<BR/>(0 to 0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0 </B>
<BR/>(0 to 0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>655<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Single study thus no pooled data available</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>5.18 Voiding dysfunction after three months </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>21 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>128 per 1000</B>
<BR/>(65 to 251)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 6.08 </B>
<BR/>(3.1 to 11.95)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>853<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>5.21 Repeat incontinence surgery</B> - not reported</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No data</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Illustrative comparative risks were based upon the mean risk on control intervention in the studies included in the meta-analysis.<BR/>
<SUP>2</SUP>Uncertainty in most studies about method of sequence generation and allocation concealment.<BR/>
<SUP>3</SUP>95% confidence interval around the pooled data includes both 1) no effect and 2) appreciable benefit or appreciable harm, thus imprecise.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" NO="3" READONLY="YES">
<TITLE MODIFIED="2010-12-07 17:30:10 +0000" MODIFIED_BY="Grade Profiler">Traditional suburethral sling operation compared to bladder neck (needle) suspension for stress urinary incontinence</TITLE>
<TABLE COLS="7" ROWS="6">
<TR>
<TD COLSPAN="7">
<P>
<B>Traditional suburethral sling operation compared to bladder neck (needle) suspension for stress urinary incontinence</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> women with stress urinary incontinence<BR/>
<B>Settings:</B> secondary care<BR/>
<B>Intervention:</B> traditional suburethral sling operation<BR/>
<B>Comparison: </B>bladder neck (needle) suspension</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Bladder neck (needle) suspension</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Traditional suburethral sling operation</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>6.1 Number with incontinence (worse, unchanged or improved) within the first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>100 per 1000</B>
<BR/>(10 to 934)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.5 </B>
<BR/>(0.05 to 4.67)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>6.2 Number with incontinence (worse, unchanged or improved) after the first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>300 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>99 per 1000</B>
<BR/>(12 to 807)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.33 </B>
<BR/>(0.04 to 2.69)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>6.4 Peri-operative surgical complications</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>900 per 1000</B>
<BR/>(256 to 1000)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 4.5 </B>
<BR/>(1.28 to 15.81)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>6.6 Voiding dysfunction after three months - urodynamic stress incontinence (only) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>200 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>400 per 1000</B>
<BR/>(94 to 1000)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 2 </B>
<BR/>(0.47 to 8.56)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>2,3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Illustrative comparative risks were based upon the mean risk on control intervention in the studies included in the meta-analysis.<BR/>
<SUP>2</SUP>Uncertainty about method of sequence generation and allocation concealment.<BR/>
<SUP>3</SUP>Single trial with few participants.<BR/>
<SUP>4</SUP>Single trial thus unable to determine inconsistency.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-04" MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" NO="4" READONLY="YES">
<TITLE MODIFIED="2010-12-07 17:30:17 +0000" MODIFIED_BY="Grade Profiler">Traditional suburethral sling operation compared to minimally invasive synthetic slings for stress urinary incontinence</TITLE>
<TABLE COLS="7" ROWS="13">
<TR>
<TD COLSPAN="7">
<P>
<B>Traditional suburethral sling operation compared to minimally invasive synthetic slings for stress urinary incontinence</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> women with stress urinary incontinence<BR/>
<B>Settings:</B> secondary care<BR/>
<B>Intervention:</B> traditional suburethral sling operation<BR/>
<B>Comparison: </B>minimally invasive slings</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Minimally invasive slings</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Traditional suburethral sling operation</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>9.1 Number with incontinence (worse, unchanged or improved) within the first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>275 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>267 per 1000</B>
<BR/>(214 to 330)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.97 </B>
<BR/>(0.78 to 1.2)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>693<BR/>(8 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>9.3 Number with incontinence (worse, unchanged or improved) after first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>253 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>311 per 1000</B>
<BR/>(230 to 420)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 1.23 </B>
<BR/>(0.91 to 1.66)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>382<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>9.11 Peri-operative surgical complications </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>208 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>331 per 1000</B>
<BR/>(214 to 508)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 1.59 </B>
<BR/>(1.03 to 2.44)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>243<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>9.12 Bladder perforations </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>82 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>51 per 1000</B>
<BR/>(28 to 91)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.62 </B>
<BR/>(0.34 to 1.11)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>563<BR/>(7 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>9.16 Voiding dysfunction</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>98 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>157 per 1000</B>
<BR/>(92 to 266)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 1.6 </B>
<BR/>(0.94 to 2.71)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>375<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<BR/>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Illustrative comparative risks were based upon the mean risk on control intervention in the studies included in the meta-analysis.<BR/>
<SUP>2</SUP>Uncertainty in most studies about method of sequence generation and allocation concealment.<BR/>
<SUP>3</SUP>Event rates very low resulting in wide confidence interval.<BR/>
<SUP>4</SUP>Wide confidence interval include possible benefit from both surgical procedures.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-05" MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" NO="5" READONLY="YES">
<TITLE MODIFIED="2010-12-07 17:30:24 +0000" MODIFIED_BY="Grade Profiler">Traditional suburethral sling operation compared to another traditional suburethral sling for stress urinary incontinence</TITLE>
<TABLE COLS="7" ROWS="6">
<TR>
<TD COLSPAN="7">
<P>
<B>Traditional suburethral sling operation compared to another traditional suburethral sling for stress urinary incontinence</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> women with stress urinary incontinence<BR/>
<B>Settings:</B> secondary care<BR/>
<B>Intervention:</B> traditional suburethral sling operation<BR/>
<B>Comparison: </B>another traditional suburethral sling</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Another traditional suburethral sling</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Traditional suburethral sling operation</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>10.1 Number with incontinence (worse, unchanged or improved) within the first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>336 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>299 per 1000</B>
<BR/>(222 to 400)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.89 </B>
<BR/>(0.66 to 1.19)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>307<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>10.3 Number with incontinence (worse, unchanged or improved) after first year (women's observations) </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>467 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>416 per 1000</B>
<BR/>(336 to 514)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.89 </B>
<BR/>(0.72 to 1.1)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>379<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>10.8 Peri-operative surgical complications </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>360 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>335 per 1000</B>
<BR/>(234 to 479)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.93 </B>
<BR/>(0.65 to 1.33)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>213<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>10.12 Voiding dysfunction </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>202 per 1000</B>
<SUP>1</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>234 per 1000</B>
<BR/>(131 to 418)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 1.16 </B>
<BR/>(0.65 to 2.07)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>165<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2,3,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Illustrative comparative risks were based upon the mean risk on control intervention in the studies included in the meta-analysis.<BR/>
<SUP>2</SUP>Uncertainty in most studies about method of sequence generation and allocation concealment.<BR/>
<SUP>3</SUP>95% confidence interval around the pooled data includes both 1) no effect and 2) appreciable benefit or appreciable harm, thus imprecise.<BR/>
<SUP>4</SUP>Widely differing estimates of the treatment effect between trials.<BR/>
<SUP>5</SUP>Single trial thus unable to determine inconsistency.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-07-21 11:40:49 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-07-21 11:38:50 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Sling versus no treatment or sham operation</NAME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2017-07-21 11:39:04 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Sling versus conservative treatment</NAME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2017-07-21 11:39:15 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Sling versus drugs</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:01:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="24" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence (worse, unchanged or improved) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>anticholinergic</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours anticholinergic</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:00:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:09:12 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="21" I2="0.0" ID="CMP-003.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-30 14:29:30 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
<DICH_DATA CI_END="0.42625132755729456" CI_START="0.07958802128310932" EFFECT_SIZE="0.1841860465116279" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="21" LOG_CI_END="-0.3703342553896873" LOG_CI_START="-1.0991522925904988" LOG_EFFECT_SIZE="-0.7347432739900931" MODIFIED="2010-07-30 14:29:30 +0100" MODIFIED_BY="[Empty name]" ORDER="6020" O_E="0.0" SE="0.4281113227592252" STUDY_ID="STD-Osman-2003" TOTAL_1="24" TOTAL_2="21" VAR="0.18327930467465348" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-07-30 14:34:09 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="17.78" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="24" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Urge symptoms or urge incontinence</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>anticholinergic</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours anticholinergic</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:01:07 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:09:45 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="9" I2="0.0" ID="CMP-003.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-30 14:33:00 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
<DICH_DATA CI_END="0.937911844217457" CI_START="0.09070089579199397" EFFECT_SIZE="0.2916666666666667" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="9" LOG_CI_END="-0.027837979711670978" LOG_CI_START="-1.0423884236830274" LOG_EFFECT_SIZE="-0.5351132016973492" MODIFIED="2010-07-30 14:33:00 +0100" MODIFIED_BY="[Empty name]" ORDER="6021" O_E="0.0" SE="0.5959519528944679" STUDY_ID="STD-Osman-2003" TOTAL_1="24" TOTAL_2="21" VAR="0.3551587301587301" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2017-07-21 11:39:24 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Sling versus injectable</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:02:51 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="23.69" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence (worse, unchanged or improved) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Injectable</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours injectable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:02:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="1.9292834525095064" CI_START="0.091018718271318" EFFECT_SIZE="0.41904761904761906" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2853960393687082" LOG_CI_START="-1.0408692845362095" LOG_EFFECT_SIZE="-0.3777366225837506" MODIFIED="2010-07-20 11:02:17 +0100" MODIFIED_BY="[Empty name]" ORDER="118" O_E="0.0" SE="0.7790548163809828" STUDY_ID="STD-Maher-2005" TOTAL_1="21" TOTAL_2="22" VAR="0.6069264069264069" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 10:58:07 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 10:58:07 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:02:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="723.02" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="13" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence (worse, unchanged or improved) after first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Injectable</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours injectable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="4" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-30 11:54:51 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="2.0163146781518955" CI_START="0.007028831240715386" EFFECT_SIZE="0.11904761904761904" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3045583116624593" LOG_CI_START="-2.1531168837862227" LOG_EFFECT_SIZE="-0.9242792860618817" MODIFIED="2010-07-30 11:54:51 +0100" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="1.4436505754949789" STUDY_ID="STD-Maher-2005" TOTAL_1="13" TOTAL_2="14" VAR="2.084126984126984" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 10:58:44 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 10:58:44 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:06:01 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="18.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence (clinician's observations) within first year</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Injectable</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours injectable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="20" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:03:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="0.5110199443340759" CI_START="0.08590707122904413" EFFECT_SIZE="0.20952380952380953" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="20" LOG_CI_END="-0.29156214967897526" LOG_CI_START="-1.0659710868164882" LOG_EFFECT_SIZE="-0.6787666182477319" MODIFIED="2010-07-20 11:03:47 +0100" MODIFIED_BY="[Empty name]" ORDER="120" O_E="0.0" SE="0.454891643060638" STUDY_ID="STD-Maher-2005" TOTAL_1="21" TOTAL_2="22" VAR="0.2069264069264069" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:02:52 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:03:07 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-02 14:03:34 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="56.49" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>Voiding dysfunction</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Injectable</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours injectable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="1" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:08:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="34.500082087619646" CI_START="0.5089869252586297" EFFECT_SIZE="4.190476190476191" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5378201284111823" LOG_CI_START="-0.2932933735786835" LOG_EFFECT_SIZE="0.6222633774162494" MODIFIED="2010-07-20 11:08:43 +0100" MODIFIED_BY="[Empty name]" ORDER="124" O_E="0.0" SE="1.075605135226867" STUDY_ID="STD-Maher-2005" TOTAL_1="21" TOTAL_2="22" VAR="1.156926406926407" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:08:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:08:43 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-02 14:03:45 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>De novo detrusor overactivity (urodynamic diagnosis)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours injectable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-004.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:05:28 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="72.95548572420083" CI_START="0.13483258677340385" EFFECT_SIZE="3.1363636363636362" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8630579532572573" LOG_CI_START="-0.8702051334271592" LOG_EFFECT_SIZE="0.49642640991504905" MODIFIED="2010-07-20 11:05:28 +0100" MODIFIED_BY="[Empty name]" ORDER="122" O_E="0.0" SE="1.6055322669889123" STUDY_ID="STD-Maher-2005" TOTAL_1="21" TOTAL_2="22" VAR="2.5777338603425557" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:04:50 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:05:04 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-02 14:03:53 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="12.15" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>Urinary tract infection</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Injectable</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours injectable</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-004.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:09:16 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="22" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="8.485049785117994" CI_START="0.29102808087621623" EFFECT_SIZE="1.5714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9286543948373829" LOG_CI_START="-0.5360651045494464" LOG_EFFECT_SIZE="0.1962946451439682" MODIFIED="2010-07-20 11:09:16 +0100" MODIFIED_BY="[Empty name]" ORDER="123" O_E="0.0" SE="0.8603834844182797" STUDY_ID="STD-Maher-2005" TOTAL_1="21" TOTAL_2="22" VAR="0.7402597402597402" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:00:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.06.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 11:00:04 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2017-07-21 11:39:44 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Sling versus open abdominal retropubic suspension</NAME>
<DICH_OUTCOME CHI2="1.0896550113834231" CI_END="1.4105083844092379" CI_START="0.11378706089642086" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.40062152142850005" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" I2_Q="100.0" ID="CMP-005.01" LOG_CI_END="0.14937567205242272" LOG_CI_START="-0.9439071201972948" LOG_EFFECT_SIZE="-0.3972657240724361" METHOD="MH" MODIFIED="2010-08-06 15:03:07 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5799419301914648" P_Q="0.0" P_Z="0.15433573859392372" Q="2.98868559567044E-32" RANDOM="NO" SCALE="158.89939409607467" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="76" WEIGHT="100.0" Z="1.424382633649565">
<NAME>Number with incontinence (worse, unchanged or improved) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.0896550113834231" CI_END="1.4105083844092379" CI_START="0.11378706089642086" DF="2" EFFECT_SIZE="0.40062152142850005" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" ID="CMP-005.01.01" LOG_CI_END="0.14937567205242272" LOG_CI_START="-0.9439071201972948" LOG_EFFECT_SIZE="-0.3972657240724361" MODIFIED="2010-07-27 23:48:39 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5799419301914648" P_Z="0.15433573859392372" STUDIES="4" TAU2="0.0" TOTAL_1="71" TOTAL_2="76" WEIGHT="100.0" Z="1.424382633649565">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="4.374093461968783" CI_START="0.14113711655755107" EFFECT_SIZE="0.7857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6408880584418241" LOG_CI_START="-0.8503587594818501" LOG_EFFECT_SIZE="-0.104735350520013" MODIFIED="2010-07-27 23:48:39 +0100" MODIFIED_BY="[Empty name]" ORDER="1499" O_E="0.0" SE="0.8759657626391669" STUDY_ID="STD-Bai-2005" TOTAL_1="28" TOTAL_2="33" VAR="0.7673160173160173" WEIGHT="35.084984561887346"/>
<DICH_DATA CI_END="3.084309693163042" CI_START="0.00900615714412612" EFFECT_SIZE="0.16666666666666666" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.4891579787431036" LOG_CI_START="-2.0454604795103912" LOG_EFFECT_SIZE="-0.7781512503836436" ORDER="5971" O_E="0.0" SE="1.4888474289418194" STUDY_ID="STD-Fischer-2001" TOTAL_1="11" TOTAL_2="9" VAR="2.2166666666666663" WEIGHT="34.74324769927156"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="5972" O_E="0.0" SE="0.0" STUDY_ID="STD-Henriksson-1978" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.326518133508866" CI_START="0.01141396257348692" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6361385282905834" LOG_CI_START="-1.9425635558412708" LOG_EFFECT_SIZE="-0.6532125137753437" ORDER="5973" O_E="0.0" SE="1.5147423690002353" STUDY_ID="STD-Sand-2000" TOTAL_1="17" TOTAL_2="19" VAR="2.2944444444444447" WEIGHT="30.17176773884109"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 14:38:45 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:03:14 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number not improved (worse or unchanged) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:13:03 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:15:40 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.2371073221706097" CI_END="0.902489011441005" CI_START="0.6151020326242911" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.74506565171027" ESTIMABLE="YES" EVENTS_1="109" EVENTS_2="142" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="-0.0445580772888847" LOG_CI_START="-0.21105283783390977" LOG_EFFECT_SIZE="-0.12780545756139725" METHOD="MH" MODIFIED="2010-08-06 15:03:39 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8719521866693507" P_Q="0.9226929954032923" P_Z="0.0026208086045701124" Q="0.00941716097204225" RANDOM="NO" SCALE="27.834813626276777" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="359" TOTAL_2="356" WEIGHT="100.0" Z="3.009032753078857">
<NAME>Number with incontinence (worse, unchanged or improved) after first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.2238940579431672" CI_END="1.6730170266521665" CI_START="0.3064768543178131" DF="3" EFFECT_SIZE="0.716059351973352" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="12" I2="0.0" ID="CMP-005.03.01" LOG_CI_END="0.223500360892731" LOG_CI_START="-0.5136023186059846" LOG_EFFECT_SIZE="-0.14505097885662677" MODIFIED="2010-07-27 23:49:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7472794929503426" P_Z="0.4404792212681641" STUDIES="4" TAU2="0.0" TOTAL_1="94" TOTAL_2="101" WEIGHT="8.050413612650534" Z="0.7713842382844431">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="2.9805555203618193" CI_START="0.11650769485383372" EFFECT_SIZE="0.5892857142857143" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.47429721607061126" LOG_CI_START="-0.9336453903272373" LOG_EFFECT_SIZE="-0.22967408712831291" MODIFIED="2010-07-27 23:49:01 +0100" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="0.8270324564263993" STUDY_ID="STD-Bai-2005" TOTAL_1="28" TOTAL_2="33" VAR="0.683982683982684" WEIGHT="2.548308982464124"/>
<DICH_DATA CI_END="5.009074665946237" CI_START="0.04990941774128532" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6997575053902041" LOG_CI_START="-1.3018174967181666" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="5974" O_E="0.0" SE="1.1757350641945108" STUDY_ID="STD-Demirci-2001" TOTAL_1="17" TOTAL_2="17" VAR="1.3823529411764706" WEIGHT="1.3879182850920675"/>
<DICH_DATA CI_END="2.3254889474370875" CI_START="0.15480615394743313" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3665142797415406" LOG_CI_START="-0.8102117789742533" LOG_EFFECT_SIZE="-0.2218487496163564" ORDER="5975" O_E="0.0" SE="0.6912147117775906" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" VAR="0.47777777777777775" WEIGHT="3.4697957127301686"/>
<DICH_DATA CI_END="22.62194860474717" CI_START="0.23541048032726553" EFFECT_SIZE="2.3076923076923075" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.354530011369287" LOG_CI_START="-0.6281742065436359" LOG_EFFECT_SIZE="0.3631779024128256" MODIFIED="2010-07-26 12:01:09 +0100" MODIFIED_BY="[Empty name]" ORDER="5976" O_E="0.0" SE="1.1646502721462166" STUDY_ID="STD-Sand-2000" TOTAL_1="13" TOTAL_2="15" VAR="1.3564102564102565" WEIGHT="0.6443906323641743"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9085689145865213" CI_START="0.6151581497231857" DF="0" EFFECT_SIZE="0.7476052249637155" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="130" I2="0.0" ID="CMP-005.03.02" LOG_CI_END="-0.041642126044928354" LOG_CI_START="-0.21101321800916545" LOG_EFFECT_SIZE="-0.1263276720270469" MODIFIED="2010-07-14 14:23:19 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.0034586439348368923" STUDIES="1" TAU2="0.0" TOTAL_1="265" TOTAL_2="255" WEIGHT="91.94958638734947" Z="2.9237301897549375">
<NAME>stress urinary incontinence (symptoms only)</NAME>
<DICH_DATA CI_END="0.9085689145865214" CI_START="0.6151581497231857" EFFECT_SIZE="0.7476052249637155" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="130" LOG_CI_END="-0.0416421260449283" LOG_CI_START="-0.21101321800916545" LOG_EFFECT_SIZE="-0.1263276720270469" MODIFIED="2010-07-14 14:23:19 +0100" MODIFIED_BY="[Empty name]" ORDER="813" O_E="0.0" SE="0.09948941782021965" STUDY_ID="STD-Albo-2007" TOTAL_1="265" TOTAL_2="255" VAR="0.009898144258206239" WEIGHT="91.94958638734947"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:03:45 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number not improved (worse or unchanged) after first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:13:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:15:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.05" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pad changes over 24 hours</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.01" MODIFIED="2010-07-20 19:13:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.02" MODIFIED="2010-07-20 19:16:14 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.06" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Incontinent episodes over 24 hours</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.06.01" MODIFIED="2010-07-30 15:45:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.06.02" MODIFIED="2010-07-20 19:16:07 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.06.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.07" MODIFIED="2010-08-02 14:09:00 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pad test weights</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.07.01" MODIFIED="2010-07-20 19:13:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.07.02" MODIFIED="2010-07-20 19:16:22 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.07.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:06:24 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence (clinician's observations) within the first year</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.08.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-27 15:04:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-27 15:04:12 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.08.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-27 15:04:12 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.5616370653849456" CI_END="1.4062217381921631" CI_START="0.640592233492735" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9491125981961012" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="43" I2="0.0" I2_Q="0.0" ID="CMP-005.09" LOG_CI_END="0.14805380722750502" LOG_CI_START="-0.1934183310042225" LOG_EFFECT_SIZE="-0.02268226188835875" METHOD="MH" MODIFIED="2010-08-06 15:06:20 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.45803109213152426" P_Q="0.33474865076300464" P_Z="0.7945699520142859" Q="0.9304404578557138" RANDOM="NO" SCALE="135.10421384141335" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="314" TOTAL_2="306" WEIGHT="99.99999999999999" Z="0.2603809295792087">
<NAME>Number with incontinence (clinician's observations) after first year</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.368940717884109" CI_START="0.011958252888468135" DF="0" EFFECT_SIZE="0.22857142857142856" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-005.09.01" LOG_CI_END="0.6403761518117705" LOG_CI_START="-1.9223322665284346" LOG_EFFECT_SIZE="-0.640978057358332" MODIFIED="2010-07-26 12:02:02 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.32686783584140333" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="15" WEIGHT="5.295315682281059" Z="0.9804423307092006">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="4.368940717884109" CI_START="0.011958252888468135" EFFECT_SIZE="0.22857142857142856" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6403761518117705" LOG_CI_START="-1.9223322665284346" LOG_EFFECT_SIZE="-0.640978057358332" MODIFIED="2010-07-26 12:02:02 +0100" MODIFIED_BY="[Empty name]" ORDER="842" O_E="0.0" SE="1.5053476105442982" STUDY_ID="STD-Sand-2000" TOTAL_1="13" TOTAL_2="15" VAR="2.2660714285714283" WEIGHT="5.295315682281059"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6342010570402197" CI_END="1.474197713278397" CI_START="0.6640318153815958" DF="1" EFFECT_SIZE="0.9894009216589862" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="41" I2="0.0" ID="CMP-005.09.02" LOG_CI_END="0.16855573320252248" LOG_CI_START="-0.17781111202708416" LOG_EFFECT_SIZE="-0.0046276894122808205" MODIFIED="2010-07-26 11:46:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4258187455646184" P_Z="0.958231629225111" STUDIES="2" TAU2="0.0" TOTAL_1="301" TOTAL_2="291" WEIGHT="94.70468431771893" Z="0.052372822079406384">
<NAME>stress urinary incontinence (symptoms only)</NAME>
<DICH_DATA CI_END="1.4242109283688285" CI_START="0.6163828605220196" EFFECT_SIZE="0.9369414101290964" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="38" LOG_CI_END="0.1535743139096045" LOG_CI_START="-0.2101494460149401" LOG_EFFECT_SIZE="-0.028287566052667818" MODIFIED="2010-07-14 14:29:34 +0100" MODIFIED_BY="[Empty name]" ORDER="818" O_E="0.0" SE="0.2136531370413266" STUDY_ID="STD-Albo-2007" TOTAL_1="265" TOTAL_2="255" VAR="0.04564766296759988" WEIGHT="87.89642129764329"/>
<DICH_DATA CI_END="6.459691520658577" CI_START="0.4300170942984254" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8102117789742533" LOG_CI_START="-0.3665142797415406" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2010-07-26 11:46:33 +0100" MODIFIED_BY="[Empty name]" ORDER="841" O_E="0.0" SE="0.6912147117775906" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" VAR="0.47777777777777775" WEIGHT="6.808263020075646"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 14:25:25 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.10" MODIFIED="2010-08-02 14:09:32 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="15.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.10.01" MODIFIED="2010-07-26 13:57:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="12.55867756955537" CI_START="-0.5186775695553774" EFFECT_SIZE="6.019999999999996" ESTIMABLE="YES" MEAN_1="60.66" MEAN_2="54.64" MODIFIED="2010-07-26 13:57:50 +0100" MODIFIED_BY="[Empty name]" ORDER="1272" SD_1="8.63" SD_2="9.29" SE="3.3361212864785412" STUDY_ID="STD-Demirci-2001" TOTAL_1="15" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.10.02" MODIFIED="2010-07-26 13:56:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.10.03" MODIFIED="2010-07-26 13:56:17 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.045261398198166276" CI_END="9.184402396696004" CI_START="6.8373901283623715" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="8.010896262529188" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.11" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.8315242467532798" P_Q="0.8315242467532798" P_Z="7.955120605906894E-41" Q="0.045261398198166276" RANDOM="NO" SCALE="25.896327934008532" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="53" TOTAL_2="55" UNITS="" WEIGHT="99.99999999999999" Z="13.379621717607309">
<NAME>Time to catheter removal (days)</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="23.268677079651106" CI_START="-4.2686770796511055" DF="0" EFFECT_SIZE="9.5" ESTIMABLE="YES" I2="0.0" ID="CMP-005.11.01" MODIFIED="2010-07-28 11:16:02 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.176272958282918" STUDIES="1" TAU2="0.0" TOTAL_1="17" TOTAL_2="19" WEIGHT="0.7264175019458785" Z="1.3523200337560923">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="23.268677079651106" CI_START="-4.2686770796511055" EFFECT_SIZE="9.5" ESTIMABLE="YES" MEAN_1="23.3" MEAN_2="13.8" MODIFIED="2010-07-28 11:16:02 +0100" MODIFIED_BY="[Empty name]" ORDER="404" SD_1="24.4" SD_2="16.5" SE="7.0249643300880384" STUDY_ID="STD-Sand-2000" TOTAL_1="17" TOTAL_2="19" WEIGHT="0.7264175019458785"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="9.177791774053645" CI_START="6.822208225946354" DF="0" EFFECT_SIZE="8.0" ESTIMABLE="YES" I2="0.0" ID="CMP-005.11.02" MODIFIED="2010-07-28 11:16:37 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.9502089459528616E-40" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="36" WEIGHT="99.27358249805411" Z="13.3128047094055">
<NAME>stress urinary incontinence (symptoms only)</NAME>
<CONT_DATA CI_END="9.177791774053645" CI_START="6.822208225946354" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="7.0" MODIFIED="2010-07-28 11:16:37 +0100" MODIFIED_BY="[Empty name]" ORDER="405" SD_1="3.0" SD_2="2.0" SE="0.6009252125773316" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" WEIGHT="99.27358249805411"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.11.03" MODIFIED="2010-07-28 11:06:28 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="127.99476821483596" CI_END="2.5937355586377895" CI_START="1.4710395630813022" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="2.032387560859546" ESTIMABLE="YES" I2="98.43743613282454" I2_Q="0.0" ID="CMP-005.12" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="1.0" P_Z="1.2828548854922987E-12" Q="0.0" RANDOM="NO" SCALE="10.176517180618989" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="68" TOTAL_2="69" UNITS="" WEIGHT="100.00000000000001" Z="7.0961443483860664">
<NAME>Length of inpatient stay (days)</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="127.99476821483596" CI_END="2.5937355586377895" CI_START="1.4710395630813022" DF="2" EFFECT_SIZE="2.032387560859546" ESTIMABLE="YES" I2="98.43743613282454" ID="CMP-005.12.01" MODIFIED="2010-07-30 10:11:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="1.2828548854922987E-12" STUDIES="3" TAU2="0.0" TOTAL_1="68" TOTAL_2="69" WEIGHT="100.00000000000001" Z="7.0961443483860664">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="1.4781281164509397" CI_START="-0.4581281164509401" EFFECT_SIZE="0.5099999999999998" ESTIMABLE="YES" MEAN_1="5.93" MEAN_2="5.42" MODIFIED="2010-07-26 13:59:28 +0100" MODIFIED_BY="[Empty name]" ORDER="1273" SD_1="1.38" SD_2="1.28" SE="0.49395199304038795" STUDY_ID="STD-Demirci-2001" TOTAL_1="15" TOTAL_2="14" WEIGHT="33.620075906003464"/>
<CONT_DATA CI_END="9.177791774053645" CI_START="6.822208225946354" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="8.0" MODIFIED="2010-07-30 10:11:38 +0100" MODIFIED_BY="[Empty name]" ORDER="5987" SD_1="3.0" SD_2="2.0" SE="0.6009252125773316" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" WEIGHT="22.715762653733314"/>
<CONT_DATA CI_END="0.9495121915490456" CI_START="-0.7495121915490464" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.0" ORDER="5988" SD_1="1.2" SD_2="1.4" SE="0.4334325519498775" STUDY_ID="STD-Sand-2000" TOTAL_1="17" TOTAL_2="19" WEIGHT="43.66416144026323"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.12.02" MODIFIED="2010-07-20 19:17:31 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.12.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.13" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Time to return to normal activity level</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.13.01" MODIFIED="2010-07-20 19:14:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.13.02" MODIFIED="2010-07-20 19:17:42 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.13.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.352787175923098" CI_END="1.511418647626733" CI_START="1.141004494677006" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3132156983073056" ESTIMABLE="YES" EVENTS_1="211" EVENTS_2="162" I2="0.0" I2_Q="0.0" ID="CMP-005.14" LOG_CI_END="0.17938477616641407" LOG_CI_START="0.05728735520662559" LOG_EFFECT_SIZE="0.11833606568651983" METHOD="MH" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.7166381792864797" P_Q="0.41850609991098864" P_Z="1.4518150948124515E-4" Q="0.6545072431307147" RANDOM="NO" SCALE="141.8467367486994" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="394" TOTAL_2="398" WEIGHT="100.0" Z="3.7991699578016505">
<NAME>Peri-operative surgical complications</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7538121490535291" CI_END="2.523600414248615" CI_START="0.2831904057935065" DF="2" EFFECT_SIZE="0.8453753162777622" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" I2="0.0" ID="CMP-005.14.01" LOG_CI_END="0.40202059002332335" LOG_CI_START="-0.5479214641938489" LOG_EFFECT_SIZE="-0.07295043708526279" MODIFIED="2010-07-26 14:03:39 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6859806562101015" P_Z="0.763392098591727" STUDIES="3" TAU2="0.0" TOTAL_1="68" TOTAL_2="69" WEIGHT="3.9912787295843417" Z="0.30102937059965673">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="18.383352781743746" CI_START="0.18954346825704163" EFFECT_SIZE="1.8666666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.26442472151255" LOG_CI_START="-0.7222911769394742" LOG_EFFECT_SIZE="0.27106677228653797" MODIFIED="2010-07-26 14:03:39 +0100" MODIFIED_BY="[Empty name]" ORDER="1274" O_E="0.0" SE="1.1670067531530235" STUDY_ID="STD-Demirci-2001" TOTAL_1="15" TOTAL_2="14" VAR="1.361904761904762" WEIGHT="0.6395920370714295"/>
<DICH_DATA CI_END="3.1149053020348907" CI_START="0.18058333896460121" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4934448479682711" LOG_CI_START="-0.7433223211848708" LOG_EFFECT_SIZE="-0.12493873660829995" ORDER="5985" O_E="0.0" SE="0.7264831572567788" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" VAR="0.5277777777777777" WEIGHT="2.4730892100095274"/>
<DICH_DATA CI_END="8.528138189282535" CI_START="0.01608489546061467" EFFECT_SIZE="0.37037037037037035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9308542290132454" LOG_CI_START="-1.7935817573312203" LOG_EFFECT_SIZE="-0.43136376415898736" ORDER="5986" O_E="0.0" SE="1.600347184554374" STUDY_ID="STD-Sand-2000" TOTAL_1="17" TOTAL_2="19" VAR="2.5611111111111113" WEIGHT="0.8785974825033848"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5340917635003803" CI_START="1.1576852541673222" DF="0" EFFECT_SIZE="1.3326647789837973" ESTIMABLE="YES" EVENTS_1="206" EVENTS_2="156" I2="0.0" ID="CMP-005.14.02" LOG_CI_END="0.18585133822438527" LOG_CI_START="0.06359050156906887" LOG_EFFECT_SIZE="0.12472091989672707" MODIFIED="2010-07-20 19:17:15 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="6.366359336211507E-5" STUDIES="1" TAU2="0.0" TOTAL_1="326" TOTAL_2="329" WEIGHT="96.00872127041566" Z="3.998803178575508">
<NAME>stress urinary incontinence (symptoms only)</NAME>
<DICH_DATA CI_END="1.5340917635003803" CI_START="1.1576852541673222" EFFECT_SIZE="1.3326647789837973" ESTIMABLE="YES" EVENTS_1="206" EVENTS_2="156" LOG_CI_END="0.18585133822438527" LOG_CI_START="0.06359050156906887" LOG_EFFECT_SIZE="0.12472091989672707" MODIFIED="2010-07-14 14:33:32 +0100" MODIFIED_BY="[Empty name]" ORDER="819" O_E="0.0" SE="0.07181662065223486" STUDY_ID="STD-Albo-2007" TOTAL_1="326" TOTAL_2="329" VAR="0.005157627001907007" WEIGHT="96.00872127041566"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.14.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-005.15" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="32.20246805757867" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="326" TOTAL_2="329" WEIGHT="0.0" Z="0.0">
<NAME>Bladder perforation</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.15.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 14:41:24 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="10" I2="0.0" ID="CMP-005.15.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 14:41:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="326" TOTAL_2="329" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
<DICH_DATA CI_END="0.9140755917880601" CI_START="0.04456916265065334" EFFECT_SIZE="0.201840490797546" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.03901788770276401" LOG_CI_START="-1.350965525205203" LOG_EFFECT_SIZE="-0.6949917064539836" MODIFIED="2010-07-14 14:41:59 +0100" MODIFIED_BY="[Empty name]" ORDER="826" O_E="0.0" SE="0.7706445365144762" STUDY_ID="STD-Albo-2007" TOTAL_1="326" TOTAL_2="329" VAR="0.5938930016596118" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.15.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 14:41:24 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="247" EVENTS_2="166" I2="0.0" I2_Q="0.0" ID="CMP-005.16" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.189191785355793" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="326" TOTAL_2="329" WEIGHT="0.0" Z="0.0">
<NAME>Urinary tract infection</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.16.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 14:40:57 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="247" EVENTS_2="166" I2="0.0" ID="CMP-005.16.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 14:40:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="326" TOTAL_2="329" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
<DICH_DATA CI_END="1.6989102406469183" CI_START="1.3272841004910556" EFFECT_SIZE="1.5016446152708995" ESTIMABLE="YES" EVENTS_1="247" EVENTS_2="166" LOG_CI_END="0.23017043418305283" LOG_CI_START="0.122963892020239" LOG_EFFECT_SIZE="0.1765671631016459" MODIFIED="2010-07-14 14:40:13 +0100" MODIFIED_BY="[Empty name]" ORDER="825" O_E="0.0" SE="0.06297365354737923" STUDY_ID="STD-Albo-2007" TOTAL_1="326" TOTAL_2="329" VAR="0.003965681041105349" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.16.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 14:38:51 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-005.17" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-02 14:10:07 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="9.842795819347806" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="36" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Urge symptoms or urge incontinence</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="3" I2="0.0" ID="CMP-005.17.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:13:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="7.387503355312876" CI_START="0.5414549148222474" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8684976911405519" LOG_CI_START="-0.26643769981258947" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="5989" O_E="0.0" SE="0.6666666666666666" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" VAR="0.4444444444444444" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.17.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:15:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.17.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.7142394991916188" CI_END="3.869694114892771" CI_START="0.5216983608494015" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4208494208494207" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" I2="19.22976424506467" I2_Q="0.0" ID="CMP-005.18" LOG_CI_END="0.5876766369919214" LOG_CI_START="-0.2825805278073899" LOG_EFFECT_SIZE="0.15254805459226578" METHOD="MH" MODIFIED="2010-08-06 16:20:47 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.2940205832794477" P_Q="1.0" P_Z="0.49200256756388416" Q="0.0" RANDOM="NO" SCALE="636.807770258902" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="98" TOTAL_2="105" WEIGHT="99.99999999999999" Z="0.6871272194155168">
<NAME>Detrusor overactivity (urodynamic diagnosis)</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.7142394991916188" CI_END="3.869694114892771" CI_START="0.5216983608494015" DF="3" EFFECT_SIZE="1.4208494208494207" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" I2="19.22976424506467" ID="CMP-005.18.01" LOG_CI_END="0.5876766369919214" LOG_CI_START="-0.2825805278073899" LOG_EFFECT_SIZE="0.15254805459226578" MODIFIED="2010-07-07 17:11:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2940205832794477" P_Z="0.49200256756388416" STUDIES="4" TAU2="0.0" TOTAL_1="98" TOTAL_2="105" WEIGHT="99.99999999999999" Z="0.6871272194155168">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="3.110028100493321" CI_START="0.009019894235506311" EFFECT_SIZE="0.16748768472906403" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.49276431308923435" LOG_CI_START="-2.04479855483115" LOG_EFFECT_SIZE="-0.7760171208709579" MODIFIED="2010-07-07 17:11:17 +0100" MODIFIED_BY="[Empty name]" ORDER="1500" O_E="0.0" SE="1.4905769897552135" STUDY_ID="STD-Bai-2005" TOTAL_1="28" TOTAL_2="33" VAR="2.221819762387714" WEIGHT="52.25225225225225"/>
<DICH_DATA CI_END="14.717663958438468" CI_START="0.06794556546636217" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1678388826597432" LOG_CI_START="-1.1678388826597432" LOG_EFFECT_SIZE="0.0" ORDER="5980" O_E="0.0" SE="1.3719886811400708" STUDY_ID="STD-Demirci-2001" TOTAL_1="17" TOTAL_2="17" VAR="1.8823529411764706" WEIGHT="16.216216216216214"/>
<DICH_DATA CI_END="27.49853429898478" CI_START="0.3272901712558648" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4393095460910985" LOG_CI_START="-0.48506703665177364" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="5981" O_E="0.0" SE="1.1303883305208782" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" VAR="1.277777777777778" WEIGHT="16.216216216216214"/>
<DICH_DATA CI_END="36.192535668379406" CI_START="0.5522177101012469" EFFECT_SIZE="4.470588235294118" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5586190110774711" LOG_CI_START="-0.2578896692724361" LOG_EFFECT_SIZE="0.6503646709025175" ORDER="5982" O_E="0.0" SE="1.067026190700522" STUDY_ID="STD-Sand-2000" TOTAL_1="17" TOTAL_2="19" VAR="1.138544891640867" WEIGHT="15.315315315315313"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.18.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:16:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.18.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7259878083649062" CI_END="11.946197525234762" CI_START="3.0950693539959406" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="6.080650446879533" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-005.19" LOG_CI_END="1.07722969134277" LOG_CI_START="0.4906703850912802" LOG_EFFECT_SIZE="0.783950038217025" METHOD="MH" MODIFIED="2010-08-06 16:20:27 +0100" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.8670750197916544" P_Q="0.6232012757976924" P_Z="1.6138421637023874E-7" Q="0.24139379802734656" RANDOM="NO" SCALE="364.3637830353587" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="422" TOTAL_2="431" WEIGHT="100.0" Z="5.239074119899419">
<NAME>Voiding dysfunction after three months</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.4169511118490903" CI_END="17.363009615544343" CI_START="1.1570213562103624" DF="2" EFFECT_SIZE="4.482117014678519" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" I2="0.0" ID="CMP-005.19.01" LOG_CI_END="1.239625005756228" LOG_CI_START="0.06334137519956" LOG_EFFECT_SIZE="0.651483190477894" MODIFIED="2010-07-07 17:14:35 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8118209740687372" P_Z="0.029927611248162043" STUDIES="4" TAU2="0.0" TOTAL_1="96" TOTAL_2="102" WEIGHT="25.64216599691459" Z="2.1710471126179733">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="24.6428751429309" CI_START="0.22546567382067154" EFFECT_SIZE="2.357142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3916913766200156" LOG_CI_START="-0.6469195682207166" LOG_EFFECT_SIZE="0.37238590419964945" MODIFIED="2010-07-07 17:13:34 +0100" MODIFIED_BY="[Empty name]" ORDER="1501" O_E="0.0" SE="1.1974901602863732" STUDY_ID="STD-Bai-2005" TOTAL_1="28" TOTAL_2="33" VAR="1.433982683982684" WEIGHT="9.79671754440731"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="5978" O_E="0.0" SE="0.0" STUDY_ID="STD-Demirci-2001" TOTAL_1="17" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="40.69812832327722" CI_START="0.6142788631805778" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.6095744368035072" LOG_CI_START="-0.21163442813146952" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="5979" O_E="0.0" SE="1.0697871023920809" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" VAR="1.1444444444444446" WEIGHT="10.671424468015106"/>
<DICH_DATA CI_END="132.95463996948232" CI_START="0.41605472560188184" EFFECT_SIZE="7.4375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.123703498327829" LOG_CI_START="-0.3808495408546176" LOG_EFFECT_SIZE="0.871426978736606" MODIFIED="2010-07-07 17:14:35 +0100" MODIFIED_BY="[Empty name]" ORDER="1502" O_E="0.0" SE="1.4711868529532615" STUDY_ID="STD-Sand-2000" TOTAL_1="15" TOTAL_2="16" VAR="2.164390756302521" WEIGHT="5.174023984492172"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.110860756438525E-31" CI_END="14.47129777735877" CI_START="3.0392659109480817" DF="0" EFFECT_SIZE="6.631901840490799" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="7" I2="100.0" ID="CMP-005.19.02" LOG_CI_END="1.160507480135793" LOG_CI_START="0.4827686989629122" LOG_EFFECT_SIZE="0.8216380895493526" MODIFIED="2010-07-14 14:36:18 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="2.0119772415500673E-6" STUDIES="1" TAU2="0.0" TOTAL_1="326" TOTAL_2="329" WEIGHT="74.35783400308542" Z="4.752217546282758">
<NAME>stress urinary incontinence (symptoms only)</NAME>
<DICH_DATA CI_END="14.471297777358764" CI_START="3.0392659109480817" EFFECT_SIZE="6.631901840490798" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="7" LOG_CI_END="1.1605074801357929" LOG_CI_START="0.4827686989629122" LOG_EFFECT_SIZE="0.8216380895493526" MODIFIED="2010-07-14 14:35:50 +0100" MODIFIED_BY="[Empty name]" ORDER="820" O_E="0.0" SE="0.39810711492202344" STUDY_ID="STD-Albo-2007" TOTAL_1="326" TOTAL_2="329" VAR="0.1584892749515372" WEIGHT="74.35783400308542"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.19.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1079888789899621" CI_START="0.036101445383155684" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" I2="0.0" I2_Q="100.0" ID="CMP-005.20" LOG_CI_END="0.044535401351317845" LOG_CI_START="-1.4424754100233554" LOG_EFFECT_SIZE="-0.6989700043360187" METHOD="MH" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="1.0" P_Q="0.0" P_Z="0.06539274516509919" Q="6.462149405633288E-32" RANDOM="NO" SCALE="238.0176020898689" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="53" TOTAL_2="53" WEIGHT="100.0" Z="1.8425636509070715">
<NAME>Prolapse</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1079888789899621" CI_START="0.036101445383155684" DF="1" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" I2="0.0" ID="CMP-005.20.01" LOG_CI_END="0.044535401351317845" LOG_CI_START="-1.4424754100233554" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2010-07-20 19:14:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.06539274516509919" STUDIES="2" TAU2="0.0" TOTAL_1="53" TOTAL_2="53" WEIGHT="100.0" Z="1.8425636509070715">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="3.87988750809627" CI_START="0.010309577253601012" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5888191340165584" LOG_CI_START="-1.9867591426885958" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="5983" O_E="0.0" SE="1.5129074290546958" STUDY_ID="STD-Demirci-2001" TOTAL_1="17" TOTAL_2="17" VAR="2.288888888888889" WEIGHT="33.333333333333336"/>
<DICH_DATA CI_END="1.6279251329310886" CI_START="0.02457115452722311" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.21163442813146957" LOG_CI_START="-1.6095744368035072" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="5984" O_E="0.0" SE="1.0697871023920809" STUDY_ID="STD-Enzelsberger-1996" TOTAL_1="36" TOTAL_2="36" VAR="1.1444444444444446" WEIGHT="66.66666666666667"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.20.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:17:06 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.20.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.21" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Repeat incontinence surgery</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.21.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:14:46 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.21.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:17:53 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.21.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.22" MODIFIED="2010-08-02 14:07:19 +0100" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Health status measures</NAME>
<GROUP_LABEL_1>Traditional sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Colposuspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.22.01" MODIFIED="2010-07-20 19:13:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.22.02" MODIFIED="2010-07-20 19:16:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.22.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2017-07-21 11:39:57 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Sling versus bladder neck (needle) suspension</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:03:56 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="34.36" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence (worse, unchanged or improved) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>needle suspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours needle suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-006.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:18:59 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="4.671852101612958" CI_START="0.05351196796527171" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6694890857160593" LOG_CI_START="-1.2715490770440216" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="5990" O_E="0.0" SE="1.1401754250991378" STUDY_ID="STD-Hilton-1989" TOTAL_1="10" TOTAL_2="10" VAR="1.2999999999999998" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:21:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:04:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="481.97" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence (worse, unchanged or improved) after the first year (women's observations)</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>needle suspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours needle suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-006.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:19:05 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="2.685665908545172" CI_START="0.04137190361525649" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.42905198632986163" LOG_CI_START="-1.3832944957691864" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="5991" O_E="0.0" SE="1.064581294844754" STUDY_ID="STD-Hilton-1989" TOTAL_1="10" TOTAL_2="10" VAR="1.133333333333333" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:21:32 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2010-08-05 13:28:34 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of inpatient stay</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>needle suspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours needle suspension</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.01" MODIFIED="2010-07-20 19:20:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="20.99751770017155" CI_START="5.002482299828452" EFFECT_SIZE="13.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="7.0" ORDER="5995" SD_1="12.9" SD_2="0.3" SE="4.080441152620633" STUDY_ID="STD-Hilton-1989" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.02" MODIFIED="2010-07-20 19:23:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-05 13:28:42 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="34.36" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Peri-operative surgical complications</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>needle suspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours needle suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="2" I2="0.0" ID="CMP-006.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:20:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="15.8119512621818" CI_START="1.280676854123178" EFFECT_SIZE="4.5" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.1989854670295135" LOG_CI_START="0.10743956052117393" LOG_EFFECT_SIZE="0.6532125137753437" ORDER="5994" O_E="0.0" SE="0.6411794687223782" STUDY_ID="STD-Hilton-1989" TOTAL_1="10" TOTAL_2="10" VAR="0.4111111111111112" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:23:01 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-006.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-05 13:28:51 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="6.85" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Urge symptoms or urge incontinence</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>needle suspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours needle suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-006.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:21:06 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="5.1676154704644395" CI_START="0.5375356958454429" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7132901897260784" LOG_CI_START="-0.26959269049336554" LOG_EFFECT_SIZE="0.2218487496163564" ORDER="5996" O_E="0.0" SE="0.5773502691896258" STUDY_ID="STD-Hilton-1989" TOTAL_1="10" TOTAL_2="10" VAR="0.33333333333333337" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:23:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-006.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-05 13:28:58 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.84" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Voiding dysfunction after three months</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>needle suspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours needle suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-006.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:20:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="8.556535477165358" CI_START="0.46747892422987236" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.932297955364332" LOG_CI_START="-0.3302379640363697" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="5992" O_E="0.0" SE="0.7416198487095663" STUDY_ID="STD-Hilton-1989" TOTAL_1="10" TOTAL_2="10" VAR="0.55" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:22:40 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.06.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-05 13:29:06 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Detrusor overactivity (urodynamic diagnosis)</NAME>
<GROUP_LABEL_1>sling</GROUP_LABEL_1>
<GROUP_LABEL_2>needle suspension</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours needle suspension</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-006.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:20:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="18.687408406451837" CI_START="0.21404787186108687" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2715490770440216" LOG_CI_START="-0.6694890857160593" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="5993" O_E="0.0" SE="1.1401754250991378" STUDY_ID="STD-Hilton-1989" TOTAL_1="10" TOTAL_2="10" VAR="1.2999999999999998" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 19:22:50 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-006.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2017-07-21 11:40:12 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Sling versus anterior repair</NAME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2017-07-21 11:40:24 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Sling versus laparoscopic procedures</NAME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2017-07-21 11:40:36 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Traditional sling versus minimally invasive sling operation</NAME>
<DICH_OUTCOME CHI2="1.5787194021595394" CI_END="1.2016135596429078" CI_START="0.7834726901969826" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9702738830611702" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="99" I2="0.0" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="0.07976482049636541" LOG_CI_START="-0.1059761372980877" LOG_EFFECT_SIZE="-0.01310565840086114" METHOD="MH" MODIFIED="2010-08-06 15:04:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9794586019933811" P_Q="0.6440382066693922" P_Z="0.7820984777309012" Q="0.21349957453782673" RANDOM="NO" SCALE="51.222073040584554" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="333" TOTAL_2="360" WEIGHT="99.99999999999999" Z="0.2765853989812875">
<NAME>Number with incontinence (worse, unchanged or improved) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.1798608121226948" CI_END="1.3378802070036429" CI_START="0.7630449629296843" DF="4" EFFECT_SIZE="1.0103775299151565" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="56" I2="0.0" ID="CMP-009.01.01" LOG_CI_END="0.12641722870356636" LOG_CI_START="-0.11744987020119346" LOG_EFFECT_SIZE="0.0044836792511864475" MODIFIED="2010-07-28 16:36:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8814031571348385" P_Z="0.9425455549002374" STUDIES="5" TAU2="0.0" TOTAL_1="222" TOTAL_2="212" WEIGHT="59.077490642984046" Z="0.07207081143805279">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="2.6578405396241136" CI_START="0.56413288831852" EFFECT_SIZE="1.2244897959183674" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.4245289213626425" LOG_CI_START="-0.2486185806523825" LOG_EFFECT_SIZE="0.08795517035512998" MODIFIED="2010-07-15 13:15:08 +0100" MODIFIED_BY="[Empty name]" ORDER="1029" O_E="0.0" SE="0.39541017481750057" STUDY_ID="STD-Amaro-2007" TOTAL_1="21" TOTAL_2="20" VAR="0.15634920634920635" WEIGHT="7.295730435433431"/>
<DICH_DATA CI_END="1.7537183373817893" CI_START="0.3081587592435043" EFFECT_SIZE="0.7351351351351352" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.24395984311011326" LOG_CI_START="-0.5112254831757058" LOG_EFFECT_SIZE="-0.13363282003279625" MODIFIED="2010-07-12 16:53:28 +0100" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.4435995988879446" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="74" TOTAL_2="68" VAR="0.1967806041335453" WEIGHT="10.604218712803023"/>
<DICH_DATA CI_END="7.344581827353028" CI_START="0.16689381845504098" EFFECT_SIZE="1.1071428571428572" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8659670737487315" LOG_CI_START="-0.7775597487646244" LOG_EFFECT_SIZE="0.044203662492053486" MODIFIED="2010-07-27 23:50:54 +0100" MODIFIED_BY="[Empty name]" ORDER="129" O_E="0.0" SE="0.9654157911333258" STUDY_ID="STD-Bai-2005" TOTAL_1="28" TOTAL_2="31" VAR="0.9320276497695853" WEIGHT="1.9313959506232166"/>
<DICH_DATA CI_END="1.4681256282762076" CI_START="0.7763887165362271" EFFECT_SIZE="1.067631103074141" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="35" LOG_CI_END="0.16676321997563198" LOG_CI_START="-0.10992078495505832" LOG_EFFECT_SIZE="0.02842121751028687" MODIFIED="2010-07-28 16:36:08 +0100" MODIFIED_BY="[Empty name]" ORDER="134" O_E="0.0" SE="0.16252555410420064" STUDY_ID="STD-Guerrero-2008" TOTAL_1="79" TOTAL_2="72" VAR="0.026414555736877447" WEIGHT="37.26091277257786"/>
<DICH_DATA CI_END="5.347744039704396" CI_START="0.05154042488825542" EFFECT_SIZE="0.525" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7281706123513129" LOG_CI_START="-1.287852005539399" LOG_EFFECT_SIZE="-0.2798406965940431" MODIFIED="2010-07-15 13:46:22 +0100" MODIFIED_BY="[Empty name]" ORDER="1030" O_E="0.0" SE="1.1842216652219095" STUDY_ID="STD-Tcherniakovsky-2009" TOTAL_1="20" TOTAL_2="21" VAR="1.4023809523809523" WEIGHT="1.985232771546512"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:36:25 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.05290460417621086" CI_END="1.2682412993927623" CI_START="0.656369254045537" DF="2" EFFECT_SIZE="0.9123785374679579" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="43" I2="0.0" ID="CMP-009.01.03" LOG_CI_END="0.10320189157791103" LOG_CI_START="-0.18285177056699167" LOG_EFFECT_SIZE="-0.03982493949454034" MODIFIED="2010-07-26 10:10:09 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9738945154351376" P_Z="0.5852447498674507" STUDIES="3" TAU2="0.0" TOTAL_1="111" TOTAL_2="148" WEIGHT="40.92250935701594" Z="0.5457398902744777">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="1.2617001453041339" CI_START="0.6490706893976217" EFFECT_SIZE="0.9049489395129615" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="38" LOG_CI_END="0.1009561530751699" LOG_CI_START="-0.18770800220809422" LOG_EFFECT_SIZE="-0.04337592456646215" MODIFIED="2010-07-26 09:58:58 +0100" MODIFIED_BY="[Empty name]" ORDER="559" O_E="0.0" SE="0.1695627537240032" STUDY_ID="STD-Basok-2008" TOTAL_1="67" TOTAL_2="72" VAR="0.02875152745046696" WEIGHT="37.27167411702414"/>
<DICH_DATA CI_END="7.599549604029784" CI_START="0.09331359240844928" EFFECT_SIZE="0.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.8807878540859515" LOG_CI_START="-1.0300550906797596" LOG_EFFECT_SIZE="-0.07463361829690421" MODIFIED="2010-07-26 10:10:09 +0100" MODIFIED_BY="[Empty name]" ORDER="563" O_E="0.0" SE="1.1224386045805053" STUDY_ID="STD-Song-2004" TOTAL_1="19" TOTAL_2="48" VAR="1.2598684210526316" WEIGHT="1.7311526071284322"/>
<DICH_DATA CI_END="7.371592284057515" CI_START="0.17016676338881104" EFFECT_SIZE="1.12" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8675613067856864" LOG_CI_START="-0.7691252614453231" LOG_EFFECT_SIZE="0.04921802267018165" MODIFIED="2010-07-15 10:31:16 +0100" MODIFIED_BY="[Empty name]" ORDER="553" O_E="0.0" SE="0.9613977919080708" STUDY_ID="STD-Wadie-2005" TOTAL_1="25" TOTAL_2="28" VAR="0.9242857142857143" WEIGHT="1.9196826328633723"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.0762743049641648" CI_END="1.2729086695435754" CI_START="0.4829675929560241" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7840750194862196" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" I2="0.0" I2_Q="0.0" ID="CMP-009.02" LOG_CI_END="0.10479724439507992" LOG_CI_START="-0.31608200935728953" LOG_EFFECT_SIZE="-0.10564238248110482" METHOD="MH" MODIFIED="2010-08-06 15:04:22 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5838349435369133" P_Q="0.6417213604437311" P_Z="0.32515601341103584" Q="0.21649796836727458" RANDOM="NO" SCALE="12.15" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="220" TOTAL_2="212" WEIGHT="99.99999999999999" Z="0.9839176583685669">
<NAME>Number not improved (worse or unchanged) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8618618468312238" CI_END="2.134532560005225" CI_START="0.39238443951366886" DF="1" EFFECT_SIZE="0.9151816006571193" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" I2="0.0" ID="CMP-009.02.01" LOG_CI_END="0.3293027838870957" LOG_CI_START="-0.4062882234310867" LOG_EFFECT_SIZE="-0.03849271977199548" MODIFIED="2010-07-28 16:37:35 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3532182793615978" P_Z="0.8374738449626833" STUDIES="2" TAU2="0.0" TOTAL_1="153" TOTAL_2="140" WEIGHT="34.03896806664997" Z="0.20512579319086288">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="4.676106509948899" CI_START="0.4063053204495486" EFFECT_SIZE="1.3783783783783783" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.6698843947387899" LOG_CI_START="-0.39114749067690724" LOG_EFFECT_SIZE="0.13936845203094134" MODIFIED="2010-07-12 17:16:18 +0100" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="0.6232553816857196" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="74" TOTAL_2="68" VAR="0.38844727080021196" WEIGHT="13.583494488652077"/>
<DICH_DATA CI_END="2.0666684392640833" CI_START="0.17863126958366976" EFFECT_SIZE="0.6075949367088608" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3152708072764688" LOG_CI_START="-0.7480425151061773" LOG_EFFECT_SIZE="-0.2163858539148542" MODIFIED="2010-07-28 16:37:35 +0100" MODIFIED_BY="[Empty name]" ORDER="918" O_E="0.0" SE="0.6245955090534004" STUDY_ID="STD-Guerrero-2008" TOTAL_1="79" TOTAL_2="72" VAR="0.39011954992967646" WEIGHT="20.455473577997896"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:36:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2907963829308255" CI_START="0.3976263252651537" DF="0" EFFECT_SIZE="0.7164179104477612" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="21" I2="0.0" ID="CMP-009.02.03" LOG_CI_END="0.11085773975372662" LOG_CI_START="-0.4005248704042051" LOG_EFFECT_SIZE="-0.14483356532523925" MODIFIED="2010-07-28 17:04:22 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.2669127275172072" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="72" WEIGHT="65.96103193335001" Z="1.1102003320071063">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="1.2907963829308255" CI_START="0.3976263252651537" EFFECT_SIZE="0.7164179104477612" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="21" LOG_CI_END="0.11085773975372662" LOG_CI_START="-0.4005248704042051" LOG_EFFECT_SIZE="-0.14483356532523925" MODIFIED="2010-07-26 09:59:52 +0100" MODIFIED_BY="[Empty name]" ORDER="560" O_E="0.0" SE="0.300388676591515" STUDY_ID="STD-Basok-2008" TOTAL_1="67" TOTAL_2="72" VAR="0.0902333570244018" WEIGHT="65.96103193335001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9000314956996187" CI_END="1.663372215659801" CI_START="0.911679982943573" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2314475844312418" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="47" I2="0.0" I2_Q="0.0" ID="CMP-009.03" LOG_CI_END="0.22098944291723185" LOG_CI_START="-0.040157580565740224" LOG_EFFECT_SIZE="0.09041593117574578" METHOD="MH" MODIFIED="2010-12-07 15:52:55 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5934127105101678" P_Q="0.3906666663044416" P_Z="0.1747235129045287" Q="0.7368660802509005" RANDOM="NO" SCALE="782.6463228225019" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="196" TOTAL_2="186" WEIGHT="100.0" Z="1.3571816088087179">
<NAME>Number with incontinence (worse, unchanged or improved) after first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.1593571876534934" CI_END="1.6040804588881348" CI_START="0.8576811396275704" DF="2" EFFECT_SIZE="1.1729405594630495" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="43" I2="0.0" ID="CMP-009.03.01" LOG_CI_END="0.20522614822169527" LOG_CI_START="-0.06667413993486071" LOG_EFFECT_SIZE="0.0692760041434173" MODIFIED="2010-07-28 16:36:58 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.560078539487221" P_Z="0.3179220038258409" STUDIES="3" TAU2="0.0" TOTAL_1="175" TOTAL_2="163" WEIGHT="92.13325653066333" Z="0.9987372505892035">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="3.592778520375335" CI_START="0.6368257882190975" EFFECT_SIZE="1.5126050420168067" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="0.5554304456088917" LOG_CI_START="-0.19597935818734102" LOG_EFFECT_SIZE="0.1797255437107753" MODIFIED="2010-07-12 16:56:27 +0100" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.4413818382884238" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="68" TOTAL_2="60" VAR="0.19481792717086832" WEIGHT="15.32376071631205"/>
<DICH_DATA CI_END="2.7934324004745212" CI_START="0.10970064157577505" EFFECT_SIZE="0.5535714285714286" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4461381661360913" LOG_CI_START="-0.9597908324799466" LOG_EFFECT_SIZE="-0.2568263331719277" MODIFIED="2010-07-27 23:52:17 +0100" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="0.8258496532478447" STUDY_ID="STD-Bai-2005" TOTAL_1="28" TOTAL_2="31" VAR="0.6820276497695853" WEIGHT="7.822298590978833"/>
<DICH_DATA CI_END="1.631271472021105" CI_START="0.8358961517402563" EFFECT_SIZE="1.1677215189873418" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="32" LOG_CI_END="0.21252624123034602" LOG_CI_START="-0.07784767414903289" LOG_EFFECT_SIZE="0.06733928354065655" MODIFIED="2010-07-28 16:36:58 +0100" MODIFIED_BY="[Empty name]" ORDER="917" O_E="0.0" SE="0.17056707526790998" STUDY_ID="STD-Guerrero-2008" TOTAL_1="79" TOTAL_2="72" VAR="0.029093127165448873" WEIGHT="68.98719722337245"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:36:45 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.0846892926859847E-32" CI_END="5.62515292042693" CI_START="0.6530686655239047" DF="0" EFFECT_SIZE="1.9166666666666665" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" I2="100.0" ID="CMP-009.03.03" LOG_CI_END="0.7501343332891534" LOG_CI_START="-0.1850411533492173" LOG_EFFECT_SIZE="0.282546589969968" MODIFIED="2010-08-04 09:21:56 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.23627998390426053" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="23" WEIGHT="7.866743469336668" Z="1.184336305234846">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="5.62515292042693" CI_START="0.6530686655239047" EFFECT_SIZE="1.9166666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7501343332891534" LOG_CI_START="-0.1850411533492173" LOG_EFFECT_SIZE="0.28254658996996806" MODIFIED="2010-08-04 09:21:56 +0100" MODIFIED_BY="[Empty name]" ORDER="2766" O_E="0.0" SE="0.5493267100446965" STUDY_ID="STD-Kondo-2006" TOTAL_1="21" TOTAL_2="23" VAR="0.30175983436853004" WEIGHT="7.866743469336668"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.10874260587758888" CI_END="2.938130458837941" CI_START="0.5742921311018766" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2989785227867994" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-009.04" LOG_CI_END="0.46807107542141285" LOG_CI_START="-0.24086713434123666" LOG_EFFECT_SIZE="0.11360197054008807" METHOD="MH" MODIFIED="2010-08-06 15:04:35 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7415802643528253" P_Q="1.0" P_Z="0.5299130716677826" Q="0.0" RANDOM="NO" SCALE="12.15" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="147" TOTAL_2="132" WEIGHT="100.0" Z="0.6281387228539914">
<NAME>Number not improved (worse or unchanged) after the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.10874260587758888" CI_END="2.938130458837941" CI_START="0.5742921311018766" DF="1" EFFECT_SIZE="1.2989785227867994" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" I2="0.0" ID="CMP-009.04.01" LOG_CI_END="0.46807107542141285" LOG_CI_START="-0.24086713434123666" LOG_EFFECT_SIZE="0.11360197054008807" MODIFIED="2010-07-28 16:38:03 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7415802643528253" P_Z="0.5299130716677826" STUDIES="2" TAU2="0.0" TOTAL_1="147" TOTAL_2="132" WEIGHT="100.0" Z="0.6281387228539914">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="3.9200525249137335" CI_START="0.3103221783440506" EFFECT_SIZE="1.1029411764705883" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.593291886185603" LOG_CI_START="-0.5081871848146755" LOG_EFFECT_SIZE="0.04255235068546376" MODIFIED="2010-07-12 17:18:21 +0100" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.6470142587149005" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="68" TOTAL_2="60" VAR="0.41862745098039217" WEIGHT="44.82276933822246"/>
<DICH_DATA CI_END="4.2544551811148335" CI_START="0.49981216547234625" EFFECT_SIZE="1.4582278481012658" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.6288439529082943" LOG_CI_START="-0.30119317731479084" LOG_EFFECT_SIZE="0.16382538779675182" MODIFIED="2010-07-28 16:38:03 +0100" MODIFIED_BY="[Empty name]" ORDER="919" O_E="0.0" SE="0.5463084140510833" STUDY_ID="STD-Guerrero-2008" TOTAL_1="79" TOTAL_2="72" VAR="0.29845288326300984" WEIGHT="55.17723066177754"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:37:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-12 17:16:55 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.886252582206007E-32" CI_END="-4.46513850718879" CI_START="-57.5348614928112" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-30.999999999999996" ESTIMABLE="YES" I2="100.00000000000001" I2_Q="0.0" ID="CMP-009.05" MODIFIED="2010-12-07 16:14:01 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="1.0" P_Z="0.022034317104728002" Q="0.0" RANDOM="NO" SCALE="59.43" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.2897757931467777">
<NAME>Pad test: mean weight of urine</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.886252582206007E-32" CI_END="-4.46513850718879" CI_START="-57.5348614928112" DF="0" EFFECT_SIZE="-30.999999999999996" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-009.05.01" MODIFIED="2010-07-30 11:00:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.022034317104728002" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="2.2897757931467777">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="-4.465138507188794" CI_START="-57.5348614928112" EFFECT_SIZE="-31.0" ESTIMABLE="YES" MEAN_1="8.4" MEAN_2="39.4" MODIFIED="2010-07-30 11:00:17 +0100" MODIFIED_BY="[Empty name]" ORDER="512" SD_1="16.44" SD_2="39.53" SE="13.538443411264089" STUDY_ID="STD-Silva-Filho-2006" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.05.02" MODIFIED="2010-07-15 12:07:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.05.03" MODIFIED="2010-12-07 16:14:01 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.04207087498786828" CI_END="3.7087971806493427" CI_START="0.44593026914548634" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2860267979217939" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-009.06" LOG_CI_END="0.5692330841419742" LOG_CI_START="-0.3507330473259039" LOG_EFFECT_SIZE="0.10925001840803514" METHOD="MH" MODIFIED="2010-08-06 15:06:42 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.8374848449046357" P_Q="1.0" P_Z="0.6415672369579342" Q="0.0" RANDOM="NO" SCALE="17.226925320711686" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="57" TOTAL_2="48" WEIGHT="100.00000000000001" Z="0.46550866182091255">
<NAME>Number with incontinence (clinician's observations) within first year</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.06.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-28 16:34:26 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-20 10:14:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.04207087498786828" CI_END="3.7087971806493427" CI_START="0.44593026914548634" DF="1" EFFECT_SIZE="1.2860267979217939" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" I2="0.0" ID="CMP-009.06.03" LOG_CI_END="0.5692330841419742" LOG_CI_START="-0.3507330473259039" LOG_EFFECT_SIZE="0.10925001840803514" MODIFIED="2010-08-04 09:50:37 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8374848449046357" P_Z="0.6415672369579342" STUDIES="2" TAU2="0.0" TOTAL_1="57" TOTAL_2="48" WEIGHT="100.00000000000001" Z="0.46550866182091255">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="7.095995785610775" CI_START="0.16904554646061176" EFFECT_SIZE="1.0952380952380953" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8510133488915211" LOG_CI_START="-0.7719962663241736" LOG_EFFECT_SIZE="0.039508541283673655" MODIFIED="2010-08-04 09:42:11 +0100" MODIFIED_BY="[Empty name]" ORDER="916" O_E="0.0" SE="0.9533638820048655" STUDY_ID="STD-Kondo-2006" TOTAL_1="21" TOTAL_2="23" VAR="0.9089026915113871" WEIGHT="35.028712059064816"/>
<DICH_DATA CI_END="5.038231562724729" CI_START="0.38287488807596254" EFFECT_SIZE="1.3888888888888888" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.7022781242781039" LOG_CI_START="-0.4169431171406408" LOG_EFFECT_SIZE="0.14266750356873154" MODIFIED="2010-08-04 09:50:37 +0100" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.0" SE="0.6574360974438673" STUDY_ID="STD-Sharifiaghdas-2008" TOTAL_1="36" TOTAL_2="25" VAR="0.43222222222222223" WEIGHT="64.9712879409352"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.639548955803174E-32" CI_END="3.6084037037842918" CI_START="0.8209018850280269" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.7210884353741498" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" I2="100.0" I2_Q="0.0" ID="CMP-009.07" LOG_CI_END="0.5573151199225173" LOG_CI_START="-0.0857087470672336" LOG_EFFECT_SIZE="0.23580318642764186" METHOD="MH" MODIFIED="2010-08-06 15:06:50 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="1.0" P_Z="0.15058273032449818" Q="0.0" RANDOM="NO" SCALE="12.15" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="23" WEIGHT="100.0" Z="1.437476201315957">
<NAME>Number with incontinence (clinician's observations) after first year</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 17:05:51 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:37:34 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.639548955803174E-32" CI_END="3.6084037037842918" CI_START="0.8209018850280269" DF="0" EFFECT_SIZE="1.7210884353741498" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" I2="100.0" ID="CMP-009.07.03" LOG_CI_END="0.5573151199225173" LOG_CI_START="-0.0857087470672336" LOG_EFFECT_SIZE="0.23580318642764186" MODIFIED="2010-08-04 09:53:01 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.15058273032449818" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="23" WEIGHT="100.0" Z="1.437476201315957">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="3.608403703784291" CI_START="0.8209018850280267" EFFECT_SIZE="1.7210884353741496" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5573151199225171" LOG_CI_START="-0.08570874706723365" LOG_EFFECT_SIZE="0.2358031864276418" MODIFIED="2010-08-04 09:53:01 +0100" MODIFIED_BY="[Empty name]" ORDER="2768" O_E="0.0" SE="0.37771540248925634" STUDY_ID="STD-Kondo-2006" TOTAL_1="21" TOTAL_2="23" VAR="0.14266892527762093" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="234.31835004892207" CI_END="63.17975192004702" CI_START="56.6177153663476" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="59.89873364319731" ESTIMABLE="YES" I2="98.29292072124746" I2_Q="98.38494064044126" ID="CMP-009.08" MODIFIED="2010-08-02 14:16:11 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="4.440892098500626E-16" P_Q="3.552713678800501E-15" P_Z="0.0" Q="61.91722886725431" RANDOM="NO" SCALE="114.01" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="95" TOTAL_2="130" UNITS="" WEIGHT="100.0" Z="35.781379667578726">
<NAME>Operative time (mins)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0038727681329458223" CI_END="51.52145144678619" CI_START="42.30735567792692" DF="1" EFFECT_SIZE="46.914403562356554" ESTIMABLE="YES" I2="0.0" ID="CMP-009.08.01" MODIFIED="2010-07-23 11:30:33 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.950378472658313" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="30" TOTAL_2="31" WEIGHT="50.719136008723666" Z="19.95866846731944">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="95.41467054958719" CI_START="1.3853294504128044" EFFECT_SIZE="48.4" ESTIMABLE="YES" MEAN_1="69.5" MEAN_2="21.1" MODIFIED="2010-07-23 11:30:33 +0100" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="74.9" SD_2="12.0" SE="23.9875175872786" STUDY_ID="STD-Silva-Filho-2006" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.48702415878119976"/>
<CONT_DATA CI_END="51.52932776879163" CI_START="42.27067223120838" EFFECT_SIZE="46.900000000000006" ESTIMABLE="YES" MEAN_1="59.7" MEAN_2="12.8" MODIFIED="2010-07-15 13:48:16 +0100" MODIFIED_BY="[Empty name]" ORDER="1031" SD_1="10.3" SD_2="2.4" SE="2.3619453241524697" STUDY_ID="STD-Tcherniakovsky-2009" TOTAL_1="20" TOTAL_2="21" WEIGHT="50.23211184994246"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.08.02" MODIFIED="2010-07-15 10:46:05 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="172.39724841353478" CI_END="77.93580723928348" CI_START="68.58822082611458" DF="2" EFFECT_SIZE="73.26201403269903" ESTIMABLE="YES" I2="98.83988867664377" ID="CMP-009.08.03" MODIFIED="2010-07-29 14:49:53 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="-6.661338147750939E-16" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="65" TOTAL_2="99" WEIGHT="49.280863991276334" Z="30.722563577838024">
<NAME>mixed urinary incontinence</NAME>
<CONT_DATA CI_END="52.27443048279804" CI_START="34.12556951720195" EFFECT_SIZE="43.199999999999996" ESTIMABLE="YES" MEAN_1="87.1" MEAN_2="43.9" MODIFIED="2010-07-26 12:09:09 +0100" MODIFIED_BY="[Empty name]" ORDER="564" SD_1="13.3" SD_2="17.3" SE="4.629896546250846" STUDY_ID="STD-Kondo-2006" TOTAL_1="21" TOTAL_2="23" WEIGHT="13.073098798640656"/>
<CONT_DATA CI_END="104.01411049967517" CI_START="91.98588950032483" EFFECT_SIZE="98.0" ESTIMABLE="YES" MEAN_1="125.0" MEAN_2="27.0" MODIFIED="2010-07-29 14:49:53 +0100" MODIFIED_BY="[Empty name]" ORDER="565" SD_1="13.0" SD_2="5.0" SE="3.068480108366127" STUDY_ID="STD-Song-2004" TOTAL_1="19" TOTAL_2="48" WEIGHT="29.76284842715935"/>
<CONT_DATA CI_END="32.92409058007935" CI_START="7.075909419920647" EFFECT_SIZE="20.0" ESTIMABLE="YES" MEAN_1="68.0" MEAN_2="48.0" MODIFIED="2010-07-15 10:39:02 +0100" MODIFIED_BY="[Empty name]" ORDER="554" SD_1="23.0" SD_2="25.0" SE="6.594044932469642" STUDY_ID="STD-Wadie-2005" TOTAL_1="25" TOTAL_2="28" WEIGHT="6.444916765476322"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.849078343985743" CI_END="0.7158277542170426" CI_START="0.26004331970547084" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.4879355369612567" ESTIMABLE="YES" I2="82.9032893527877" I2_Q="82.9032893527877" ID="CMP-009.09" MODIFIED="2010-08-02 14:16:28 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.015585248313757849" P_Q="0.015585248313757849" P_Z="2.711429186007591E-5" Q="5.849078343985743" RANDOM="NO" SCALE="1.04" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="33" UNITS="" WEIGHT="99.99999999999999" Z="4.196440276623775">
<NAME>Length of hospital stay (days)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.9130297955759029" CI_START="0.38697020442409735" DF="0" EFFECT_SIZE="0.6500000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-009.09.01" MODIFIED="2010-07-31 21:18:55 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.2759180925691366E-6" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="75.06700568634717" Z="4.8434687300793">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="0.9130297955759029" CI_START="0.38697020442409735" EFFECT_SIZE="0.6500000000000001" ESTIMABLE="YES" MEAN_1="1.85" MEAN_2="1.2" MODIFIED="2010-07-31 21:18:55 +0100" MODIFIED_BY="[Empty name]" ORDER="514" SD_1="0.24" SD_2="0.35" SE="0.13420134127496638" STUDY_ID="STD-Silva-Filho-2006" TOTAL_1="10" TOTAL_2="10" WEIGHT="75.06700568634717"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.09.02" MODIFIED="2010-07-15 10:52:31 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.45639646805577616" CI_START="-0.45639646805577616" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-009.09.03" MODIFIED="2010-07-26 12:09:24 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="23" WEIGHT="24.932994313652813" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
<CONT_DATA CI_END="0.45639646805577616" CI_START="-0.45639646805577616" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="9.2" MODIFIED="2010-07-26 12:09:24 +0100" MODIFIED_BY="[Empty name]" ORDER="565" SD_1="0.9" SD_2="0.6" SE="0.23285961969493993" STUDY_ID="STD-Kondo-2006" TOTAL_1="21" TOTAL_2="23" WEIGHT="24.932994313652813"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.522634054792346" CI_END="0.2990672930312199" CI_START="-0.07042741255743067" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.11431994023689464" ESTIMABLE="YES" I2="71.61215203039453" I2_Q="0.0" ID="CMP-009.10" MODIFIED="2010-08-02 14:16:42 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.06053630347556249" P_Q="1.0" P_Z="0.2252034693796321" Q="0.0" RANDOM="NO" SCALE="4.73" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="54" TOTAL_2="59" UNITS="" WEIGHT="100.0" Z="1.2128074486053864">
<NAME>Time to catheter removal (days)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.10.01" MODIFIED="2010-07-15 10:54:16 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-009.10.02" MODIFIED="2010-07-15 10:54:16 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.522634054792346" CI_END="0.2990672930312199" CI_START="-0.07042741255743067" DF="1" EFFECT_SIZE="0.11431994023689464" ESTIMABLE="YES" I2="71.61215203039453" ID="CMP-009.10.03" MODIFIED="2010-07-15 11:39:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.06053630347556249" P_Z="0.2252034693796321" STUDIES="2" TAU2="0.0" TOTAL_1="54" TOTAL_2="59" WEIGHT="100.0" Z="1.2128074486053864">
<NAME>mixed urinary incontinence</NAME>
<CONT_DATA CI_END="0.2853515702147372" CI_START="-0.0853515702147375" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.3" MODIFIED="2010-07-15 11:39:29 +0100" MODIFIED_BY="[Empty name]" ORDER="566" SD_1="0.5" SD_2="0.1" SE="0.09456886538567386" STUDY_ID="STD-Kondo-2006" TOTAL_1="29" TOTAL_2="31" WEIGHT="99.3490936255957"/>
<CONT_DATA CI_END="4.589912890529635" CI_START="0.01008710947036473" EFFECT_SIZE="2.3" ESTIMABLE="YES" MEAN_1="6.6" MEAN_2="4.3" MODIFIED="2010-07-15 10:56:44 +0100" MODIFIED_BY="[Empty name]" ORDER="556" SD_1="5.3" SD_2="2.6" SE="1.1683443719334516" STUDY_ID="STD-Wadie-2005" TOTAL_1="25" TOTAL_2="28" WEIGHT="0.6509063744043073"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.9672181081123243" CI_END="2.440725401040993" CI_START="1.0311979415577468" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.586464941138372" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="25" I2="49.586840312350844" I2_Q="0.0" ID="CMP-009.11" LOG_CI_END="0.3875189209489374" LOG_CI_START="0.013342037422340271" LOG_EFFECT_SIZE="0.20043047918563886" METHOD="MH" MODIFIED="2010-07-28 22:58:11 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.13757202522092715" P_Q="0.5365737643137822" P_Z="0.035751984221413485" Q="0.3819275670605806" RANDOM="NO" SCALE="25.266413430601474" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="123" TOTAL_2="120" WEIGHT="100.0" Z="2.099736984847882">
<NAME>Peri operative surgical complications</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.703899063079332" CI_END="2.9639476998810643" CI_START="1.0147819329735448" DF="1" EFFECT_SIZE="1.7342896459697261" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="16" I2="73.00142409473156" ID="CMP-009.11.01" LOG_CI_END="0.47187053606388585" LOG_CI_START="0.0063727265042244075" LOG_EFFECT_SIZE="0.2391216312840551" MODIFIED="2010-07-21 13:23:33 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.05428570798205756" P_Z="0.04404857120856498" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="89" WEIGHT="65.44345094743048" Z="2.0136283162515993">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="2.2850892671673657" CI_START="0.6319203678294177" EFFECT_SIZE="1.2016632016632016" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="13" LOG_CI_END="0.35890317048068315" LOG_CI_START="-0.1993376463872886" LOG_EFFECT_SIZE="0.07978276204669726" MODIFIED="2010-07-21 13:23:33 +0100" MODIFIED_BY="[Empty name]" ORDER="179" O_E="0.0" SE="0.3279134191648566" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="74" TOTAL_2="68" VAR="0.10752721046838695" WEIGHT="53.81803494993021"/>
<DICH_DATA CI_END="12.707043802602994" CI_START="1.3882064368414717" EFFECT_SIZE="4.2" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" LOG_CI_END="1.1040445269863033" LOG_CI_START="0.14245405380949785" LOG_EFFECT_SIZE="0.6232492903979004" MODIFIED="2010-07-15 13:52:28 +0100" MODIFIED_BY="[Empty name]" ORDER="1033" O_E="0.0" SE="0.5648430038936652" STUDY_ID="STD-Tcherniakovsky-2009" TOTAL_1="20" TOTAL_2="21" VAR="0.319047619047619" WEIGHT="11.625415997500262"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:37:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.6865117050126353" CI_START="0.6353879967188469" DF="0" EFFECT_SIZE="1.3065134099616857" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" I2="0.0" ID="CMP-009.11.03" LOG_CI_END="0.4291887371106774" LOG_CI_START="-0.19696099380224386" LOG_EFFECT_SIZE="0.11611387165421673" MODIFIED="2010-07-14 17:14:05 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.46727765997176274" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="31" WEIGHT="34.55654905256953" Z="0.7269156091977003">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="2.6865117050126353" CI_START="0.6353879967188469" EFFECT_SIZE="1.3065134099616857" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4291887371106774" LOG_CI_START="-0.19696099380224386" LOG_EFFECT_SIZE="0.11611387165421673" MODIFIED="2010-07-14 17:14:05 +0100" MODIFIED_BY="[Empty name]" ORDER="2770" O_E="0.0" SE="0.3678034514294059" STUDY_ID="STD-Kondo-2006" TOTAL_1="29" TOTAL_2="31" VAR="0.13527937888338334" WEIGHT="34.55654905256953"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.475027774940841" CI_END="1.1112702275951432" CI_START="0.34154990409820474" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6160797348252183" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="24" I2="0.0" I2_Q="9.253125218218312" ID="CMP-009.12" LOG_CI_END="0.045819679177821517" LOG_CI_START="-0.4665458322721604" LOG_EFFECT_SIZE="-0.21036307654716946" METHOD="MH" MODIFIED="2010-08-05 11:08:19 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.4832316170371518" P_Q="0.29383548536409076" P_Z="0.10752589714145752" Q="1.1019663238041997" RANDOM="NO" SCALE="135.10421384141335" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="270" TOTAL_2="293" WEIGHT="100.00000000000001" Z="1.6094137661322452">
<NAME>Bladder perforations</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="72.92191868001707" CI_START="0.13545380043757582" DF="0" EFFECT_SIZE="3.142857142857143" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-009.12.01" LOG_CI_END="1.8628580870424774" LOG_CI_START="-0.8682088054265785" LOG_EFFECT_SIZE="0.4973246408079494" MODIFIED="2010-07-15 13:55:58 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.47534153044019734" STUDIES="2" TAU2="0.0" TOTAL_1="94" TOTAL_2="89" WEIGHT="1.968798230762567" Z="0.7138150935048501">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-07-12 17:00:13 +0100" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.0" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="74" TOTAL_2="68" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="72.92191868001707" CI_START="0.13545380043757582" EFFECT_SIZE="3.142857142857143" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8628580870424774" LOG_CI_START="-0.8682088054265785" LOG_EFFECT_SIZE="0.4973246408079494" MODIFIED="2010-07-15 13:55:58 +0100" MODIFIED_BY="[Empty name]" ORDER="1034" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-Tcherniakovsky-2009" TOTAL_1="20" TOTAL_2="21" VAR="2.5735930735930737" WEIGHT="1.968798230762567"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.12.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:38:19 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.5034935899038304" CI_END="1.040723163224571" CI_START="0.3070960383010786" DF="4" EFFECT_SIZE="0.5653334948456818" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="24" I2="0.0" ID="CMP-009.12.03" LOG_CI_END="0.01733522069861594" LOG_CI_START="-0.5127257861459198" LOG_EFFECT_SIZE="-0.2476952827236519" MODIFIED="2010-07-28 23:10:34 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.47734738184390046" P_Z="0.06698630870862657" STUDIES="5" TAU2="0.0" TOTAL_1="176" TOTAL_2="204" WEIGHT="98.03120176923744" Z="1.8317658798139482">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="1.455951518377557" CI_START="0.11154009479174683" EFFECT_SIZE="0.40298507462686567" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.16314691367780393" LOG_CI_START="-0.9525689907614823" LOG_EFFECT_SIZE="-0.39471103854183914" MODIFIED="2010-07-26 10:01:38 +0100" MODIFIED_BY="[Empty name]" ORDER="562" O_E="0.0" SE="0.6553770451504356" STUDY_ID="STD-Basok-2008" TOTAL_1="67" TOTAL_2="72" VAR="0.4295190713101161" WEIGHT="31.090689703744875"/>
<DICH_DATA CI_END="2.67473066387309" CI_START="0.42721582867580543" EFFECT_SIZE="1.0689655172413792" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4272800566066701" LOG_CI_START="-0.369352664736037" LOG_EFFECT_SIZE="0.028963695935316558" MODIFIED="2010-07-14 17:14:57 +0100" MODIFIED_BY="[Empty name]" ORDER="2771" O_E="0.0" SE="0.46794600391227514" STUDY_ID="STD-Kondo-2006" TOTAL_1="29" TOTAL_2="31" VAR="0.218973462577467" WEIGHT="27.278793264010236"/>
<DICH_DATA CI_END="1.0549778768743512" CI_START="0.0507912795551857" EFFECT_SIZE="0.23148148148148148" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.023243352475292994" LOG_CI_START="-1.2942108461051172" LOG_EFFECT_SIZE="-0.635483746814912" MODIFIED="2010-07-20 10:31:03 +0100" MODIFIED_BY="[Empty name]" ORDER="110" O_E="0.0" SE="0.7738791177495933" STUDY_ID="STD-Sharifiaghdas-2008" TOTAL_1="36" TOTAL_2="25" VAR="0.5988888888888888" WEIGHT="28.549879730402377"/>
<DICH_DATA CI_END="19.212247245225942" CI_START="0.03471454619189194" EFFECT_SIZE="0.8166666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.2835781670022344" LOG_CI_START="-1.4594885077124944" LOG_EFFECT_SIZE="-0.08795517035512998" MODIFIED="2010-07-28 23:10:34 +0100" MODIFIED_BY="[Empty name]" ORDER="136" O_E="0.0" SE="1.6112909431264613" STUDY_ID="STD-Song-2004" TOTAL_1="19" TOTAL_2="48" VAR="2.5962585034013608" WEIGHT="3.5055206593287944"/>
<DICH_DATA CI_END="5.808195778662353" CI_START="0.05399267034903964" EFFECT_SIZE="0.56" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7640412468379957" LOG_CI_START="-1.2676651928255949" LOG_EFFECT_SIZE="-0.25181197299379954" MODIFIED="2010-07-15 11:04:07 +0100" MODIFIED_BY="[Empty name]" ORDER="557" O_E="0.0" SE="1.1934344197674684" STUDY_ID="STD-Wadie-2005" TOTAL_1="25" TOTAL_2="28" VAR="1.4242857142857142" WEIGHT="7.6063184117511575"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-009.13" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-07-31 21:38:28 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="833.81" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="29" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>Urethral injury</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.13.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 17:16:40 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:39:21 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-009.13.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 17:17:07 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="8.394184190041877" CI_START="0.015060397797369413" EFFECT_SIZE="0.35555555555555557" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9239784945205962" LOG_CI_START="-1.8221635567594336" LOG_EFFECT_SIZE="-0.4490925311194189" MODIFIED="2010-07-14 17:17:07 +0100" MODIFIED_BY="[Empty name]" ORDER="2773" O_E="0.0" SE="1.6130974345442786" STUDY_ID="STD-Kondo-2006" TOTAL_1="29" TOTAL_2="31" VAR="2.6020833333333333" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.897475027477218" CI_END="10.242528895023066" CI_START="0.9588453626372196" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="3.133847688173532" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-009.14" LOG_CI_END="1.0104071978076423" LOG_CI_START="-0.01825142783299777" LOG_EFFECT_SIZE="0.4960778849873223" METHOD="MH" MODIFIED="2010-07-28 23:37:28 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.6384336841580178" P_Q="1.0" P_Z="0.058702754205183096" Q="0.0" RANDOM="NO" SCALE="938.789929546717" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="90" TOTAL_2="84" WEIGHT="100.0" Z="1.8904129394655447">
<NAME>De novo detrusor urgency or urge symptoms</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-14 17:21:55 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.14.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:38:45 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.897475027477218" CI_END="10.242528895023066" CI_START="0.9588453626372196" DF="2" EFFECT_SIZE="3.133847688173532" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="3" I2="0.0" ID="CMP-009.14.03" LOG_CI_END="1.0104071978076423" LOG_CI_START="-0.01825142783299777" LOG_EFFECT_SIZE="0.4960778849873223" MODIFIED="2010-07-20 10:29:40 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6384336841580178" P_Z="0.058702754205183096" STUDIES="3" TAU2="0.0" TOTAL_1="90" TOTAL_2="84" WEIGHT="100.0" Z="1.8904129394655447">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="8.919217499511669" CI_START="0.2882591856859425" EFFECT_SIZE="1.603448275862069" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9503267545385717" LOG_CI_START="-0.540216844556576" LOG_EFFECT_SIZE="0.20505495499099782" MODIFIED="2010-07-14 17:22:29 +0100" MODIFIED_BY="[Empty name]" ORDER="2776" O_E="0.0" SE="0.8755526884183011" STUDY_ID="STD-Kondo-2006" TOTAL_1="29" TOTAL_2="31" VAR="0.7665925101965146" WEIGHT="53.907526941297064"/>
<DICH_DATA CI_END="41.681572043479036" CI_START="0.7404758510228218" EFFECT_SIZE="5.555555555555555" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.6199440902562792" LOG_CI_START="-0.13048910046289142" LOG_EFFECT_SIZE="0.7447274948966939" MODIFIED="2010-07-20 10:29:40 +0100" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="1.0282131210124787" STUDY_ID="STD-Sharifiaghdas-2008" TOTAL_1="36" TOTAL_2="25" VAR="1.0572222222222223" WEIGHT="32.9113222705488"/>
<DICH_DATA CI_END="78.59758332323574" CI_START="0.14245661366053858" EFFECT_SIZE="3.3461538461538463" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8954091927885353" LOG_CI_START="-0.8463173834929338" LOG_EFFECT_SIZE="0.5245459046478006" MODIFIED="2010-07-19 12:32:41 +0100" MODIFIED_BY="[Empty name]" ORDER="632" O_E="0.0" SE="1.6105037626731702" STUDY_ID="STD-Wadie-2005" TOTAL_1="25" TOTAL_2="28" VAR="2.5937223695844387" WEIGHT="13.181150788154142"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.4397083743088687E-4" CI_END="8.026335717090705" CI_START="1.2875962849858669" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="3.2147597190731627" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-009.15" LOG_CI_END="0.9045173209884934" LOG_CI_START="0.10977971497500358" LOG_EFFECT_SIZE="0.5071485179817484" METHOD="MH" MODIFIED="2010-08-06 16:21:10 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.9852029216611577" P_Q="1.0" P_Z="0.012369061980216995" Q="0.0" RANDOM="NO" SCALE="105.00526687761159" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="118" TOTAL_2="127" WEIGHT="100.0" Z="2.501436505674098">
<NAME>De novo detrusor overactivity (urodynamic diagnosis)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.15.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-23 10:58:42 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-07-23 10:58:42 +0100" MODIFIED_BY="[Empty name]" ORDER="130" O_E="0.0" SE="0.0" STUDY_ID="STD-Bai-2005" TOTAL_1="28" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.15.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:38:54 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.4397083743088687E-4" CI_END="8.026335717090705" CI_START="1.2875962849858669" DF="1" EFFECT_SIZE="3.2147597190731627" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="5" I2="0.0" ID="CMP-009.15.03" LOG_CI_END="0.9045173209884934" LOG_CI_START="0.10977971497500358" LOG_EFFECT_SIZE="0.5071485179817484" MODIFIED="2010-07-26 10:00:57 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9852029216611577" P_Z="0.012369061980216995" STUDIES="2" TAU2="0.0" TOTAL_1="90" TOTAL_2="96" WEIGHT="100.0" Z="2.501436505674098">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="8.385151501839433" CI_START="1.2395012900517455" EFFECT_SIZE="3.2238805970149254" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" LOG_CI_END="0.9235109137898636" LOG_CI_START="0.09324698311034517" LOG_EFFECT_SIZE="0.5083789484501045" MODIFIED="2010-07-26 10:00:57 +0100" MODIFIED_BY="[Empty name]" ORDER="561" O_E="0.0" SE="0.4877011427538892" STUDY_ID="STD-Basok-2008" TOTAL_1="67" TOTAL_2="72" VAR="0.23785240464344942" WEIGHT="90.77586683625505"/>
<DICH_DATA CI_END="73.014034432097" CI_START="0.13374997116591358" EFFECT_SIZE="3.125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.863406346292985" LOG_CI_START="-0.8737063029327973" LOG_EFFECT_SIZE="0.494850021680094" MODIFIED="2010-07-23 11:37:37 +0100" MODIFIED_BY="[Empty name]" ORDER="633" O_E="0.0" SE="1.6077935190813526" STUDY_ID="STD-Wadie-2005" TOTAL_1="23" TOTAL_2="24" VAR="2.585" WEIGHT="9.224133163744954"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.020416655340153" CI_END="2.7138030092776164" CI_START="0.9430881610840238" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5997985778103183" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="18" I2="0.5078243647467285" I2_Q="57.14712964134232" ID="CMP-009.16" LOG_CI_END="0.4335783197096119" LOG_CI_START="-0.025447706962931624" LOG_EFFECT_SIZE="0.2040653063733401" METHOD="MH" MODIFIED="2010-08-06 16:20:13 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.4032500269242403" P_Q="0.12661168636604814" P_Z="0.08139492407898713" Q="2.33356597033171" RANDOM="NO" SCALE="241.88459480780463" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="192" TOTAL_2="183" WEIGHT="100.0" Z="1.7426491211627946">
<NAME>Voiding dysfunction</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6682133961274312" CI_END="2.252501331043255" CI_START="0.4190032273022972" DF="1" EFFECT_SIZE="0.9714964370546317" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" I2="0.0" ID="CMP-009.16.01" LOG_CI_END="0.3526650562835401" LOG_CI_START="-0.37778263194019324" LOG_EFFECT_SIZE="-0.012558787828326546" MODIFIED="2010-07-23 10:59:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.41367551459383956" P_Z="0.9462661360481266" STUDIES="2" TAU2="0.0" TOTAL_1="102" TOTAL_2="99" WEIGHT="52.16557576951122" Z="0.06739639875610264">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="3.35052700275903" CI_START="0.4480420098963662" EFFECT_SIZE="1.2252252252252251" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5251131223769885" LOG_CI_START="-0.3486812632098685" LOG_EFFECT_SIZE="0.08821592958356005" MODIFIED="2010-07-12 17:11:23 +0100" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.5132711474456868" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="74" TOTAL_2="68" VAR="0.26344727080021196" WEIGHT="32.459131184278284"/>
<DICH_DATA CI_END="2.7934324004745212" CI_START="0.10970064157577505" EFFECT_SIZE="0.5535714285714286" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4461381661360913" LOG_CI_START="-0.9597908324799466" LOG_EFFECT_SIZE="-0.2568263331719277" MODIFIED="2010-07-23 10:59:13 +0100" MODIFIED_BY="[Empty name]" ORDER="131" O_E="0.0" SE="0.8258496532478447" STUDY_ID="STD-Bai-2005" TOTAL_1="28" TOTAL_2="31" VAR="0.6820276497695853" WEIGHT="19.706444585232934"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.16.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:39:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7261652858799215" CI_END="4.624289001231032" CI_START="1.1290773239218073" DF="2" EFFECT_SIZE="2.284990120449316" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="8" I2="0.0" ID="CMP-009.16.03" LOG_CI_END="0.6650449680850091" LOG_CI_START="0.052723685239970744" LOG_EFFECT_SIZE="0.35888432666248987" MODIFIED="2010-07-20 10:30:08 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.4218599710954153" P_Z="0.02159095519339528" STUDIES="3" TAU2="0.0" TOTAL_1="90" TOTAL_2="84" WEIGHT="47.834424230488786" Z="2.297487853455518">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="170.84134191876242" CI_START="0.5394478816715421" EFFECT_SIZE="9.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2325929740497106" LOG_CI_START="-0.2680505079705737" LOG_EFFECT_SIZE="0.9822712330395684" MODIFIED="2010-07-14 17:18:00 +0100" MODIFIED_BY="[Empty name]" ORDER="2774" O_E="0.0" SE="1.4688903597235872" STUDY_ID="STD-Kondo-2006" TOTAL_1="29" TOTAL_2="31" VAR="2.157638888888889" WEIGHT="2.5115500371444623"/>
<DICH_DATA CI_END="3.8560296639451126" CI_START="0.605313014081841" EFFECT_SIZE="1.5277777777777777" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.5861403662157829" LOG_CI_START="-0.21801998876186984" LOG_EFFECT_SIZE="0.18406018872695656" MODIFIED="2010-07-20 10:30:08 +0100" MODIFIED_BY="[Empty name]" ORDER="109" O_E="0.0" SE="0.47236777317182965" STUDY_ID="STD-Sharifiaghdas-2008" TOTAL_1="36" TOTAL_2="25" VAR="0.2231313131313131" WEIGHT="30.63267586287672"/>
<DICH_DATA CI_END="9.03362965724246" CI_START="0.7560096406692677" EFFECT_SIZE="2.6133333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.9558622822500797" LOG_CI_START="-0.12147266632052761" LOG_EFFECT_SIZE="0.417194807964776" MODIFIED="2010-07-15 11:16:16 +0100" MODIFIED_BY="[Empty name]" ORDER="558" O_E="0.0" SE="0.6328318816843779" STUDY_ID="STD-Wadie-2005" TOTAL_1="25" TOTAL_2="28" VAR="0.4004761904761905" WEIGHT="14.690198330467608"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7556325389555132" CI_END="14.218729933309788" CI_START="0.9488624581589995" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="3.673093932425261" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-009.17" LOG_CI_END="1.1528608054240475" LOG_CI_START="-0.022796735930661418" LOG_EFFECT_SIZE="0.565032034746693" METHOD="MH" MODIFIED="2010-08-02 14:17:26 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.384698808376591" P_Q="0.3952408025763612" P_Z="0.05957118081392138" Q="0.7227578321855938" RANDOM="NO" SCALE="493.64" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="103" TOTAL_2="99" WEIGHT="100.0" Z="1.8839541265372195">
<NAME>Release of sling required</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="11.451988701328464" CI_START="0.46084352768853604" DF="0" EFFECT_SIZE="2.2972972972972974" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" I2="0.0" ID="CMP-009.17.01" LOG_CI_END="1.058880910869547" LOG_CI_START="-0.33644650757495154" LOG_EFFECT_SIZE="0.36121720164729776" MODIFIED="2010-07-12 17:23:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3102124134743386" STUDIES="1" TAU2="0.0" TOTAL_1="74" TOTAL_2="68" WEIGHT="81.16044578100124" Z="1.014776455284293">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="11.451988701328464" CI_START="0.46084352768853604" EFFECT_SIZE="2.2972972972972974" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.058880910869547" LOG_CI_START="-0.33644650757495154" LOG_EFFECT_SIZE="0.36121720164729776" MODIFIED="2010-07-12 17:23:15 +0100" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.8196222325764141" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="74" TOTAL_2="68" VAR="0.6717806041335453" WEIGHT="81.16044578100124"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.17.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:39:56 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="170.84134191876242" CI_START="0.5394478816715421" DF="0" EFFECT_SIZE="9.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" I2="0.0" ID="CMP-009.17.03" LOG_CI_END="2.2325929740497106" LOG_CI_START="-0.2680505079705737" LOG_EFFECT_SIZE="0.9822712330395684" MODIFIED="2010-07-14 17:19:22 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.12361480196559405" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="31" WEIGHT="18.839554218998764" Z="1.5397766644063244">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="170.84134191876242" CI_START="0.5394478816715421" EFFECT_SIZE="9.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2325929740497106" LOG_CI_START="-0.2680505079705737" LOG_EFFECT_SIZE="0.9822712330395684" MODIFIED="2010-07-14 17:19:22 +0100" MODIFIED_BY="[Empty name]" ORDER="2775" O_E="0.0" SE="1.4688903597235872" STUDY_ID="STD-Kondo-2006" TOTAL_1="29" TOTAL_2="31" VAR="2.157638888888889" WEIGHT="18.839554218998764"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-009.18" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-05 13:33:20 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="78.95" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="74" TOTAL_2="68" WEIGHT="0.0" Z="0.0">
<NAME>Retention up to 6 weeks</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="1" I2="0.0" ID="CMP-009.18.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-12 17:21:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="74" TOTAL_2="68" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="44.63174273247001" CI_START="0.6811033897087935" EFFECT_SIZE="5.513513513513513" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.6496438450372235" LOG_CI_START="-0.1667869583194159" LOG_EFFECT_SIZE="0.7414284433589037" MODIFIED="2010-07-12 17:21:22 +0100" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="1.0669804453691791" STUDY_ID="STD-Arunkalaivanan-2003" TOTAL_1="74" TOTAL_2="68" VAR="1.138447270800212" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.18.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:39:31 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.18.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-12 17:20:10 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-009.19" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-05 13:33:47 +0100" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="364.36" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="45" TOTAL_2="49" WEIGHT="0.0" Z="0.0">
<NAME>Vaginal erosion</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-009.19.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-15 14:02:32 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="8.102435408890784" CI_START="0.015050422270841747" EFFECT_SIZE="0.3492063492063492" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9086155776031525" LOG_CI_START="-1.8224513148659038" LOG_EFFECT_SIZE="-0.4569178686313755" MODIFIED="2010-07-15 14:02:32 +0100" MODIFIED_BY="[Empty name]" ORDER="1036" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-Tcherniakovsky-2009" TOTAL_1="20" TOTAL_2="21" VAR="2.5735930735930737" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.19.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:40:06 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.19.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-15 11:23:03 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-07-15 11:23:03 +0100" MODIFIED_BY="[Empty name]" ORDER="562" O_E="0.0" SE="0.0" STUDY_ID="STD-Wadie-2005" TOTAL_1="25" TOTAL_2="28" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-009.20" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-05 13:33:58 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="26.73" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="25" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Wound pain (6 months)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>Minimally Invasive Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours MISO</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.20.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-15 11:24:23 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-009.20.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:40:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="2" I2="0.0" ID="CMP-009.20.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-15 11:25:01 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="25" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="17.15206767538321" CI_START="0.8958919875330238" EFFECT_SIZE="3.92" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.2343164815730483" LOG_CI_START="-0.047744347532133954" LOG_EFFECT_SIZE="0.5932860670204573" MODIFIED="2010-07-15 11:25:01 +0100" MODIFIED_BY="[Empty name]" ORDER="563" O_E="0.0" SE="0.75308887731984" STUDY_ID="STD-Wadie-2005" TOTAL_1="25" TOTAL_2="28" VAR="0.5671428571428571" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2017-07-21 11:40:49 +0100" MODIFIED_BY="[Empty name]" NO="10">
<NAME>One type of traditional sling versus another</NAME>
<DICH_OUTCOME CHI2="0.4290705352310679" CI_END="1.1943123277681016" CI_START="0.6580546781905942" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.886522878728179" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="49" I2="0.0" I2_Q="100.0" ID="CMP-010.01" LOG_CI_END="0.07711791514226751" LOG_CI_START="-0.18173801907620446" LOG_EFFECT_SIZE="-0.05231005196696844" METHOD="MH" MODIFIED="2010-12-03 17:12:26 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8069164659219411" P_Q="0.0" P_Z="0.42827568645117076" Q="8.330077280862706E-33" RANDOM="NO" SCALE="18.06" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="161" TOTAL_2="146" WEIGHT="100.0" Z="0.7921457794214286">
<NAME>Number with incontinence (worse, unchanged or improved) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.4290705352310679" CI_END="1.1943123277681016" CI_START="0.6580546781905942" DF="2" EFFECT_SIZE="0.886522878728179" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="49" I2="0.0" ID="CMP-010.01.01" LOG_CI_END="0.07711791514226751" LOG_CI_START="-0.18173801907620446" LOG_EFFECT_SIZE="-0.05231005196696844" MODIFIED="2010-07-28 16:39:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8069164659219411" P_Z="0.42827568645117076" STUDIES="3" TAU2="0.0" TOTAL_1="161" TOTAL_2="146" WEIGHT="100.0" Z="0.7921457794214286">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="1.2822912040614072" CI_START="0.6698087453975401" EFFECT_SIZE="0.9267631103074141" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="28" LOG_CI_END="0.10798666321370579" LOG_CI_START="-0.17404918636751848" LOG_EFFECT_SIZE="-0.033031261576906355" MODIFIED="2010-07-28 16:39:48 +0100" MODIFIED_BY="[Empty name]" ORDER="920" O_E="0.0" SE="0.16566925414398254" STUDY_ID="STD-Guerrero-2008" TOTAL_1="79" TOTAL_2="50" VAR="0.027446301768623473" WEIGHT="64.42019426789783"/>
<DICH_DATA CI_END="1.657052422843686" CI_START="0.4620403008651365" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.21933624806424007" LOG_CI_START="-0.3353201420196135" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2010-07-16 10:49:04 +0100" MODIFIED_BY="[Empty name]" ORDER="202" O_E="0.0" SE="0.32580790912866686" STUDY_ID="STD-Lucas-2000" TOTAL_1="72" TOTAL_2="72" VAR="0.10615079365079363" WEIGHT="30.05499117742792"/>
<DICH_DATA CI_END="3.6051025749907013" CI_START="0.06390941594792052" EFFECT_SIZE="0.48" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.5569176260925309" LOG_CI_START="-1.1944351513413562" LOG_EFFECT_SIZE="-0.3187587626244128" MODIFIED="2010-07-22 23:51:59 +0100" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="1.0287532908007309" STUDY_ID="STD-Pacetta-2005" TOTAL_1="10" TOTAL_2="24" VAR="1.0583333333333331" WEIGHT="5.52481455467425"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:43:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:43:25 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.940093287881763" CI_END="0.9796533360948289" CI_START="0.21004707709387482" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4536224419183669" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="15" I2="66.3304951105709" I2_Q="80.24510480283338" ID="CMP-010.02" LOG_CI_END="-0.008927578241992716" LOG_CI_START="-0.677683357500583" LOG_EFFECT_SIZE="-0.34330546787128785" METHOD="MH" MODIFIED="2010-12-03 17:21:43 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.05130102606166975" P_Q="0.02445551720118" P_Z="0.04418903908517619" Q="5.062036472577322" RANDOM="NO" SCALE="683.97" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="121" TOTAL_2="90" WEIGHT="200.0" Z="2.01229319758362">
<NAME>Number not improved (worse or unchanged) within the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.2809477466616479" CI_END="0.5859749504023456" CI_START="0.0807218401825544" DF="1" EFFECT_SIZE="0.21748787620775184" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="15" I2="0.0" ID="CMP-010.02.01" LOG_CI_END="-0.2321209490579515" LOG_CI_START="-1.0930089462258077" LOG_EFFECT_SIZE="-0.6625649476418796" MODIFIED="2010-07-28 16:41:02 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.596080765116292" P_Z="0.0025538003995421747" STUDIES="2" TAU2="0.0" TOTAL_1="89" TOTAL_2="74" WEIGHT="99.99999999999999" Z="3.016892880534723">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="0.563902355064251" CI_START="0.06725354723047813" EFFECT_SIZE="0.19474196689386564" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.2487960916338973" LOG_CI_START="-1.1722848042326968" LOG_EFFECT_SIZE="-0.710540447933297" MODIFIED="2010-07-28 16:41:02 +0100" MODIFIED_BY="[Empty name]" ORDER="132" O_E="0.0" SE="0.5424618411233878" STUDY_ID="STD-Guerrero-2008" TOTAL_1="79" TOTAL_2="50" VAR="0.29426484907497563" WEIGHT="91.24495613223262"/>
<DICH_DATA CI_END="8.70532379845816" CI_START="0.023733932824477798" EFFECT_SIZE="0.45454545454545453" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.9397849295335695" LOG_CI_START="-1.624630291177982" LOG_EFFECT_SIZE="-0.3424226808222062" MODIFIED="2010-07-22 15:40:35 +0100" MODIFIED_BY="[Empty name]" ORDER="128" O_E="0.0" SE="1.506350194706035" STUDY_ID="STD-Pacetta-2005" TOTAL_1="10" TOTAL_2="24" VAR="2.269090909090909" WEIGHT="8.75504386776737"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 11:46:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="111.93891211193475" CI_START="0.4006596301139917" DF="0" EFFECT_SIZE="6.696969696969698" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" I2="0.0" ID="CMP-010.02.03" LOG_CI_END="2.048981081862479" LOG_CI_START="-0.39722441424803245" LOG_EFFECT_SIZE="0.8258783338072233" MODIFIED="2010-07-21 11:58:05 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.18569217068951907" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="16" WEIGHT="100.0" Z="1.323430752197917">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="111.93891211193475" CI_START="0.4006596301139915" EFFECT_SIZE="6.696969696969697" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.048981081862479" LOG_CI_START="-0.3972244142480326" LOG_EFFECT_SIZE="0.8258783338072232" MODIFIED="2010-07-21 11:58:05 +0100" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="1.4369132173278103" STUDY_ID="STD-Barbalias-1997" TOTAL_1="32" TOTAL_2="16" VAR="2.064719594131359" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.665648047636983" CI_END="1.1039365908021097" CI_START="0.7211108596270465" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8922223175683628" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="79" I2="65.38054645759513" I2_Q="64.22304362015885" ID="CMP-010.03" LOG_CI_END="0.04294412859642465" LOG_CI_START="-0.14199796409711365" LOG_EFFECT_SIZE="-0.049526917750344485" METHOD="MH" MODIFIED="2010-12-03 17:12:40 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.03408305709899795" P_Q="0.09455324451196512" P_Z="0.2938355999191613" Q="2.7950952266120073" RANDOM="NO" SCALE="62.31" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="210" TOTAL_2="169" WEIGHT="100.0" Z="1.0497445296761723">
<NAME>Number with incontinence (worse, unchanged or improved) after first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.018749837296227" CI_END="1.0325179213222369" CI_START="0.6741450296056775" DF="2" EFFECT_SIZE="0.8343061935753395" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="77" I2="60.14943830957176" ID="CMP-010.03.01" LOG_CI_END="0.013897598404767854" LOG_CI_START="-0.17124666313546022" LOG_EFFECT_SIZE="-0.07867453236534619" MODIFIED="2010-07-28 16:40:32 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.08131912689523701" P_Z="0.0957691959764266" STUDIES="3" TAU2="0.0" TOTAL_1="178" TOTAL_2="153" WEIGHT="96.97675464634327" Z="1.6657200029189674">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="0.8615021069212014" CI_START="0.5138874144501657" EFFECT_SIZE="0.6653683868873742" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="39" LOG_CI_END="-0.06474365608811442" LOG_CI_START="-0.28913201843425834" LOG_EFFECT_SIZE="-0.17693783726118634" MODIFIED="2010-07-28 16:40:32 +0100" MODIFIED_BY="[Empty name]" ORDER="921" O_E="0.0" SE="0.1318068347824323" STUDY_ID="STD-Guerrero-2008" TOTAL_1="79" TOTAL_2="50" VAR="0.0173730416953634" WEIGHT="54.15476124776978"/>
<DICH_DATA CI_END="1.5652923609973803" CI_START="0.7574808654852071" EFFECT_SIZE="1.0888888888888888" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="30" LOG_CI_END="0.1945954657863155" LOG_CI_START="-0.1206283332799756" LOG_EFFECT_SIZE="0.036983566253169946" MODIFIED="2010-07-16 12:01:10 +0100" MODIFIED_BY="[Empty name]" ORDER="210" O_E="0.0" SE="0.1851640199545103" STUDY_ID="STD-Lucas-2000" TOTAL_1="75" TOTAL_2="70" VAR="0.03428571428571429" WEIGHT="35.18432092617752"/>
<DICH_DATA CI_END="2.303324443079552" CI_START="0.3206345475314756" EFFECT_SIZE="0.859375" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.36235511639016066" LOG_CI_START="-0.4939896853694472" LOG_EFFECT_SIZE="-0.06581728448964333" MODIFIED="2010-07-21 11:52:22 +0100" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.5030211755287277" STUDY_ID="STD-Shin-2001" TOTAL_1="24" TOTAL_2="33" VAR="0.25303030303030305" WEIGHT="7.637672472395963"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 10:43:40 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="10.952436037060965" CI_START="0.6904856576573406" DF="0" EFFECT_SIZE="2.75" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="2" I2="0.0" ID="CMP-010.03.03" LOG_CI_END="1.039510725549589" LOG_CI_START="-0.16084533788906388" LOG_EFFECT_SIZE="0.43933269383026263" MODIFIED="2010-07-21 11:55:32 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.15137220758623" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="16" WEIGHT="3.023245353656735" Z="1.4347013913047721">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="10.952436037060965" CI_START="0.6904856576573406" EFFECT_SIZE="2.75" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="2" LOG_CI_END="1.039510725549589" LOG_CI_START="-0.16084533788906388" LOG_EFFECT_SIZE="0.43933269383026263" MODIFIED="2010-07-21 11:55:32 +0100" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="0.7050950935222078" STUDY_ID="STD-Barbalias-1997" TOTAL_1="32" TOTAL_2="16" VAR="0.49715909090909094" WEIGHT="3.023245353656735"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.6862371163476222" CI_END="0.6426826904853852" CI_START="0.16961006071740303" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.33015973430333706" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="22" I2="40.69635934915292" I2_Q="0.0" ID="CMP-010.04" LOG_CI_END="-0.1920033968811279" LOG_CI_START="-0.7705483903784629" LOG_EFFECT_SIZE="-0.4812758936297954" METHOD="MH" MODIFIED="2010-12-03 17:26:24 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.19409782524896524" P_Q="1.0" P_Z="0.0011106633095228217" Q="0.0" RANDOM="NO" SCALE="52.92" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="135" TOTAL_2="99" WEIGHT="100.0" Z="3.2608817939622328">
<NAME>Number not improved (worse or unchanged) after the first year (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.6862371163476222" CI_END="0.6426826904853852" CI_START="0.16961006071740303" DF="1" EFFECT_SIZE="0.33015973430333706" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="22" I2="40.69635934915292" ID="CMP-010.04.01" LOG_CI_END="-0.1920033968811279" LOG_CI_START="-0.7705483903784629" LOG_EFFECT_SIZE="-0.4812758936297954" MODIFIED="2010-07-28 16:41:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.19409782524896524" P_Z="0.0011106633095228217" STUDIES="2" TAU2="0.0" TOTAL_1="103" TOTAL_2="83" WEIGHT="100.0" Z="3.2608817939622328">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="0.5620531727703729" CI_START="0.12635173052553028" EFFECT_SIZE="0.2664890073284477" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.2502225962665405" LOG_CI_START="-0.8984188055640754" LOG_EFFECT_SIZE="-0.574320700915308" MODIFIED="2010-07-28 16:41:29 +0100" MODIFIED_BY="[Empty name]" ORDER="922" O_E="0.0" SE="0.3807536619643561" STUDY_ID="STD-Guerrero-2008" TOTAL_1="79" TOTAL_2="50" VAR="0.14497335109926715" WEIGHT="90.20718013601139"/>
<DICH_DATA CI_END="5.06917362083569" CI_START="0.16576228013260508" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.704937166204579" LOG_CI_START="-0.7805142879833787" LOG_EFFECT_SIZE="-0.0377885608893998" MODIFIED="2010-07-21 12:00:10 +0100" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.8725615372932939" STUDY_ID="STD-Shin-2001" TOTAL_1="24" TOTAL_2="33" VAR="0.7613636363636364" WEIGHT="9.792819863988612"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 11:46:19 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 12:01:14 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="16" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-07-21 12:01:14 +0100" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.0" STUDY_ID="STD-Barbalias-1997" TOTAL_1="32" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="42" EVENTS_2="34" I2="0.0" I2_Q="0.0" ID="CMP-010.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 15:05:11 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="7.04" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="73" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>Number with incontinence (worse, unchanged or improved) after five years (women's observations)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="42" EVENTS_2="34" I2="0.0" ID="CMP-010.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:02:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="1.592076224617588" CI_START="0.8563067178036627" EFFECT_SIZE="1.1676067687348912" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="34" LOG_CI_END="0.20196385683024595" LOG_CI_START="-0.06737064888535647" LOG_EFFECT_SIZE="0.06729660397244476" MODIFIED="2010-07-16 12:02:43 +0100" MODIFIED_BY="[Empty name]" ORDER="211" O_E="0.0" SE="0.15820842188465017" STUDY_ID="STD-Lucas-2000" TOTAL_1="73" TOTAL_2="69" VAR="0.025029904755231452" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:01:38 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:01:38 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.06" MODIFIED="2010-08-05 13:35:39 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="15.13" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="81" TOTAL_2="84" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pad test: mean weight of urine</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.06.01" MODIFIED="2010-07-16 12:13:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="13.501775991613787" CI_START="-7.301775991613788" EFFECT_SIZE="3.0999999999999996" ESTIMABLE="YES" MEAN_1="7.71" MEAN_2="4.61" MODIFIED="2010-07-16 12:13:22 +0100" MODIFIED_BY="[Empty name]" ORDER="214" SD_1="34.08" SD_2="34.08" SE="5.30712608683714" STUDY_ID="STD-Lucas-2000" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.06.02" MODIFIED="2010-07-16 11:46:30 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.06.03" MODIFIED="2010-07-16 11:47:44 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.07" MODIFIED="2010-08-06 18:06:18 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="16.39" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="81" TOTAL_2="84" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Operative time (mins)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.07.01" MODIFIED="2010-07-22 23:41:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<CONT_DATA CI_END="12.678967897636133" CI_START="3.3210321023638674" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="62.0" MEAN_2="54.0" MODIFIED="2010-07-22 23:41:37 +0100" MODIFIED_BY="[Empty name]" ORDER="219" SD_1="15.33" SD_2="15.33" SE="2.387272385892411" STUDY_ID="STD-Lucas-2000" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.07.02" MODIFIED="2010-07-16 12:14:46 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-010.07.03" MODIFIED="2010-07-16 12:15:17 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="34" EVENTS_2="36" I2="0.0" I2_Q="0.0" ID="CMP-010.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 18:06:18 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="621.81" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="113" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>Peri operative surgical complications</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="34" EVENTS_2="31" I2="0.0" ID="CMP-010.08.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 13:20:55 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="1.6617615167816089" CI_START="0.7784922320741596" EFFECT_SIZE="1.1373954599761051" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="31" LOG_CI_END="0.22056869731972734" LOG_CI_START="-0.10874571653729861" LOG_EFFECT_SIZE="0.055911490391214354" MODIFIED="2010-07-21 13:20:55 +0100" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.19344091683225606" STUDY_ID="STD-Lucas-2000" TOTAL_1="81" TOTAL_2="84" VAR="0.0374193883049038" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 13:10:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="5" I2="0.0" ID="CMP-010.08.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 13:10:26 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="16" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="0.7978150696302887" CI_START="0.002749048218125943" EFFECT_SIZE="0.046831955922865015" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="-0.09809776472275918" LOG_CI_START="-2.560817642592918" LOG_EFFECT_SIZE="-1.3294577036578386" MODIFIED="2010-07-21 13:10:26 +0100" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="1.446613846920935" STUDY_ID="STD-Barbalias-1997" TOTAL_1="32" TOTAL_2="16" VAR="2.092691622103387" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-010.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 18:06:18 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="37.89" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>Bladder perforation</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-010.09.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 13:12:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="4.030422581588934" CI_START="0.11859201079523064" EFFECT_SIZE="0.691358024691358" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6053505834192208" LOG_CI_START="-0.9259445671641195" LOG_EFFECT_SIZE="-0.16029699187244936" MODIFIED="2010-07-21 13:12:11 +0100" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="0.8994903514858987" STUDY_ID="STD-Lucas-2000" TOTAL_1="81" TOTAL_2="84" VAR="0.8090828924162257" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.09.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 11:46:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 13:11:08 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-010.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 18:06:18 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="12.15" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>Urinary tract infection</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="6" I2="0.0" ID="CMP-010.10.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 13:13:20 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="4.536686357157539" CI_START="0.6584871102437917" EFFECT_SIZE="1.728395061728395" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.6567387554475901" LOG_CI_START="-0.1814527218484136" LOG_EFFECT_SIZE="0.23764301679958824" MODIFIED="2010-07-21 13:13:20 +0100" MODIFIED_BY="[Empty name]" ORDER="177" O_E="0.0" SE="0.4923578228784012" STUDY_ID="STD-Lucas-2000" TOTAL_1="81" TOTAL_2="84" VAR="0.24241622574955907" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.10.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 13:12:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.10.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 13:12:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-010.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 18:06:18 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="18.35" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>De novo detrusor urgency or urge symptoms or detrusor overactivity</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-010.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:04:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="14.967903686047283" CI_START="0.6466511642977468" EFFECT_SIZE="3.111111111111111" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1751609799467388" LOG_CI_START="-0.18932993614095023" LOG_EFFECT_SIZE="0.49291552190289434" MODIFIED="2010-07-16 12:04:47 +0100" MODIFIED_BY="[Empty name]" ORDER="213" O_E="0.0" SE="0.8015087184488757" STUDY_ID="STD-Lucas-2000" TOTAL_1="81" TOTAL_2="84" VAR="0.6424162257495591" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:02:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.11.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:03:32 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="19" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-010.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-08-06 18:06:18 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.31" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>Voiding dysfunction</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="19" EVENTS_2="17" I2="0.0" ID="CMP-010.12.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:22:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="2.067580736274606" CI_START="0.6497337348014385" EFFECT_SIZE="1.159041394335512" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="17" LOG_CI_END="0.31546247717691994" LOG_CI_START="-0.18726458366134605" LOG_EFFECT_SIZE="0.06409894675778695" MODIFIED="2010-07-16 12:22:01 +0100" MODIFIED_BY="[Empty name]" ORDER="223" O_E="0.0" SE="0.2953043640754832" STUDY_ID="STD-Lucas-2000" TOTAL_1="81" TOTAL_2="84" VAR="0.08720466744202554" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.12.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:19:51 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.12.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-16 12:20:00 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>mixed urinary incontinence</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.0341444251377285" CI_END="2.770048810412627" CI_START="0.4754535275722687" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1476190476190475" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="3.301707605606551" I2_Q="3.2682179938737574" ID="CMP-010.13" LOG_CI_END="0.4424874217381304" LOG_CI_START="-0.3228919260562321" LOG_EFFECT_SIZE="0.059797747840949086" METHOD="MH" MODIFIED="2010-12-03 17:32:44 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.3091875665477316" P_Q="0.30927132957934034" P_Z="0.7594088957376035" Q="1.033786392911347" RANDOM="NO" SCALE="12.15" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="56" TOTAL_2="49" WEIGHT="200.0" Z="0.30625710626400904">
<NAME>De novo detrusor overactivity (urodynamic diagnosis)</NAME>
<GROUP_LABEL_1>Traditional Sling</GROUP_LABEL_1>
<GROUP_LABEL_2>New Sling</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours traditional sling</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours new sling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.735442181409788" CI_START="0.5150608216529652" DF="0" EFFECT_SIZE="1.71875" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" I2="0.0" ID="CMP-010.13.01" LOG_CI_END="0.7585669060286397" LOG_CI_START="-0.288141483679964" LOG_EFFECT_SIZE="0.23521271117433787" MODIFIED="2010-07-21 12:11:33 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3783867139634115" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="33" WEIGHT="100.0" Z="0.880872738081455">
<NAME>urodynamic stress incontinence (only)</NAME>
<DICH_DATA CI_END="5.735442181409788" CI_START="0.5150608216529652" EFFECT_SIZE="1.71875" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.7585669060286397" LOG_CI_START="-0.288141483679964" LOG_EFFECT_SIZE="0.23521271117433787" MODIFIED="2010-07-21 12:11:33 +0100" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="0.6148416894049257" STUDY_ID="STD-Shin-2001" TOTAL_1="24" TOTAL_2="33" VAR="0.37803030303030305" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-010.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2010-07-21 12:09:38 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>stress urinary incontinence (symptoms only)</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.627219951350568" CI_START="0.16916910371968288" DF="0" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-010.13.03" LOG_CI_END="0.41949643352421184" LOG_CI_START="-0.7716789516355743" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2010-07-21 12:12:03 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.5622637894093061" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="16" WEIGHT="100.0" Z="0.5794822996533819">
<NAME>mixed urinary incontinence</NAME>
<DICH_DATA CI_END="2.6272199513505674" CI_START="0.1691691037196829" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.4194964335242118" LOG_CI_START="-0.7716789516355742" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2010-07-21 12:12:03 +0100" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.699702317656111" STUDY_ID="STD-Barbalias-1997" TOTAL_1="32" TOTAL_2="16" VAR="0.48958333333333326" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION/>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAAC1CAMAAAC6VA/0AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION/>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAQQAAAQmCAIAAABZNlbHAAAuoElEQVR42u3dv24cyfX2cQIGfnDA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2017-07-21 11:18:54 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-11-24 09:57:17 +0000" MODIFIED_BY="[Empty name]">Details of extra literature searching performed for older versions of this review</TITLE>
<APPENDIX_BODY MODIFIED="2017-07-21 11:15:18 +0100" MODIFIED_BY="[Empty name]">
<P>For previous versions of this review (which covered all sling types) one of the review authors (Carlos Bezerra) performed extra, specific searches. These are detailed below.</P>
<P>Systematic searches of electronic bibliographic databases:<BR/>
</P>
<UL>
<LI>PubMed - years searched: January 1966 to January 2000, date searched: 30 January 2000;</LI>
<LI>UK National Research Register - Issue 1, 2001, date searched: May 2001.</LI>
</UL>
<P>Search term used: TVT</P>
<P>Handsearching of conference proceedings: Brazilian Congress of Urology Annual Meeting: 1991 to 2003 inclusive</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2017-07-21 11:18:54 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2017-07-21 11:18:54 +0100" MODIFIED_BY="[Empty name]">Search strategies for brief economic commentary</TITLE>
<APPENDIX_BODY MODIFIED="2017-07-21 11:15:19 +0100" MODIFIED_BY="[Empty name]">
<P>On 6 April 2017 we performed additional searches for the brief economic commentary. These were conducted in NHS EED (1st Quarter 2016), MEDLINE (1 January 1946 to March 2017), and Embase (1 January 1980 to 2017 Week 12). We used one search strategy on NHS EED (OVID) and two different search strategies on MEDLINE and Embase (OvidSP). Details of the searches run and the search terms used can be found below. We did not apply any year, publication type or language restrictions to the searches.</P>
<SUBSECTION>
<HEADING LEVEL="4">
<I>NHS EED (Ovid) (1st Quarter 2016)</I>
</HEADING>
<P>NHS EED was searched using the following search strategy:</P>
<P>1. Urinary incontinence/</P>
<P>2. Urinary incontinence, stress/</P>
<P>3. ((stress$ or mix$ or urg$ or urin$) adj3 incontinen$).tw.</P>
<P>4. Colporrhaphy.tw.</P>
<P>Single-incision sling operations for urinary incontinence in women</P>
<P>63 / 85</P>
<P>5. Colpoperineoplast$.tw.</P>
<P>6. Sling procedure$.tw.</P>
<P>7. Sling$ procedure$.tw.</P>
<P>8. Bladder neck needle suspension$.tw.</P>
<P>9. Anterior vaginal repair$ .tw.</P>
<P>10. Or/1-9</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">
<I>MEDLINE (1 January 1946 to March 2017) and Embase (1 January 1980 to 2017 Week 12)</I>
</HEADING>
<P>We used two different search strategies on MEDLINE and EMBASE (OvidSP) - these are given below.</P>
<SUBSECTION>
<HEADING LEVEL="5">Search strategy 1:</HEADING>
<P>1. Economics, Pharmaceutical/ or Economics, Medical/ or Economics/ or Economics, Hospital/ or economics.mp. or</P>
<P>Economics, Nursing/</P>
<P>2. exp "costs and cost analysis"/</P>
<P>3. "Value of Life"/</P>
<P>4. exp "fees and charges"/</P>
<P>5. exp budgets/</P>
<P>6. budget*.ti,ab.</P>
<P>7. cost*.ti.</P>
<P>8. (economic* or pharmaco?economic*).ti.</P>
<P>9. (price* or pricing*).ti,ab.</P>
<P>10. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.</P>
<P>11. (financ* or fee or fees).ti,ab.</P>
<P>12. (value adj2 (money or monetary)).ti,ab.</P>
<P>13. ((energy or oxygen) adj cost).ti,ab.</P>
<P>14. (metabolic adj cost).ti,ab.</P>
<P>15. ((energy or oxygen) adj expenditure).ti,ab.</P>
<P>16. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15</P>
<P>17. exp Urinary Incontinence/</P>
<P>18. ((stress* or mix* or urg* or urin*) adj3 incontinen*).tw.</P>
<P>19. Urodynamics/ or Urinary Incontinence, Stress/ or Urinary Incontinence/ or Suburethral Slings/ or mixed incontinence.mp. or Urinary Bladder/ or Urinary Incontinence, Urge/</P>
<P>20. 17 or 18 or 19</P>
<P>21. anterior vaginal repair*.tw.</P>
<P>22. 16 and 20 and 21</P>
<P>23. anterior colporrhaphy*.tw.</P>
<P>24. 21 or 23</P>
<P>25. 16 and 20 and 23</P>
<P>26. bladder neck needle suspension$.tw.</P>
<P>27. 16 and 20</P>
<P>28. 26 and 27</P>
<P>29. open abdominal retropubic colposuspension*.tw.</P>
<P>30. retropubic colposuspension*.tw.</P>
<P>31. burch colposuspension*.tw.</P>
<P>32. 29 or 30 or 31</P>
<P>33. 27 and 32</P>
<P>34. laparoscopic retropubic colposuspension*.tw.</P>
<P>35. laparoscopic colposuspension*.tw.</P>
<P>36. 34 or 35</P>
<P>37. 27 and 36</P>
<P>38. traditional suburethral retropubic sling procedure$*.tw.</P>
<P>39. traditional sling procedure$*.tw.</P>
<P>40. suburethral retropubic sling procedure$*.tw.</P>
<P>41. retropubic sling procedure$*.tw.</P>
<P>42. traditional suburethral sling*.tw.</P>
<P>43. Suburethral Slings/ or Urinary Incontinence, Stress/ or Urologic Surgical Procedures/</P>
<P>44. 27 and 43</P>
<P>45. remove duplicates from 44</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Search strategy 2:</HEADING>
<P>1. economics.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]</P>
<P>2. value of life.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]</P>
<P>3. exp "costs and cost analysis"/</P>
<P>4. exp economics, hospital/</P>
<P>5. exp economics, medical/</P>
<P>6. economics, nursing.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]</P>
<P>7. economics, pharmaceutical.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]</P>
<P>8. exp "fees and charges"/</P>
<P>9. exp budgets/</P>
<P>10. budget*.ti,ab.</P>
<P>11. cost*.ti.</P>
<P>12. (economic* or pharmaco?economic*).ti.</P>
<P>13. (price* or pricing*).ti,ab.</P>
<P>14. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.</P>
<P>15. (financ* or fee or fees).ti,ab.</P>
<P>16. (value adj2 (money or monetary)).ti,ab.</P>
<P>17. or/1-16</P>
<P>18. economics.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]</P>
<P>19. value of life.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]</P>
<P>20. exp "costs and cost analysis"/</P>
<P>21. exp economics, hospital/</P>
<P>22. exp economics, medical/</P>
<P>23. economics, nursing.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs]</P>
<P>24. economics, pharmaceutical.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs</P>
<P>25. exp "fees and charges"/</P>
<P>26. exp budgets/</P>
<P>27. budget*.ti,ab.</P>
<P>28. cost*.ti.</P>
<P>29. (economic* or pharmaco?economic*).ti.</P>
<P>30. (price* or pricing*).ti,ab.</P>
<P>31. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab.</P>
<P>32. (financ* or fee or fees).ti,ab.</P>
<P>33. (value adj2 (money or monetary)).ti,ab.</P>
<P>34. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33</P>
<P>Single-incision sling operations for urinary incontinence in women</P>
<P>65 / 85</P>
<P>35. ((energy or oxygen) adj cost).ti,ab.</P>
<P>36. (metabolic adj cost).ti,ab.</P>
<P>37. ((energy or oxygen) adj expenditure).ti,ab.</P>
<P>38. 34 or 35 or 36 or 37</P>
<P>39. urinary incontinence.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>40. ((stress$ or mix$ or urg$ or urin$) adj3 incontinen$).tw.</P>
<P>41. URINARY INCONTINENCE, STRESS.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>42. stress urinary incontinence*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>43. 39 or 40 or 41 or 42</P>
<P>44. intervention surgery*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>45. colporrhaphy.tw.</P>
<P>46. Bologna procedure*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>47. Kelly-Kennedy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>48. Marion Kelly.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>49. Diaphragmplasty.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>50. Vaginal urethrocystopexy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>51. Cystocele repair.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>52. Kelly plication.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>53. anterior vaginal repair$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>54. anterior colporrhaphy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>55. 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54</P>
<P>56. 38 and 43 and 55</P>
<P>57. remove duplicates from 56</P>
<P>58. Bladder neck needle suspension$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>59. 38 and 43 and 58</P>
<P>60. burch colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>61. open abdominal retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw,</P>
<P>fs]</P>
<P>62. Paravaginal defect repair.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>63. Marshall-Marchetti-Krantz.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>64. abdominal burch.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>65. abdominal colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>66. endopelvic Fascia Plication.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>67. 60 or 61 or 62 or 63 or 64 or 65 or 66</P>
<P>68. 38 and 43</P>
<P>69. 67 and 68</P>
<P>70. laparoscopic retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>71. laparoscopic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>72. retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>73. 70 or 71 or 72</P>
<P>74. 68 and 73</P>
<P>75. remove duplicates from 74</P>
<P>76. suburethral sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>77. abdominal sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>78. traditional sling procedure$*.tw.</P>
<P>Single-incision sling operations for urinary incontinence in women</P>
<P>66 / 85</P>
<P>79. suburethral sling procedure.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>80. 76 or 77 or 78 or 79</P>
<P>81. 68 and 80</P>
<P>82. remove duplicates from 81</P>
<P>83. mid$urethral sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>84. retropubic sling procedure$*.tw.</P>
<P>85. transobturator sling procedure$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>86. 83 or 84 or 85</P>
<P>87. remove duplicates from 86</P>
<P>88. 68 and 87</P>
<P>89. TVT-Secur.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>90. mini-arc.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>91. ajust.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>92. needleless.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>93. solyx.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>94. single$incision sling$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>95. miniarc.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>96. mini$sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>97. Ophira.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>98. Tissue Fixation System.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>99. 89 or 90 or 91 or 92 or 93 or 94 or 95 or 96 or 97 or 98</P>
<P>100. 68 and 99</P>
<P>101. remove duplicates from 100</P>
<P>102. ((urethra$ or periurethra$ or transurethra$) adj3 (agent$ or bulk$ or injection$ or injectable$)).tw.</P>
<P>103. injection therapy.tw.</P>
<P>104. injectable$.tw.</P>
<P>105. (injectable$ adj2 agent$).tw.</P>
<P>106. (bulk$ adj3 agent$).tw.</P>
<P>107. Peri$urethral injection$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>108. Autologous fat.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>109. Macroplastique.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>110. Calcium hydroxylapatite.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>111. Hyaluronic acid with dextranomer.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>112. Porcine dermal implant.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>113. Ethylene vinyl alcohol copolymer.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>114. Silicon particles.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs]</P>
<P>115. 102 or 103 or 104 or 105 or 106 or 107 or 108 or 109 or 110 or 111 or 112 or 113 or 114</P>
<P>116. 68 and 115</P>
<P>117. remove duplicates from 116</P>
</SUBSECTION>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>